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„It is not difficult to make microbes resistant to penicillin in the laboratory by exposing them to 
concentrations not sufficient to kill them, and the same thing has occasionally happened in the body. 
The time may come when penicillin can be bought by anyone in the shops. Then there is the danger 
that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal 
quantities of the drug make them resistant.“ 
Alexander Fleming (1881-1955) 
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Summary 
Nicrophorus vespilloides is a native species of burying beetles, the reproduction of which depends on 
small vertebrate carcasses e.g. those of small rodents. Carrion is buried is buried in the soil in order to 
reduce competitition with other scavenger insects. However, this behaviour unevitably increases the 
exposition of the carrion to a broad range of soil-borne microorganisms. Therefore, beetles of the 
genus Nicrophorus have evolved an efficient strategy for carcass preservation, thus to preserving the 
carrion as food source for its larvae.  
It appears, however, that the phenomenon of carcass preservation by burying beetles is one of 
nature’s best kept secrets. A number of pioneering studies have shown that oral and anal secretions 
of N. vespilloides contain antimicrobial and preserving and repellent molecules. Notably, beetles of the 
genus Nicrophorus harbour a unique gut flora, which is applied onto the surface of the carcass in order 
to contribute to its preservation. 
This study focusses on the cultivation of bacterial isolates originating from the gut flora and the 
antimicrobial compounds produced by those microbes. Therefore, N. vespilloides caught in the wild as 
well as laboratory-hatched animals were investigated. Beetles were dissected, their gut was removed, 
and gut-associated microorganisms were cultivated. Pure cultures obtained by this procedure were 
identified by 16S rRNA gene analysis.  
To identify producers of antimicrobial activities, a classical screening for natural products was 
performed. Approximately 800 extracts were subsequently tested against a broad spectrum of 
taxonamically defined bacteria and fungi. In the course of this screening, a multitude of antimicrobial 
activities could be observed. 
Some isolates of the highly abundant genus Serratia displayed a broad spectrum of antimicrobial 
activity. A single isolate, which could be identified as Serratia marcescens, effectively inhibbite 
Staphylococcus aureus. This strain was selected for further detailed studies. The antibiotic activity was 
isolated and its structure elucidated by NMR spectroscopy. Finally, the antibiotic principle was 
identified as serrawettin W2. After purification, this cyclic pentadepsipeptide exhibited antimicrobial 
activity against further Gram-positive bacteria. Serrawettin W2, which has previously been reported 
as a nematode repellent, was shown to act as a nematostatic agent. The combination of these 
antimicribial and nematostatic bioactivities could be of importance for the ecology of burying beetles. 
After burying, the carcass is not only threatened by microorganisms but also by soil-borne nematodes. 
Consequently, a symbiosis of Nicrophorus sp. with a beneficial gut bacterium is hypothesised to 
positively contribute to to the preservation of the carcass, which is used for reproduction of the 
beetles.  
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Zusammenfassung 
Der Totengräber Nicrophorus vespilloides ist ein heimischer Käfer, der zur Reproduktion das Aas kleiner 
Wirbeltiere, v. a. Nager, benötigt. Das Vergraben des Kadavers dient der Vermeidung von Konkurrenz 
mit anderen necrophilen Arthropoden. Dieses Verhalten führt jedoch zwangsläufig zur Exposition des 
Kadavers gegenüber einer mannigfaltigen, bodenbürtigen Mikrobenflora. Daher sind Käfer der 
Gattung Nicrophorus auf eine hoch effiziente Konservierungsstrategie angewiesen, um den Kadaver 
vor unkontrollierter Verwesung zu schützen und ihren Larven als Nahrung zugänglich zu machen.  
Diese Konservierung ist ein bislang kaum verstandenes Phänomen in der Natur. Erste Untersuchungen 
zeigten jedoch, dass im Oral- und Analsekret von N. vespilloides antimikrobielle, konservierende und 
repellente Substanzen enthalten sind. Darüber hinaus verfügt er über eine ungewöhnliche Darmflora. 
Diese wird auf die Oberfläche des vorgefundenen Kadavers aufgebracht und trägt 
höchstwahrscheinlich zu dessen Konservierung bei.  
Ziel dieser Studie war die Kultivierung von bakteriellen Isolaten aus der Darmflora des Totengräbers 
N. vespilloides und deren Untersuchung auf die Bildung antimikrobieller Naturstoffe. Dazu wurden 
sowohl Wildfänge, als auch im Labor gezüchtete Exemplare untersucht. Die Tiere wurden seziert, der 
Verdauungstrakt entnommen und die darmassoziierten Mikroorganismen mit verschiedenen 
mikrobiologischen Methoden kultiviert. Die erhaltenen Darmisolate wurden auf Basis des 16S rRNA 
Gens identifiziert.  
Zur Auffindung von Antibiotikaproduzenten, erfolgte ein klassisches Naturstoff-Screening. Etwa 800 
der gewonnenen Extrakte wurden anschließend in Bioaktivitätstests gegen ein umfangreiches, aus 
taxonomisch definierten Bakterien- und Pilzkulturen bestehendes Spektrum von Testkeimen geprüft. 
Hierbei wurde eine große Vielfalt an antimikrobiell aktiven Extrakten vorgefunden.  
Einige Isolate der häufig isolierten Gattung Serratia zeigten breite antimikrobielle Aktivität gegen die 
Testorganismen. Ein Isolat, welches als Serratia marcescens identifiziert werden konnte, hemmte 
Staphylococcus aureus und wurde für eine vertiefende Bearbeitung, d.h. Isolierung und anschließende 
Strukturaufklärung des antibiotischen Prinzips mittels Kernresonanzspektroskopie (NMR), ausgewählt. 
Dieses konnte schließlich als Serrawettin W2 identifiziert werden. Das aufgereinigte zyklische 
Pentadepsipeptid zeigte antimikrobielle Wirkung gegen weitere gram-positive Testkeime. Für das in 
der Literatur als Repellent gegenüber Nematoden beschriebene Serrawettin W2 wurden außerdem 
nematostatische Eigenschaften nachgewiesen. Die Kombination dieser antimikrobiellen und 
nematostatischen Bioaktivitäten könnte von Bedeutung für die Ökologie des Totengräbers sein. Da der 
Kadaver durch das Vergraben nicht nur Mikroorganismen ausgesetzt ist, sondern auch Nematoden, 
könnte die Symbiose mit einem solchen Darmbakterium maßgeblich für den Erfolg der Konservierung 
des als Brutstätte genutzten Kadavers sein.  
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Introduction 
  
2.1 Insects - a treasure chest of nature 
Insects are the most diverse group of organisms in the animal kingdom. More than 70% of all validly 
described, recent animal species known so far are members of the class of insects (Figure 1) 
(Chapman, 2009). However, recent estimates account for up to 5-6 million insect species, 
approximately 20% of which have scientifically been described and classified to date 
(Groombridge, 2002). In the course of evolution, insects have colonised almost every possible habitat, 
including even those that appear as hostile to life at first sight such as arctic and desert environments. 
Their ability to adapt, even under harsh environmental conditions, made them the most successful 
group of animals on earth. Consequently, an impressive number of insect species have evolved highly 
sophisticated physiological, biochemical, and behavioural adaptations and strategies in order to utilise 
otherwise inaccessible ressources.  
 
 
Figure 1: Animal diversity on earth according to Chapman (2009). 
The figure shows the biodiversity on earth, indicating the abundance of insects, the most successful but yet a relatively less 
explored group of the animal kingdom. 
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The Antarctic midge Beldica antactica and the Sahara Desert ant Cataglyphis bicolor are often referred 
to as paradigms of insects from extreme habitats. B. antactica is the largest land-living animal 
permanently residing in Antarctica, and is able to withstand the extreme cold (Lee et al., 2006). In 
contrast, C. bicolor is well-adapted to the extreme heat of the Sahara and survives temperatures 
constantly ranging above 50 °C in the daytime, which are lethal to most of the other animal species 
(Sherwood, 1996).  
Beside extreme habitats, unusual food sources are also utilised by insects. Keratin, the main protein of 
wool and feathers, for example, is an extremely stable material, which can only be digested by a rather 
limited number of insects and bacteria. The clothes moth Tineola bisselliella is able to feed on clothes 
or feathers, thus using keratin as a nutrient source (Day, 1951). Other insects, e. g. the larvae of the 
black soldier fly Hermetia illucens, even utilises oily food, manure and other organic matters that are 
hardly biodegradable. Thus, this insect may be developed into a perfect solution for the rising global 
waste problem. Notably, several applications in bioconversion have already been reported (Sheppard 
et al., 2002). Another example for an outstanding insect life style is the burying beetle Nicrophorus 
vespilloides, which depends on vertebrate carcasses for reproduction (Pukowski, 1933).  
 
2.2 The burying beetle Nicrophorus vespilloides 
N. vespilloides is a widespread species of burying beetles across Northern America and Europe. It can 
regularly be found all over Germany. This beetle is 12-18 mm in size and belongs to the family of 
Silphidae. At present, the genus Nicrophorus includes 68 species with unique strategies for 
reproduction and parental care (Sikes et al., 2008).  
 
 
Figure 2: N. vespilloides with its black and orange elytra. 
The picture was taken at the Hoherodskopf (Vogelsberg)/Germany. 
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Adult N. vespilloides hunt for dipteran larvae but cadavers of small vertebrates, preferably rodents, are 
necessarily required for reproduction. The beetle perceives the odour of carrion over long distances 
and locates the carcass where mating takes place after a couple of burying beetles has successfully 
conquered and defended the carrion against competing arthropod scavengers (Pukowski, 1933). To 
effectively protect the carrion against competitors and scavengers, N. vespilloides is burying the 
carcass. This, on the other hand, leads to different problems. Burying a rich nutrient source such as a 
dead animal in the ground exposes it to a very high microbial load of soil- borne bacteria, fungi and 
nematodes. This scenario normally accelerates the decay of the carcass (Vogel et al., 2017). In order 
to preserve the carrion, the beetle uses its own oral and anal secretions that are applied to the surface 
after the hairs or feathers of the animal have been removed (Hall et al., 2011). This process is thought 
to promote the spread of secretions on the shaved carcass surface.  
 
 
Figure 3: Simplified life cycle of Nicrophorus vespilloides.  
The burying beetle’s life cycle is initiated by the detection of a carcass, which triggers the mating of the couple. Mating takes 
place on the carcass, which then will be shaved. After applying oral and anal secretion on the surface, the carrion it is buried 
in the ground. Eggs are laid in the close proximity of the brood ball, and the freshly hatched larvae are guided to the processed 
brood ball. Once inside, the larvae are initially fed by the adults – a phenomenon that is referred to biparental care. In 
addition, both parents contribute to the continuous preservation of crypt and brood ball. Finally, 3rd instar larvae laeve the 
brood ball, and after a migratory phase they return to the soil in order to pupate. Drawing kindly provided by Dr. Henrike 
Schmidtberg.  
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After preservation, the carcass is buried in the ground. This highly sophisticated process turns the 
carrion into a round brood ball (Pukowski, 1933; Milne and Milne, 1976). The brood ball is then stored 
in the so-called crypt and eggs are laid in the close proximity (Pukowski, 1933). After hatching, the 
larvae are guided into the brood ball and feed from the pre-digested food inside whilst the parents 
take care of the larvae as well as carcass preservation and defence. Up to now, little is known about 
the preservation process on a molecular level. Studies unveiled the increase of lytic activity in the 
secretions during the presence of a carcass (Cotter and Kilner, 2010) and the upregulated expression 
of antimicrobial peptides (AMPs) (Jacobs et al., 2016). 
 
2.2.1 Anatomy of the burying beetle 
Most of the body of the burying beetle N. vespilloides is coloured in black but the elytra carry four 
squares that are lively coloured in orange. The small head is covered by an extremely hard cuticle and 
is equipped with strong mandibles and two highly evolved club-like antennae. The sensilia of these 
antennae are specialised to detect sulphuric volatiles in low quantity. This helps the beetle to locate 
carrion by its odour (Kalinova et al., 2009). Behind the head, the pronotum represents a solid chitin 
shield, which forms a strong functional unit with the head.  
 
 
Figure 4: Anatomy of the burying beetle and its gut. 
A: N. vespilloides and its characteristic appearance 
B: Scheme of the gut compartments and the salivary glands. For graphical reasons, the hindgut has been shortened but it is 
the longest part of all gut segments. 
 
The most remarkable internal organ of the beetle is its gut, which can be subdivided into four 
compartments. The oral opening represents the first part of the foregut. The latter opens to form a 
voluminous part, the midgut, which is of mesodermal origin. It ends up in a bottleneck-shaped 
narrower part. The thick part of the midgut is covered by caeca (Vogel et al., 2017) and joins into the 
hindgut, which is formed by ectodermal tissue. The coiled hindgut is a thin and flat compartment, being 
the longest of all gut segments. Anatomically, it is located on top of the midgut. The long hindgut 
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terminates in the rectum close to the anal abdominal part, often referred to as the anal bladder. Most 
of the microbial gut flora is harboured in the area between the midgut and the rectum. 
 
2.3 Microbiome studies  
The question behind the mechanisms of carcass preservation by burying beetles has been addressed 
by different authors. Recently, the upregulation and secretion of immune-related AMPs by the beetles 
was taken into account (Jacobs et al., 2016). However, the hitherto neglected contribution of the highly 
specialised microbial gut community of N. vespilloides to the biosynthesis of simple disinfecting, 
carcass-preserving metabolites was also suggested (Degenkolb et al., 2011; Shukla et al., 2018).  
The first cultivation-independent studies of male and female N. vespilloides beetles using 
pyrosequencing uncovered the microbial community (Kaltenpoth and Steiger, 2014). The microbiomes 
of both male and female hindgut did not differ much and were dominated by the phyla of 
Gammaproteobacteria, and Firmicutes. Alpha- and, Betaproteobacteria as well as Bacteriodetes and 
Actinobacteria were less dominant (Vogel et al., 2017). Enterobacteriaceae, Xanthomonadaceae as 
well as Enterococcaceae and the phylum Firmicutes were identified as the most abundant bacterial 
taxa. A remarkable feature of N. vespilloides is the presence of the yeast genus Yarrowia in the rectum. 
The Yarrowia species found seem to be unique for this species of burying beetle; however, their role 
still remains hypothetical. Recent, ongoing investigations have indicated a possible contribution of 
Yarrowia sp. to the metabolic decomposition of the two malodorous, putrefaction-associated diamines 
cadavarine (1,5-pentanediamine) and putrescine (1,4-diaminobutane) (Brinkrolf et al., in preparation).  
Insects often host a unique community of microbes, which play a key role for digestion and metabolism 
of the harbouring organism (Rajagopal, 2009). Hence, this facilitates insects to utilise diverse nutrient 
sources. This connection has also been appreciated by the applied biotechnology, which therefore 
focuses on mining of insect gut microbiomes as sources for new species of microorganisms, enzymes, 
proteins, and secondary metabolites (Krishnan et al., 2014; Piel et al., 2004). The primary focus is laied 
on cellulose and xylan hydrolysis for biofuels (Warnecke et al., 2007) or vitamin production (Akman et 
al., 2002). Furthermore, the challenge of antibiotic resistance has been addressed and novel antibiotic 
compounds have been identified, for example, a β-lactam from the midgut microbes of the gypsy moth 
Lymantria dispar (Allen et al., 2009). 
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2.4 Natural product research 
The application of medical plants is very common among all cultures and indigenous tribes. The 
knowledge about such “natural pharmacies“ is often age-old (Wohlleben et al., 2016); nevertheless is 
still used to formulate remedies that have not only been praised in folk medicine, but also serve as 
modern pharmaceuticals. Nowadays the most notable difficulty is, amongst others, the discovery of 
bioactive substances with novel modes of action to meet the demands of modern medical applications. 
For more than 200 years, plants and microorganisms have been used as a prolific source of purified, 
pharmaceutically active secondary metabolites, which were then used as drugs (Li and Vederas, 2009). 
These secondary metabolites are still of high value for modern drug discovery and the pharmaceutical 
industry. 
Secondary metabolites are organic molecules synthesised by most, if not all living organisms such as 
microbes, algae, corals, sponges, plants and lower animals (Maplestone et al., 1992). They are not 
involved in the primary development of the organism itself. In contrast to primary metabolites, which 
are crucial for the development of the species, secondary metabolites support, for example, the 
survival of their producers by acting as an immune defensive (Agostini-Costa et al., 2012). Therefore, 
secondary metabolites are of interest to pharmaceutical research and can still be considered as a 
prolific source of new drugs.  
 
2.4.1 Antibiotic drug discovery - the past 
About 200 years ago, Friedrich Sertürner marked the beginning of modern drug discovery by isolating 
morphine as a pain killer from the seed pods of immature poppy (Papaver somniferum). Morphine is 
the main alkaloid of crude opium, which has been known and applied as a pain killer for millennia 
(Hamilton and Baskett, 2000).  
Until 1928, drugs were mainly derived from higher plants. In autumn of 1928, Alexander Fleming 
accidently discovered the antibiotic effects of a substance, later called penicillin, which has produced 
by the mould Penicillium rubens (Houbraken et al., 2011) growing on a blood-agar plate with 
staphylococci (Fleming, 1929). By the time of World War II, penicillin became the first industrially 
produced antimicrobial drug on the Allied side, which satisfied the urgent need for a potent anti-
infective. 
After World War II, the pharmaceutical research initiated the massive screening of soil microorganisms 
due to Fleming´s pioneering discovery. Those screening campaigns required the acquisition of bacteria, 
which were mostly screened for the inhibition of human pathogens (bioactivity-guided drug discovery). 
Companies like Eli Lilly, Novartis or Höchst asked their employees to collect soil samples on their trips 
around the world to find new antibiotic-producing bacteria, actinomycetes, or fungi. This global 
sampling led to the discovery of numerous valuable antibiotics from soil-borne bacteria, mainly 
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Streptomyces sp. (Katz and Baltz, 2016). These days, such sampling approaches are prevented by the 
Nagoya protocol for the protection of genetic resources of a country (Soares, 2011).  
In the early decades of drug discovery, bioactivity-guided-screenings and flask fermentations were the 
limiting factors resulting in a screening capacity of 35.000 strains per year at Eli Lilly’s reported by 
Richard H. Baltz. Due to high success rates in Streptomyces, screening was mainly focused was on 
filamentous Actinobacteria. 
Progress in screening techniques and physico-chemical structure elucidation led to a higher 
throughput. Moreover, the exploitation of novel sources for natural products, for example marine 
bacteria and algae, promoted the discovery of new drugs. During the past two decades, the upcoming 
availability of DNA cloning and sequencing, has remarkably accelerated modern approaches in natural 
products discovery of the 21st century. 
By the end of the so-called ‘Golden Age’ of antibiotic drug discovery in the 1970s, “low hanging fruits 
were harvested” and it became more and more difficult to make new discoveries (Baltz, 2007). This is 
also represented in the timeline of antibiotic discoveries (see Fig. 5), which clearly indicates a gap from 
1987 until present (Lewis, 2012).  
 
 
Figure 5: Discovery timeline of antibiotic classes. 
This timeline illustrates the discovery of the most important classes of antibiotics during the last 90 years. The time from 1928 
until the end of the 1970s is commonly referred to as the “Golden age of antibiotic drug discovery” because of the abundant 
findings made in these decades. With the last new class, the lipopeptides, being discovered in 1987, we are now facing a 
three decades void of newly approved antibiotic classes. 
 
To overcome this lack, combinatorial chemistry was propagaed in the 1990s, which aimed at screening 
of large chemical libraries containing synthetic substances by high-throughput approaches. The 
principle of combinatorial chemistry is the generation of chemically synthesised molecules in large 
varieties and the screening of those molecule libraries for antimicrobial compounds (Navre, 1998). 
Despite the fact that the concept was extensively promoted, the scientific outcome and the value for 
the pharmaceutical industry were close to nothing. This was mainly because these artificially 
generated compounds were devoid of the chemical diversity that is known from natural products 
(Feher and Schmidt, 2003). This failure led to the conclusion that mimicking the characteristic features 
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of naturally occurring antibiotic compounds is a decisive step to introduce target-oriented chemical 
modifications (Newman and Cragg, 2007).  
As soon as genetic tools became more and more inexpensive in the late 1990s and early 2000s, 
techniques such as whole genome sequencing led to the rapid discovery of a lot more of secondary 
metabolite gene clusters in Streptomyces genomes (Bentley et al., 2002; Baltz, 2014) than previously 
expected. Notably, only a limited number of all biosynthetic gene clusters (BGC) are expressed under 
standard laboratory conditions. This insight broadened the options for triggering and manipulating of 
silent BGCs (Bode et al., 2002) and led to the modern approaches of antibiotic drug discovery. 
 
2.4.2 Antibiotic drug discovery - the present  
Approximately only 1% of all bacteria on earth can be cultivated and stored under laboratory 
conditions. Consequently, the discovery of new bacterial taxa is a challenging and demanding, but 
necessary, inevitable task (Pham and Kim, 2012). Nevertheless, the availability of genomes marked the 
decisive change in drug discovery techniques (Katz and Baltz, 2016). 
Due to the common availability and the decreasing expense of genetic techniques, the focus in drug 
discovery shifted towards genomics-based approaches. Streptomyces spp., for example, have been 
screened for antibiotic secondary metabolites from the beginning of natural products research. 
Nevertheless, a large set of BGCs were additionally discovered by genome analyses. Therefore, 
genome mining is currently regarded as the key technology of the modern antibiotic drug discovery 
(Zerikly and Challis, 2009). More and more BGCs, such as the well-known polyketide synthases (PKS) 
and non-ribosomal peptide synthetase (NRPS) clusters, are unraveled, thus opening up the field for 
genetic work such as cluster cloning and overexpression of these constructs (Cimermancic et al., 2014). 
Different attempts of direct cluster activation are currently considered techniques. Usually, chemicals 
or stress during fermentation, are applied but also genetic strategies such as overexpression of 
regulators, gene cluster duplication or synthetic biology (Baltz, 2016; Piel, 2011). Still, these techniques 
do not seem very potent for industrial large-scale drug discovery approaches. 
Until the year 2002, more than 22,000 bioactive secondary metabolites have been published with 90% 
of all compounds originating from microorganisms. Roughly 55% of these are derived from fungi, ~ 
20% from the bacterial genus Streptomyces, ~ 10% from rare Actinobacteria, and ~ 15% from other 
bacteria (Berdy, 2005). 
Nevertheless, recent studies corroborated the decisive importance of classical microbiology besides 
all modern, genome-based techniques. Recently, R. Müller and colleagues published on the correlation 
of the taxonomic distance between members of the well-studied group of Myxobacteria and the 
chemical diversity. It was concluded that a larger genetic distance between secondary metabolite-
producing strains increases the probability of finding novel chemical structures (Hoffmann et al., 2018). 
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By leaving the classically explored taxa aside, the focus is to be redirected to the cultivation of hitherto 
neglected bacteria (Lewis et al., 2010). Consequently, symbiotic microorganisms appear as a yet 
underexplored but highly promising, source of new secondary metabolites (Piel, 2004).  
 
2.4.3 Antibiotic resistance 
Antibiotic resistances are on the rise (Bush et al., 2011; Schäberle and Hack, 2014). According to recent 
reports of the World Health Organisation (WHO), antibiotic resistance is one of the biggest threats to 
global health. Therefore, people become increasingly aware of the problems approaching due to the 
misuse of therapeutic antibiotics in human medicine, animal farming, and agriculture (Witte, 1998; 
McManus et al., 2002). 
However, it should be kept in mind that antibiotic resistance is a naturally occurring phenomenon in 
bacterial communities (American-Academy-of-Microbiology, 2009; Cavanagh et al., 2016). Some 
bacteria are using secondary metabolites such as antibiotics to outcompete others and resistances 
may help to win this arms race (Waksman and Woodruff, 1940). Antibiotics used in medication make 
their way into the environment, which significantly contributes to the uncontrolled spread of 
resistances all over the world (Allen et al., 2010). When human pathogens become resistant not only 
to standard antibiotics but also to antibiotics of last resort, we are running out of options. According 
to the WHO, this alarming process is already progressing. Multiply resistant bacteria are on the rise, 
which results in increasing numbers of severe infections, especially in hospitalenvironments.  
For example carbapenem, a β-lactam drug of last resort, which had been the weapon of choice against 
multidrug resistant (MDR) bacterial infections for a long time, is becoming increasingly ineffective due 
to spread of resistance (Potter et al., 2016).  
All of these facts underline the importance of antibiotic drug discovery and the urgent need of a 
scientific renaissance of this research field. By the end of the 1990s, most of the large pharmaceutical 
companies suspended their research for new antibiotics, because of the immense costs and 
comparatively low revenue expected (Lewis, 2012). Therefore, it is high time to resolve this problem 
by private-public partnerships, as in the case of neglected tropical diseases. Alliances of academia, big 
pharmaceutical companies are necessarily required to promote the antibiotic drug discovery 
(Schäberle and Hack, 2014). The recently established Fraunhofer-Sanofi (Evotec) partnership in Gießen 
is a paradigm of a joint antibiotic drug discovery approach for the future. 
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The aim of the project 
The burying beetle Nicrophorus vespilloides may serve as an intriguing, hitherto unexplored source to 
study food conservation and the production of antimicrobials associated with it. Furthermore, it is a 
potential model organism for knowledge-based research in the field of anti-invective natural products. 
The preservation of carrion requires a highly specialised chemical ecology. Such an extraordinary 
lifestyle can be of immense value for target-oriented screening of pharmaceutically active secondary 
metabolites. Therefore, it is of decisive importance to study the gut microbiota of the beetle and to 
investigate a possible role of the microbiome for carcass preservation.  
 
Aim 1: isolation, cultivation and identification of the gut microbes 
A fundamental part of the project is the cultivation of microbes from the beetles’ gut. The dissection 
of the beetle leads to the accessibility of the gut. Microbiological techniques have to be applied to 
cultivate as many gut microbiota as possible. In order to find suitable conditions for microbial growth, 
different media and cultivation conditions have to be tested. The identification of the microbes will be 
achieved by 16S gene amplification and Sanger sequencing. The establishment of a strain collection of 
gut microorganisms is crucial for further work.  
 
Aim 2: fermentation, chemical extraction and antimicrobial screening 
The obtained microbial isolates have to be de-replicated bioinformatically by 16S gene sequences. 
Selected isolates will then be cultivated. Liquid cultures on rotary shakers will be performed to 
maximise the chance of BGC induction by nutrient limitation. Chemical extraction and bioactivity 
testing will be performed according to special operation procedures of the Fraunhofer-Sanofi 
cooperation to include the obtained material in the daily testing routine. The antimicrobial screening 
will be performed in the high throughput setup of the Sanofi facility. In parallel, the test procedures 
will also be established for in-house use. 
 
Aim 3: Analytic and isolation of interesting candidates 
The positive tested extracts from the primary antimicrobial screening have to be analysed by high-
performance liquid chromatography (HPLC) and mass spectrometry. Therefore, crude extracts will be 
separated by fractionation, and bioactivity tests will be repeated to finally identify the active fractions. 
For identification and dereplication of the screened natural products, mass spectrometry will be used 
in combination with the natural products database AntiBase. If a hit remains unknown, the compound 
will be isolated and its structure will be analysed by nuclear magnetic resonance spectroscopy (NMR). 
This will also require a scale-up of the fermentation process and the chemical isolation. 
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13 
 
Methods 
  
4.1 Insects 
Nicrophorus vespilloides beetles were either caught in the wild during the warm period in Giessen 
(Germany) or bred in captivity by H. Vogel (Max-Plank Society, Jena, Germany). The wild beetles can 
be found from May to the middle of September. The temperature is therefore the limiting factor, 
nights with temperatures below 10°C and days with hot weather (> 27°C) were considered as 
unsuitable for catching. 
The wild beetles were caught by placing a dead mouse (Mus musculus) on the soil surface in a modified 
container with a lid featuring a hole of ~3 cm in diameter. The container was then buried with the lid 
at ground level and checked daily. The volatiles of the decaying carcass allured the beetles from 
distance, which then crawled into the container where they were trapped. Furthermore, N. vespilloides 
was tried to be hatched in captivity. For this, a so called Faunarium (Exo Terra/HAGEN Deutschland 
GmbH & Co, Holm, Germany) was filled with soil from the habitat and humidified by spraying. The 
beetles were provided with a dead mouse to induce the mating. Successful breeding was investigated 
but humidity issues prevented the transformation from pupae to adults. The rearing therefore was 
stopped after several trials. 
 
4.2 Dissection and sample preparation 
Before dissection, the beetles were cooled in the fridge to reduce movement and then washed 
sequentially in 1% bleach, water, 70% ethanol and again in water for 1 min each for surface 
sterilisation. Subsequently, the beetles then were dissected in phosphate buffered saline (PBS) and the 
gut was removed. An open reaction tube with PBS buffer was located next to the dissection and was 
used as a control for airborne contamination. Gut sections were crushed in 1x PBS buffer using a 1000 
µL pipette tip and each preparation was serially diluted and plated on brain heart infusion (BHI), 
trypticase soy as well as trypticase soy yeast extract (TSB), each supplemented with 1.5% agar. 
 
4.3 Cultivation 
The isolated bacteria were cultivated on brain heart infusion broth (BHI) agar, potato glucose agar (PGS) 
or tryptic soy broth (TSB) agar for 1–4 days. Beside complex media, 1.5% water-agar was also used for 
cultivation for up to 3 weeks. Antibiotic-resistant cultures were selected on media supplemented with 
50 µg/mL ampicillin and 25 µg/mL kanamycin. All cultures were primarily incubated at 28°C. In case of 
rapid growth, the temperature was reduced to 21°C (room temperature) and/or the nutrient yield was 
lowered by 50% for enhanced colony selection (e.g. for the genus Proteus). Colonies were visually 
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selected, picked and streaked out onto fresh agar until no contamination was detected by microscopy. 
Isolates were then kept in Roti®-Store cryo vials at –80°C for long-term storage. 
For fungal cultivation, yeast extract glucose chloramphenicol agar (YGC) was used. This agar is selective 
for fungi and eliminates bacterial growth by the use of chloramphenicol. Cultivation was performed in 
the same manner as described before. 
 
4.3.1 Media  
 
brain heart infusion (BHI) broth (Agar)  pig brain infusion 
pig heart infusion 
peptone 
glucose 
sodium chloride (NaCl) 
disodium phosphate 
pH-value   
(agar) 
7.5 g/L 
10 g/L 
10 g/L 
2 g/L 
5 g/L 
2.5 g/L 
7.4 ± 0.2 
(15 g/L) 
tryptic soy broth (TSB) casein peptone  
soy peptone  
d(+)-glucose 
sodium chloride (NaCl) 
K2HPO4  
pH-value 
(agar) 
17 g/L 
3 g/L 
2.5 g/L 
5 g/L 
2.5 g/L 
7.3 ± 0.2 
(15 g/L) 
yeast glucose chloramphenicol (YGC) 
Agar 
yeast extract 
glucose 
chloramphenicol 
pH-value  
(agar) 
5 g/L 
20 g/L 
0.2 g/L 
6.6 ± 0.2 
15 g/L 
potato glucose agar (PGS)  potato extract 
desxtrose 
pH-value 
(agar) 
4 g/L 
20 g/L 
5.6 ± 0.2 
15 g/L 
Mannitol Salt Agar lab-lemco’ powder  
peptone 
mannitol 
sodium chloride 
phenol red 
ph-value 
agar 
 
1.0 
10.0 
10.0 
75.0 
0.025 
7.5 ± 
0.2
  
15.0 
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4.4 Identification 
4.4.1 Bacterial colony PCR 
The bacterial isolates from the N. vespilloides gut were identified by 16S rRNA gene amplification and 
Sanger sequencing (Eurofins, Germany). Therefore, the commonly used 16S primer set 
27F (5ꞌ-AGA GTT TGA TCM TGG CTC AG-3ꞌ) and 1492R (5ꞌ-ACC TTG TTA CGA CTT-3ꞌ) were chosen (Lane, 
1991; Masschelein et al., 2013). Each amplification was based either on a standard colony PCR or was 
achieved by previously lysing the cells in 0.2% SDS (Packeiser et al., 2013) followed by a 10-fold dilution 
in PCR-clean water. For the standard colony PCR, cell material was picked using a pipette tip and mixed 
with 30 µL of double-distilled PCR-clean water before heating the cell suspension to 95°C for 5 min in 
a thermal block. Afterwards, 1-3 µL of the lysed cells were then used as the template. 
The PCR comprised 32 cycles of denaturation (95°C, 5 min), annealing (56°C, 30 s) and extension 
(72°C, 1 min) followed by a final elongation at 72°C, 1 min before storage at 4°C. The PCR products 
were separated by agarose gel electrophoresis using 1.5% agarose gel at 110 V for 40 min, and product 
bands were isolated using the Qiagen Gene Jet gel extraction kit.  
 
4.4.2 Eukaryotic colony PCR 
The ITS1 and NL4 primer set was used to amplify a 1200 basepairs (bp) fungal DNA fragment. This 
amplicon is covering a terminal part of the 18S small ribosomal subunit, the whole Internal Transcribed 
Spacer (ITS) 1 and 2 as well as the 5.8S region in between and the beginning of the 28S large ribosomal 
subunit (Figure 6). 
 
 
Figure 6: Binding site of the eukaryotic primer set. 
The ITS1 primer binds to the 18S small ribosomal subunit region, the NL4 primer binds reverse to the antisense strain in the 
region of the 28S large ribosomal subunit. Both reads cover a distance of 1200 bp including the ITS1, the 5.8S region and the 
ITS2. 
 
The colony PCR programme was initialised by denaturation for 10 min at 95°C, followed by annealing 
(55°C, 1 min) and elongation at 70°C for 2 min. It comprised 36 cycles end ended with a final elongation 
step of 5 min at a temperature of 70°C before storage at 4°C. Gel electrophoresis and gel extraction 
were performed as described above.   
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4.4.3 Genetic identification 
Sanger sequencing was performed by Eurofins, Germany. Therefore, the Mix2Seq Kit of Eurofins was 
used. The obtained sequences were checked for high quality and then used for BLASTn search 
implemented into CLC Main Workbench 7. In parallel the forward and reverse reads were aligned and 
also BLASTn checked via the internal pipeline of the bioinformatics group (AG Goesmann/University of 
Giessen) by Sebastian Jaenicke.  
For phylogenetic analysis, Mega 7 was used to build and display phylogenetic trees. After the alignment 
of 16S sequences from isolated bacteria with 16S type-strain references from the National Institute for 
Biotechnology Information (NCBI) with the CLC Main Workbench, a maximum-likelihood phylogenetic 
tree was generate with Mega 7. 
 
4.4.4 Genomic DNA extraction 
For whole genome PacBio sequencing of three selected bacterial isolates, genomic DNA (gDNA) 
isolation was performed using the Genomic tip 500/G and the Genomic DNA Buffer Kit from Qiagen. 
For the gDNA isolation, the strains were fermented in 100 mL media (media dependent on strain) 
within 300 mL Erlenmeyer flasks. The suspension was then centrifuged in two 50 mL reaction tubes at 
full speed for 3 min to sediment cells and the supernatant was discarded. Depending on the size of the 
pellet, either a single pellet or both pellets were used for gDNA isolation. The isolation was performed 
according to the Qiagen Genomic DNA Handbook. 
 
4.5 Genome analysis  
Whole genome sequencing was ordered at Macrogen Korea (Seoul, Korea). Genomic DNA was used to 
construct PacBio RS II SMRT libraries with an insert size of 20 kb. Whole genome sequencing was 
performed on a PacBio RS II instrument according to the supplier’s standard practice. Genome 
assemblies were prepared using the Hierarchical Genome Assembly Process Pipeline (HGAP.3) 
including a read correction, a Celera-based assembly, and assembly polishing with Quiver (Chin et al., 
2013). Circularization of bacterial genomes was achieved with Circlator (Hunt et al., 2015) using the 
PacBio sequencing reads. Prediction of plasmid sequences was achieved with PlasFlow 
(doi: 10.1093/nar/gkx1321). Phylogenetic classification of the genomes was calculated with 
REFERENCESEEKER (Oliver Schwengers, not yet published) in order to estimate the percentage of 
homologous sequence regions (conserved DNA) with the most closely related genome available from 
the public data bases and respective ANI (average nucleotide identity).  
Gene finding and functional annotation was carried out in two steps using (i) Prokka (Seemann, 2014) 
and (ii) a reannotation involving a best BLAST hit method versus Swiss-Prot and Trembl (UniProt-
Consortium, 2018) in order to improve the standard function annotation output from Prokka. 
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Subsequently, AntiSMASH was used for the prediction of secondary metabolite producing gene 
clusters (Blin et al., 2017).  
 
4.6 Fermentation and chemical extraction  
Preliminary to the fermentation process, pre-cultures of 30 mL within 100 mL Erlenmeyer flasks were 
incubated over night at 200 rpm and 28°C. One millilitre of the pre-culture was used for the inoculation 
of 100 mL media within 300 mL Erlenmeyer flasks with paper plugs. These flasks were then incubated 
for one, six and nine days and afterwards shell-frozen on liquid nitrogen in 1000 mL round bottom 
flasks. The shell-freezing provides a high surface ratio for increased freeze drying. After freeze drying, 
the resulted material was scraped of the flask wall and collected in 50 mL Greiner tubes. The lyophilised 
fermentation then was mixed with ~ 50 mL ethyl acetate (EtOAc) and ultrasonicated in an ultrasonic 
water bath for 15 min to open up the cells. Subsequently, the resulting EtOAc crude extract was filtered 
and collected in a fresh 50 mL tube. The folding filter with the remaining filtrate was then returned to 
the original Greiner tube and 50 mL of methanol (MeOH) was added. The ultrasonic treatment and 
filtering was repeated as described, resulting in crude MeOH extracts. These crude extracts were 
evaporated within a Speedvac. Here, the operation temperature was critical and should not exceed 
35°C to prevent damage to the samples by heat. Afterwards, the dry samples were resolved in 5 mL 
MeOH and transferred to glass vials. Another evaporation and resolving step within one mL MeOH 
resulted in a 100 fold concentrated crude extract, which was stored at 4°C.  
The described process was scaled up to obtain higher amounts of biological material for compound 
isolation. Therefore, culture volume was scaled up to 2000 mL each flask, incubated in 5000 mL 
Erlenmeyer flasks. Liquid-liquid extraction was performed with EtOAc for scaled up fermentation 
eperiments, but without a positive result.  
 
4.7 Bioassay (growth inhibition assay) 
4.7.1 Bioassay (Sanofi-FhG) 
The activity tests were set up against clinicaly relevant strains using 10, 1, 0.5 and 0.25 µL of each crude 
extract tested in duplicates in 96-well plates to ensure high throughput. For S. aureus, E. coli or C. 
albicans, 100 μL cation-adjusted Müller-Hinton broth was used, inoculated with ~ 5x105 cells/mL and 
incubated shaking (180 rpm) at 37°C for18 h. M. smegmatis was grown for 48 h at 37°C in BHI 
supplemented with 1% Tween 80. Afterwards, the cell suspension was diluted to ∼1×105 cells/mL in 
cation-adjusted Müller-Hinton broth. One hundred μL of the diluted suspension were dispensed on 
white 96-well flat bottom plates and incubated for 48 h at 37°C shaking at 180 rpm. Cell viability was 
determined by using the BacTiter-Glo assay (Promega, Germany) and a LUMIstar OPTIMA microplate 
luminometer (BMG Labtech, Germany) for the read-out (Dardic et al., 2017).  
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4.7.2 Bioassay (in-house) 
For in-house fraction testing, it was mandatory to establish a liquid testing method for fast 
identification of active fractions after HPLC fraction collection as well as Flash purification. 
Growth inhibition was measured against both positive and negative controls (gentamycin serial 
dilution/fluconazole) with E. coli D31 K12 and Staphylococcus aureus DSMZ 799 used as screening 
strains. Therefore, liquid cultures were grown to an optical density (OD600) of 1 and subsequently 
diluted 1:500 with medium. A volume of 100 µL was used as inoculum per well. Cultivation was 
performed for 18 to 24 h within the separated and evaporated crude extract fractions. The read-out 
was performed by measuring the OD600 using a plate reader. 
 
4.7.3 Nematode motility assay 
Caenorhabditis elegans was grown on nematode growth medium (NGM) covered with a lawn of E. coli 
OP20 for 4 days at 20 °C. The worms were washed off the Petri dish into a 15-ml Falcon tube using a 
glass Pasteur pipette and M9 buffer. The nematode suspension was then centrifuged at 440 g for 2 
min and the supernatant was removed. The pellet was washed again with M9 buffer and, after another 
round of centrifugation as above, the content of the tube was reduced to 3.5 ml. To eliminate the 
worms and synchronize the suspension, we added 1.5 ml of bleach mix (0.5 ml 5 M NaOH, 0.5 ml NaOCl 
and 0.5 ml water). The suspension was briefly mixed and shaken until the color of the solution changed 
from yellowish to clear (4–6 min). The tube was filled up to 15 ml with M9 buffer and centrifuged for 
another 4 min at 2760 g. The supernatant was quickly removed without touching the pellet until only 
0.1 ml remained, and 15 ml of M9 buffer was added. In order to completely remove the bleach mix, 
the tube was carefully inverted and the pellet was rinsed three times with M9 buffer before 
centrifugation at 2760 g to remove all liquid. Finally, we added 10 ml of M9 buffer and 10 µl of 
cholesterol (5 mg/ml in 99% ethanol). Nematodes hatched overnight while the culture was shaking at 
room temperature. The nematode-containing medium was centrifuged for 4 min at 1200 g to remove 
all liquid. After a final washing step with 15 ml M9 buffer, the freshly hatched nematodes were 
centrifuged and the concentration was adjusted to 10 L1 nematodes per 100 µl by diluting with NGM 
seeding medium. The latter was prepared by supplementing 10 ml NGM with 10 µl 5 mg/ml 
cholesterol, 10 µl 25 mg/ml carbenicillin and 50 µl of an E. coli OP50 overnight culture. 
The tests were carried out in triplicate in a 96-well plate with ivermectin (10 µg/ml in DMSO) as the 
positive control. Purified serrawettin W2 in DMSO was serially diluted from 256 to 2 µg/ml. DMSO was 
used as the negative control. Non-motile nematodes were counted under the microscope after 24 h. 
To test for nematicidal effects, the incubated suspension was diluted 1:10 in M9 buffer and seeded on 
NGM agar plates containing E. coli OP50. The Petri dishes were checked for vital nematodes after 4 
days of incubation at room temperature. 
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4.8 Chemical Analytics 
4.8.1 High-performance liquid chromatography (crude extract) 
The crude extracts were fractionated by high-performance liquid chromatography (HPLC) using a 
Dionex ICS 3000 instrument fitted with a Dionex Acclaim 120 C8 column. The separation was carried 
out using solvent A (water plus 1% formic acid) and B (acetonitrile plus 1% formic acid) at a flow rate 
of 250 µL/min. The initial solvent ratio was 80%/20% A/B held for 5 min, increasing to 100% B over 55 
min followed by a 15-min hold, finally the ratio was set to the initial condition for the duration of 1 
min. The column was re-equilibrated for 15 min. Fractions were collected during the first 75 min. The 
injection volume was 10 µL of filtered crude extract. Active fractions were analysed by mass 
spectroscopy and the putative antimicrobial agents were screened against AntiBase (Wiley) for 
identification.  
 
4.8.2 Large-scale purification by FLASH chromatography 
For compound isolation, large-scale fermentation with up to 10 litre fermentation volume was 
extracted. The methanol crude extract was then treated multiple times with acetonitrile to precipitate 
proteins and to reduce the obtained crude extract. The precipitated proteins were filtrated and 
resolved in water. Afterwards the aquatious protein extract was freeze dried and then resolved in 
methanol with a concentration of 50 mg/mL. Both obtained fractions (MeOH and aquatious with a 
concentration of 50 mg/mL) were again tested for activity to calculate the chemical polarity (lipophilic 
or hydrophilic). 
The active extract was subsequently blended with Celite in ratio of 1 gram dry crude extract to 1 gram 
Celite and dried in a vacuum evaporator. The Celite/sample blend was then used for the preparation 
of a pre-column. Separation was obtained by using a C18 reverse phase column (Puriflash C18-AQ 30 
µm F0120 (Interchim)) Water (eluent A)and acetonitrile (MeCN, eluent B) were used starting from 
A:80%/B: 20% for 8 min and then rising linear to 100% MeCN over 45 min. Full MeCN flow was 
maintained for another 10 min. The fraction collection was performed peak dependent with the 
detector collecting peaks appearing in 210 nm and 254 nm wavelength and the Evaporative Light 
Scattering Detector (ELSD).Collected reaction tubes were combined in logical order to reunite 
separated peak fractions and the solvents were evaporated. The remaining substances were then 
resolved in methanol with a concentration of 25 mg/mL and retested on antimicrobial activity by 
growth inhibition (3.7.2). 
 
4.8.3 Mass spectrometry 
The samples were analysed on a high-resolution quadrupole time-of-flight mass spectrometer (QqTOF-
ESI-HRMS) from Bruker Daltonics (Bremen, Germany) running with oTOF Control v3.4 and Compass 
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v1.7. The instrument was equipped with an orthogonal ESI source. Source parameters were adjusted 
as follows: capillary voltage 4.5 kV; end plate offset 500 V, nebulizer 1.6 bar, dry gas 8 L/min with a dry 
temperature of 200°C. Samples were screened in the positive-ion mode. The mass spectrometer was 
coupled to a Dionex UltiMate 3000 HPLC system running under Chromeleon Express (Dionex, 
Germany). Both instruments were controlled by HyStar v3.2 SR 4. For separation, an Acclaim 120, C8, 
3 μm, 120 Å, 2.1 × 150 mm column (Dionex) was used at a flow rate of 0.25 mL/min at 35°C. Eluent A 
consisted of 0.1% formic acid in distilled water, and eluent B was 0.1% formic acid in MeCN. Amounts 
of 10 μL of crude extract (50 mg/mL) solutions in MeOH were injected in the column. The following 
gradient was applied for separation: 5 min at 20% B, from 5 to 55 min a linear gradient from 20% B to 
100% B, from 55 to 70 min the column was held at 100% B, from 70 to 71 min the solvent was returned 
to 20% B, and from 71 to 85 min the column was equilibrated at 20% B.  
 
4.8.4 Nuclear magnetic resonance analysis (NMR) 
To investigate the structure of unknown chemical compounds, NMR analysis was used. Therefore, the 
pure substance serrawettin W2 was submitted to measure proton (1H), carbon (13C), correlation 
spectroscopy (COSY), heteronuclear single quantum coherence (HSQC), heteronuclear multiple bond 
correlation (HMBC) spectra on a Bruker AV400 spectrometer. Chemical shifts were referenced to the 
MeOH-d6 solvent residual peaks, δH= 3.310 ppm for 1H and δH=49.000 ppm for C13. 
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4.9 Strains 
The following clinically relevant strains were used to measure antimicrobial activity in a high-
throughput set up at our Sanofi-Fraunhofer cooperation group: 
 
Table 1: Organisms used for bioactivity tests 
Organism Strain Number 
Candida albicans in-house strain of Sanofi Frankfurt 
Escherichia coli ATCC25922 
Mycobacterium smegmatis ATCC607 
Escherichia coli D31 K12 
Pseudomonas aeruginosa ATCC27853 
Staphylococcus aureus ATCC25923 
Staphylococcus aureus DSM 799 
Saccaromyces cerevisiae  
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Material 
Table 2: Chemicals  
Substance Supplier 
2-Propanol, 70% Roth 
2-Propanol, Rotisolv® Roth 
Acetic acid ethyl ester  Roth 
Acetone, 99.5% Roth 
Acetonitrile Rotisolv® UV/IR Grade  Roth 
Agar-Agar, BioScience Grade Roth 
Ampicill in Sodium Salt  Roth 
Brain Heart Infusion Agar Roth 
Dichloromethane Sigma-Aldrich 
Egg Yolk Emulsion Roth 
Ethanol, Rotipuran Roth 
Ethylenediaminetetraacetic acid  Roth 
Gentamycin Sigma 
Formic acid 45% Roth 
Fluconazole Sigma 
Kanamycin sulphate Roth 
LB Broth (Lennox) Roth 
MacConkey Broth Roth 
Mannitol-Salt-Agar Roth 
Mannitol-Egg yolk-Polymyxin Roth 
Methanol Rotisolv® Roth 
SDS Pellets ≥ 99%  Roth 
PBS Roti®fair PBS 7.2 Roth 
Streptomycin sulphate Roth 
Tryptic Soy Broth Sigma 
TrisPufferan Roth 
Tween 80 Sigma-Aldrich 
Water BioScience Grade Roth 
Yeast Glucose Chloramphenicol Agar  Roth 
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Table 3: Consumables  
Material  Supplier 
50 mL Cellstar® Polypropylene Tube  Greiner Bio-One 
15 mL Cellstar® Polypropylene Tube  Greiner Bio-One 
Acclaim® 120 3 µm C8 120 Å,  
150 x 2.1 mm 
Thermo Fischer 
BacTiter-Glo Promega 
Celite 454 ServaElektrophoresis GmbH 
Cellstar® 96 Well Suspension Culture, F -
bottom, clear 
Greiner Bio-One 
Cellstar® 96 Well Suspension Culture, F -
bottom, white 
Greiner Bio-One 
Gloves TouchNTuff® Ansell  
Parafilm® M Roth 
Puriflash C18-AQ 30 µM F0120 Interchim 
Roti®-Store cryo vials Roth 
Genomic DNA Buffer Kit  Qiagen 
Genomic tip 500/G Qiagen 
GeneJet Gel Extraction Kit  Thermo 
Mix2Seq Sanger Sequencing Kit  Eurofins 
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Table 4: Devices  
Machine Model Company 
Air compressor CPM 160-8-6 W oil free CompactMaster 
Autoclave 5075 ELV Tuttnauer 
Autoclave 3850 EL Tuttnauer 
Balance ABT 220-5DM Kern 
Balance Excellence XA 1502 S Mettler Toledo 
Balance Excellence XA 105 Dual Range  Mettler Toledo 
Biosafety cabinet  MSC-Advance Thermo Scientific  
Breeding box Faunarium HAGEN Deutschland  
GmbH & Co 
Centrifuge Mikro 220R Hettich 
Centrifuge Rotina 420R Hettich 
Dishwasher Compact Desinfektor G7783 CD 
Mielabor 
Miele 
Electrophoresis Power 
Supply 
EV231 Consort 
FLASH chromatography PuriFlash Interchim 
Freezer  -20°C Froster Kirsch 
Freezer  -80°C 6343-6345/6383-6385 GFL 
Gel Documentation 
Station 
VersaDoc Imaging System 4000 
MP 
BioRad 
Gel Electrophoresis 
Chamber 
Mini-PROTEAN Tetra System BioRad 
Hearing Protectors Sperian T1 Howard Leight 
Hearing Protectors Optime I Peltor 
Hotplate Stirrer  Hotplate Stirrer Model L-81 Labinco 
Hotplate Stirrer  VMS-A VWR 
HPLC UltiMate 3000 Dionex 
Ice Machine AF 80 Scotsman 
Incubator Multitron Binder 
Lyophilizer / Freeze 
dryer 
RVC 2-33IR CHRIST 
Microscope DM2500 LED Leica 
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Microplate Reader Eon Biotek Instruments  
Microplate 
luminometer 
LUMIstar OPTIMA  BMG Labtech 
Microwave Grill Hot Air  Sharp 
Multichannel Pipette  Rainin Pipet-Lite XLS 2-20 µL Mettler Toledo  
Multichannel Pipette  Rainin Pipet-Lite XLS 20-200 µL Mettler Toledo 
Multichannel Pipette  Reference® 2 10-100 µL Eppendorf 
PCR Cycler C1000 Thermal Cycler BioRad 
pH-Meter Seven Multi  Mettler Toledo 
Pipette Rainin Pipet-Lite XLS 0.1-2 µL Mettler Toledo 
Pipette Rainin Pipet-Lite XLS 2-20 µL Mettler Toledo 
Pipette Rainin Pipet-Lite XLS 10-100 µL Mettler Toledo 
Pipette Rainin Pipet-Lite XLS 20-200 µL Mettler Toledo 
Pipette Rainin Pipet-Lite XLS 100-1000 µL Mettler Toledo 
Pipette Reference® 2 0.5-10 µL Eppendorf 
Pipette Reference® 2 10-100 µL Eppendorf 
Pipette Reference® 2 20-200 µL Eppendorf 
Pipette Reference® 2 10-1000 µL Eppendorf 
Purified Water System TKA-GenPure Thermo 
Refrigerator Super Kirsch 
Evaporator Rotavapor® R-100  Büchi 
Shake Incubator Multitron II  Infors HAT 
Thermoshaker  TS-100 SC-20  bioSan 
Ultrasonic Bath Sonorex Bandelin 
Vortex VV3 VWR 
 
Table 5: Primer 
Name Sequence Reference 
27F AGAGTTTGATCMTGGCTCAG (Lane, 1991) 
1492R ACCTTGTTACGACTT (Lane, 1991) 
ITS1 TCCGTAGGTGAACCTGCGG (White et al., 1990) 
NL4 CTTCCGTCAATTCCTTTAAG (O’Donnell, 1993)  
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Results 
Aim 1: Isolation, cultivation, and identification of gut microbes 
  
6.1 Beetles and breeding 
In a first step, it was tried to catch N. vespilloides in their natural habitat (see Material and 
Methods section). The first beetles were caught in Schiffenberg Forest in mid of May, when 
temperatures during night time were constantly above 8 °C. During the summer months, catching of 
Nicrophorus species was relatively easy. As soon as the cadaver emitted a strong odour, beetles could 
successfully be caught even within a few hours. Catching was most successful when traps were baited 
3-4 hrs before sunset.  
In order to limit the possible impact of a chage from habitat soil one of those artifical soils usually used 
in literature, N. vespilloides was kept plastic boxes filled (see Material and Methods section) filled with 
soil material from Schiffenberg Forest. The substrate was moistened with tap water whenever it 
appeared to be dry. Non-breeding beetles were fed with larvae of Galleria mellonella twice a week. To 
induce breeding, a dead mouse was provided. As soon as a couple of beetles had successfully 
conquered and defended the carcass, the beetles started preparing it by shaving off the fur. After this 
procedure, the carcass was buried in the soil, and beetles started breeding. Within a few weeks, 
mature L3 larvae could be observed. Unfortunately, no adults emerged from the pupation chamber. 
Therefore, any attempts of breeding N. vespilloides under those artifical laboratory conditions were 
stopped, and the beetles were either caught on demand, or parasite-free animals were provided from 
the laboratory of Dr. H. Vogel (MPI, Jena) and dissected directly. 
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6.2 Dissection 
In order to obtain gut microbes, cooled beetles were directly dissected under a binocular microscope 
using a micro forceps. Surface contaminants of the beetle were killed and removed as described in 
chapter 3.2. The aim of this dissection was to remove the gut without disrupting and spilling of its 
content. 
Due to its life cycle, Nicrophorus spp. evolved a very hard cuticle, especially around the head. To open 
up the body cavity, elytra were removed, and the abdomen was carefully accessed. Every abdominal 
segment was thoroughly removed, and the last abdominal part was handled with utmost care to 
prevent perforation of the beetle’s rectum. In a next step, the pronotum of the beetle was removed 
carefully by using a micro scissors and a micro forceps. The anterior part of the gut is arranged in a 
straight line, but the hindgut is coiled on top of the midgut. Only the last part is straightened to the 
rectum, which serves a reservoir for anal secretions (Figure 7). 
 
Figure 7: Dissection of N. vespilloides. 
The dissected body of the beetle unveils the orientation of the gut. The head is still partly covered by the hard cuticle, followed 
by a fat body covering the foregut. The coiled hindgut is clearly visible, on top of the voluminous midgut segment. The filled, 
dark brown coloured rectum is completely embedded in fat body.  
 
Afterwards the gut was separated in its three compartments. In most cases, the foregut and midgut 
had to remain together because of the shortness of the former. In contrast, hindgut and rectum could 
easily be separated from each other. The resulting three segments were physically opened by crushing 
(see Material and Methods section) to get access to the gut lumen with its crypts. A self-made piston 
(from a 1000 µL-pipette tip) was found to be superior to the use of a tissue-lyser system for breaking 
up these gut segments  
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6.3 Cultivation of the gut microbiome 
6.3.1 Cultivation of bacteria  
A decisive part of this study was aimed at cultivating the beetle’s gut bacteria and eukaryotic microbes. 
First of all, a number of suitable complex and standard selective media for cultivation of gut microbiotia 
had to be chosen. Therefore, it was important to consider the composition of the beetles’ natural diet. 
Consequently, complex media rich in proteins and amino acids were used to cultivate the gut. Brain 
Heart Infusion (BHI) was chosen as a rich and sufficient source of those components. The bacteria from 
laboratory-hatched beetles were cultivated after an overnight enrichment step in BHI media. The 
inocula were afterwards serially diluted from 103 to 106 and spread on BHI agar. Bacterial colonies 
were picked and streaked on fresh BHI agar plates for multiple times to obtain pure cultures for 16S 
amplification and cryo storage.  
 
 
Figure 8: Example of 16S rRNA amplification. 
Colony PCR was performed with the denaturised cell suspension and was used as the template for the PCR with different 
amounts (1/2/3 µL) to amplify the 16S ribosomal gene. The resulting product is 1465 bp long as the 1.5 kb band of the 
marker also indicates. The shown samples are isolated from female foregut sample number 6 and 9, cultivated on H2O agar 
(FF6-H2O and FF9-H2O).   
 
This enrichment step might have supported the growth of generalists. Consequently, this procedure 
was not considered for the final, optimised isolation process. In contrast, direct plating of the diluted 
gut fragment suspension on solid media resulted in sufficient microbial growth and an improved colony 
picking. To limit excessive growth of fast-growing and swarming bacteria, agar of low nutrient 
concentration and even water agar were used. Growth sufficient for selective colony picking was 
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reached after a period of time of up to 3 weeks to. Ampicillin and kanamycin were used to inhibit the 
growth of sensitive bacteria and to select for resistant strains. Both antibiotics were chosen because 
of their different mode of action.  
In this study, 320 bacterial samples were isolated from the gut of N. vespilloides and sequenced after 
16S gene amplification. The Basic Local Alignment Search Tool for nucleotides (BLASTn) was 
subsequently used for identification. The results are shown in Figure 9. Bacteria were identified to the 
genus level based on their 16S gene sequences. The species diversity could not be taken into account 
because of the insufficient species identification based on the 16S gene.  
Microorganisms were cultivated mainly on BHI agar but also on TSB as well as on different selective 
media such as mannit yolk polymyxin agar (MYP), mannit salt agar (MSA), water agar (H2O), yeast 
extract glucose chloramphenicol agar (YGC) and peptone glucose starch agar (PGS)  
.  
 
Figure 9: Bacterial diversity of the cultivable gut microbiome. 
From outside to inside: classordergenus 
The field sizes are based on abundance. Identification was achieved by 16S gene amplification followed by BLASTn search.  
 
The most abundant bacteria isolated were of the class of Gammaproteobacteria with a total of 59.1%. 
The family of Enterobacteriales was cultivated with ~ 43% prevalence of all bacterial families, followed 
by ~ 10% Xanthomonadales and ~ 6% Pseudomonadales. The most abundant genus was Serratia with 
a total of ~ 43% among all isolates belonging to the Enterobacteriales, followed by the genera Hafnia 
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(~ 22%) and Proteus (~ 15%). Genera of regular but lower abundance comprise Morganella (~ 11%) 
and Providencia (~ 7%), followed by Enterobacter, Citrobacter and Erwinia.  
Beside the order of Enterobacteriales, Xanthomonadales and Pseudomonadales were also identified. 
They were represented by the genera of Pseudomonas (Pseudomonadaceae) and Stenotrophomonas 
(Xanthomonadaceae). Next to the Gammaproteobacteria, the class of Bacilli (17.2%) was the second 
most abundant represented by the order Lactobacillales. The genera Carnobacterium, Vagococcus and 
Achromobacter as well as Lactococcus and Enterococcus were the most abundant. The third largest 
group of isolated bacteria is previously not further specified with a total of 12.8% percent. Next to 
these identified two major classes, Alphaproteobacteria, Betaproteobacteria, Actinobacteria and 
Flavobacteria were also isolated and cultivated. In total, 25 different genera were isolated, next to 
some undefined species of Microbacterium, Lactococcus and Enterobacteriaceae. The full BLASTn 
identification list can be found in the appendix (Table S1).  
During the process of undirected bacterial isolation on complex media, strong swarming occurred 
irregularly. In those cases a reduction of the nutrient yield limited the swarming. In general, 100% BHI 
agar was used; however, if swarming occurred, especially with Proteus mirabilis, the nutrient 
concentration was reduced to 50%. 
It should be pointed out that the cultivation of the microbiome aimed at all bacteria, not only at those 
that have already been scientifically described. However, the isolation of unspecified bacteria was 
achieved extremely rarely. Difficulties in the isolation of those bacteria might have arisen from 
numerous reasons. Strain 3MH1, isolated from the hindgut of a male beetle, was grown from a diluted 
gut suspension, which has been plated out on TSB agar. After colony picking, PCR amplification and 
Sanger sequencing, the BLASTn analysis revealed an identity coverage of 95.3% with its closest 
ancestor Wohlfahrtiimonas larvae. However, a major problem arose after several successful passages 
on solid agar media and cryo conservation. The strain 3MH1 failed to grow from cryo stocks as well as 
from the agar plates so that a further characterization was impossible. A change of growth conditions 
was a first starting point to resolve this issue. The strain was grown at different cultivation 
temperatures, i. e., 4°C, 15°C 21°C, 26°, 30°C and 37°C. Growth was regularly checked over a period of 
4 weeks, but no colonies could be detected, anymore. Thereafter, the strain was grown under 
microaerophilic and anaerobic conditions. Even the use of an anaerobic jar did not lead to success. 
Supplementation of the growth medium with iron(II)sulfate (FeSO4), which is commonly recommended 
as a strategy for isolation and cultivation of rare bacteria with siderophore activity, showed no effect 
either. 
Cultivation on non-selective media in an anaerobic jar revealed the presence of the genera. 
Carnobacterium (Latobacillales, Carnobacteriaceae), and Enterobacter (Enterobacteriales, 
Enterobacteriaceae). Both genera are facultatively anaerobic and were also found under aerobic 
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conditions. Overall, time and effort required for anaerobic cultivation were comparatively high; and 
the low taxonomic diversity of the isolates obtained did not justify any future application of this 
method.  
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6.3.2 Cultivation of fungi  
For cultivation of eukaryotic microorganisms, a selective medium, yeast extract glucose 
chloramphenicol agar (YGC), was used successfully. Chloramphenicol is a broad-spectrum antibiotic, 
which is supplemented here to prevent bacterial growth, thus promoting the selection of yeasts and 
fungi. The cultivation itself was performed in the same manner as for bacteria, i. e., by direct plating 
of 101 diluted gut suspensions. 
Figure 10 summarizes the results of the eukaryotic cultivation approach. With 68% of all isolates, 
Yarrowia was the most frequently isolated genus of all eukaryotic isolates. The genus Yarrowia 
(Saccharomycetales, Dipodascaceae) belongs to the true yeasts. BLASTn search either revealed 
Yarrowia lipolytica (28%) or Yarrowia sp. (40%). Isolates identified as Yarrowia sp. had a BLAST 
coverage of 98% of identity for the amplified ITS regions, indicating a genetic difference compared to 
the references. The genus Candida (Saccharomycetales, Saccharomycetaceae) was the second most 
common (8%) fungal isolate.  
  
Figure 10: Fungal diversity of the cultivable gut microbiome. 
Outside to inside: classordergenus 
The most abundant isolates were Yarrowia lipolytica and Yarrowia sp. of the family Dipodascaceae and Candida sp. of the 
family Saccharomycetaceae.  
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Cultivation of Yarrowia species revealed obvious differences in the morphology of the isolates. At least 
four different colony shapes could be distinguished when isolates were growing on the same YGC agar 
plate (Figure 11).  
Full genome sequencing has been performed for Yarrowia sp. isolates by our collaboration partners 
from the Max Planck Institute for Chemical Ecology and Dr. Karina Brinkrolf. The results suggest 
different subspecies but this cannot be linked to the morphological differences, so far. Most notably, 
Yarrowia was the only fungal genus isolated from the rectum of the beetle, and it seems to be endemic 
to this gut compartment. 
 
Figure 11: Differences in growth morphology of Yarrowia isolates. 
The isolates growing on YGC agar plates are yeasts of the genus Yarrowia and fungi of the genus Candida. Under the same 
growth conditions, the Yarrowia isolates exhibit different morphologies. .Red circles indicate different growth shapes of 
Yarrowia colonies. Smooth (1) can be found as well as concave (2) and spiky (3) colonies in different orientation. The most 
divergent shape, however, is best described as a spaghetti-shaped colony (4). 
 
Besides the genus Yarrowia, the genera Penicillium (Eurotiales, Aspergillaceae), Geomyces (Incertae 
sedis, Pseudeurotiaceae) as well as Cephalotheca (Sordariales, Cephalothecaceae) and Humicola 
(Sordariales, Chaetomiaceae) were cultivated.  
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Aim 2: Fermentation, chemical extraction, and antimicrobial screening 
 
6.3 Testing for antimicrobial activity 
6.3.1 Pre-screening with crude extracts 
After the cultivation of 320 bacterial isolates from the gut of both wild and laboratory-reared N. 
vespilloides beetles, a selection of strains based on 16S gene similarity was made. Isolation and 
cultivation of the microbial samples was based on morphological differences of the colonies obtained. 
Therefore, the genetic differences indicated by 16S analysis were used for the following screening of 
antimicrobial activity. Based on that, 113 bacterial strains and 6 Yarrowia isolates were selected. This 
de-replication process is limited by the genetic differences in the bacterial 16S gene but was necessary 
for the reduction of the number of isolates. Because of this selection, at least one representative of 
each species was chosen for fermentation. All of the 119 microbial isolates were grown in liquid culture 
in conical flasks (Erlenmeyer-Kolben). Afterwards, the cultures were freeze-dried and extracted. Liquid 
cultures were sampled after one, six and nine days, respectively, because the time-point of induction 
of antimicrobial compound production is not predictable. Secondary metabolite production can be 
induced by numerous metabolic events. It can result, for example, from nutrient limitation, from 
growth during the stationary phase.etc. In this study, a strong increase in antibiotic activity was 
detected between the 1st and 9th day of cultivation. The freeze dried material was subsequently 
extracted with EtOAc and MeOH, as described in the Material and Methods section. Only five crude 
EtOAc extracts displayed sufficient antimicrobial activity, whereas the number of bioactive MeOH 
extracts was significantly higher (231 extracts).  
The primary screening was performed with a set of relevant microbial organisms, including Gram-
negative pathogens such as wild-type Escherichia coli, the efflux pump mutant E. coli ΔTolC, and 
Pseudomonas aeruginosa. Gram-positive bacteria such as Staphylococcus aureus and 
Mycobacterium smegmatis were also included as well as the eukaryotic human pathogen Candida 
albicans. However, it should be kept in mind that M. smegmatis1 is a highly sensitive, organism. 
Consequently, the high inhibition rates recorded from testing of crude extracts have to be scrutinised 
in order to avoid false positive hits. In a later stage of screening, E. coli ΔTolC had to be excluded from 
the spectrum of test organisms because of inconstant growth, which corresponded to false positive 
inhibitions.  
By screening the crude extracts for antimicrobial activity, a huge number of active isolates was 
identified (Figure 12). The highest number of antimicrobially active extracts originated from the group 
of undetermined isolates  remarkably, a total of 26% of all strains was found in this group. 
                                                          
1 M. smegmatis is used as a safety level 1 screening strain for tuberculosis. 
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Surprisingly, most of the bioactive isolates were found in the orders of Pseudomonadales (19%), 
Lactobacillales (17%), and Enterobacteriales (17%). In contrast, the orders Actinomycetales (10%), 
Flavobacteriales (2%) and Burkholderiales (2%), which are most well-known as classical sources of 
antibiotics, were less represented. Here, it has to be emphasised that only a small number of isolates 
obtained from Nicrophorus guts belonged to these orders.  
 
Figure 12: Taxonomic diversity of bacteria producing bioactive crude extrats.  
Outside to inside: classordergenus 
The diagram combines all observed antimicrobial activities from the 113 bacterial isolates tested. More than 26% of all 
biologically active extracts were obtained from undetermined bacteria. Strains of the genus Pseudomonas were the most 
abundant producers of bioactivity, compared to the other genera. 
 
Screening of crude extracts resulted in a huge number of antimicrobial activities (Table 6) against the 
pathogens tested. For instance, the Serratia isolate FF6-H20 or the Enterococcus isolate 42, exhibited 
broad-spectrum activity against all test organisms. In total, 71% of all MeOH extracts showed ≥ 70% 
inhibition of M. smegmatis. In contrast, selective inhibition of C. albicans has only been observed 
comparatevely rarely. One of those examples is the unspecified isolate Wild Mid 14, obtained from the 
midgut of a wild living beetle.  
The least inhibition rates were recorded against Gram-negative bacteria with only 11.5% of all extracts 
displaying sufficient inhibition rates of ≥ 70%. Crude extracts that are active against Gram-negatives 
Results 
36 
 
are regarded most interesting. This is due to the fact that the pharmacutical market is devoid of 
novelties in this field of application. Inhibition of E. coli and P. aeruginosa is therefore of high value for 
the developement of modern, selective antibiotics. As examples, the MeOH extracts of isolate 
2FH1_PGS (genus Hafnia) and the so far undetermined bacterium 2MH4 can be listed. Those extracts 
were capable of effectively inhibiting either E. coli or P. aueruginosa. Remarkably, the genera 
Enterococcus and Serratia (Enterobacteriales) produced extracts that exhibited a pronounced anti-
Gram-negative activity.  
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Table 6: Heat map of selected antimicrobial effects produced by the gut bacteria. 
Colours indicate inhibition rates: < 50% ≥50-70% ≥70-90% ≥90-100%. 
 
Indication of inhibition
0-50%
50-70%
70-90%
90-100%
Indication of inhibition
0-50%
50-70%
70-90%
90-100%
Indication of inhibition
0-50%
50-70%
70-9 %
90-100%
Indication of inhibition
0-50%
50-70%
70-90%
90-100%
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Isolated bacteria were not analysed down to their subspecies diversity, but the different antimicrobial 
activities between isolates of the same species clearly indicate a chemical diversity. This suggests a 
subspecies diversity which cannot be uncovered by 16S gene analysis.  
Therefore, a phylogenetic analysis based on partial 16S sequences was used in combination with the 
spectrum of antimicrobial activity to investigate the isolates of the genus Serratia 
(order: Enterobacteriales).
 
Figure 13Figure 13 displays the phylogeny of all isolated bacteria identified as members of this genus 
and the antimicrobial activity of the respective strains. For the phylogenetic tree, all Serratia 16S 
forward amplificates were aligned to Serratia 16S references downloaded from the National Center 
for Biotechnology Information (NCBI). The reference species include S. grimesii, S. proteamaculans, 
S. ficaria, S. vespertiliones, S. entomophilia, S. symbiotica, S. plymuthica, S. liquefaciens, S. glossinae, 
S. fonticola, S. aquatilis, S. rubidaea, S. ureilytica, and S. marcescens. The alignment was then trimmed 
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to 650 bp length for equalization. By computing a pairwise distance analysis with MEGA 7, a maximum-
likelihood phylogenetic tree was generated. The phylogeny joint with the antimicrobial activity could 
indicate differences, also within closely related isolates. Comparing, for example, the related isolates 
2MH1 PGS and 2MH3-2 BHI in terms of their antimicrobial activity displayed obvious differences. The 
extracts of both isolates were able to inhibit M. smegmatis but only isolate 2MH3-2 BHI was also active 
against S. aureus. Besides this, the isolates 56 and FF6-H2O, both clustering to the reference 
S. plymuthica, exhibited a broad antimicrobial activity against all tested pathogens (see also Table 6). 
Moreover, antifungal activity, represented by the inhibition of C. albicans, was rarely observed among 
the genus Serratia. Remarkably, Faek1 PGS was the only strain that was found to inhibit C. albicans. 
 
Figure 13: Phylogeny of the Serratia isolates and their antibiotic active crude extracts. 
      strains tested         antimicrobial activity 
The phylogenetic tree in combination with the antibiotic bioactivity indicates the chemical diversity of closely related strains. 
The isolates FF6 H2O and 56 seem to be phylogenetically closely related, as also suggests by bioactivity data. Nevertheless, 
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closely related Serratia isolates, e.g., 2MH3-2 BHI and 2MH1 PGS, both related to S. marcescens, differ in their activity against 
S. aureus. 
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6.3.2 HPLC separation of the crude extracts 
To investigate the antimicrobial effects of a crude extract, it is necessary to effectively separate the 
substances by HPLC. After that, another bioactivity test is required to identify the active fractions and 
to avoid possible losses of antibiotic activity. A total of 44 bioactive crude MeOH extracts was selected 
for further investigation. The fractions were collected within 96 well plates and again tested for 
antimicrobial activity after the solvent mixture of MeCN and H2O was removed. Subsequnetly, each 
residue was resuspended with an incoculum of the appropriate test organism. The retesting was 
carried out in-house using E. coli and the yeast Saccaromyces cerevisiae, but it revealed no positive 
results. In addition, all HPLC fractions collected were also tested by the Sanofi-Fraunhofer (Dr. Benedikt 
Leis), who confirmed these negative results. Surprisingly, only fresh crude extracts displayed 
antimicrobial activity. This indicated that long-term storage in MeOH at 4°C can lead to the loss of 
activity. Thus, a complete re-fermentation and extraction of all 44 selected isolates was inevitable. This 
time, the solvent MeOH was evaporated before storage. Extracts of the numbers 1 to 9 (Table 7) were 
tested against E. coli, numbers 10 to 13 were tested against P. aeruginosa. Numbers 14 to 18 were 
tested for antifungal activity against C. albicans, and numbers 19 to 21 had to be tested against S. 
aureus. All other extracts were tested against M. smegmatis. Afterwards, the crude extracts of the 
listed strains were separated by HPLC as previously described, and fractions were tested for 
antimicrobial activity. 
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Table 7: Selected antibiotic effects by percentage of inhibition from methanol crude extracts. 
Dark green: ≥85% inhibition  light green: 71-85% inhibition  yellow: 50-70% inhibition 
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1 Serratia plymuthica  FF6-H2O d9  100 100 72 98 100 
2 Enterococcus durans  38 d6  99 97 91 0 0 
3 Arthrobacter sp.  39 d6  80 25 0 0 100 
4 Enterococcus sp.  42 d6  100 100 100 0 0 
5 Carnobacterium sp.  76 d6  54 31 0 0 0 
6 Enterococcus avium  89 d9 MeOH 101 101 100 0 0 
7 Hafnia alvei  2FH1_PGS d6  93 0 0 0 0 
8 Enterococcus malodoratus 2FM6_PGS d6  100 101 100 0 0 
9 Enterococcus raffinosus 2MF6_PGS d6  99 98 101 0 0 
10 Uncultured bacterium 2AB_FH4 _BHI d1  0 99 97 0 0 
11 Lactococcus lactis  2FH3 d6  13 100 8 0 55 
12 Uncultured bacterium clone 2MH4 d9  3 100 0 0 0 
13 Variovorax boronicumulans  29 d1  1 87 0 0 85 
14 Hafnia sp.  2FM1d9  24 0 0 54 95 
15 Morganella morganii  Wild Hind 5 d6  13 0 0 70 20 
16 Pseudomonas sp.  20 d1  9 0 51 73 83 
17 Uncultured organism clone  Wild Mid 14 d9  1 0 0 94 0 
18 Bacterium DS8(2012)  2MF4-BHI d9  0 0 0 73 64 
19 Serratia marcescens  2MH3-2 d9  11 0 86 0 100 
20 Serratia marcescens  2MH1 d1  15 0 81 0 49 
21 Serratia marcescens  2MH1_PGS d6  2 0 68 0 0 
22 Serratia proteamaculans  15 d9  15 0 0 0 92 
23 Rhodococcus qingshengii  44 d6  12 12 0 0 93 
24 Pseudomonas fluorescens  60 d9  19 0 0 0 97 
25 Pseudomonas fragi  62 d9  23 0 0 21 97 
26 Pseudomonas sp.  66 d9  16 0 0 0 96 
27 Pseudomonas brenneri  80 d9  10 0 0 0 97 
28 Pseudomonas extremorientalis  81 d9  9 0 0 0 100 
29 Pseudomonas sp. 86 d9  4 2 0 0 100 
30 Myroides odoratus strain 2ABMH1 d9  0 0 0 0 88 
31 Pseudomonas sp. 20 d9  11 0 0 0 98 
32 Uncultured bacterium clone  48 d1  0 0 0 0 79 
33 Uncultured bacterium clone 50 d9  6 0 0 23 99 
34 Uncultured Microbacterium sp. clone                  54 d6  10 0 0 0 97 
35 Stenotrophomonas humi  71 d9  0 0 0 0 90 
36 Uncultured gamma proteobacterium clone        79 d6 0 0 0 0 99 
37 Uncultured bacterium clone 2ABMF2 d6  0 0 0 0 91 
38 Wohlfahrtiimonas larvae  3FM1 d1  5 0 0 0 99 
39 Stenotrophomonas pavanii  3MA3 d9  3 0 0 12 100 
40 Streptomyces herbaricolor  3FA1 d9  5 0 0 0 100 
41 Enterococcus phoeniculicola  3MA5 d6  7 0 0 0 95 
42 Kitasatospora griseola  3FA1.1 d9  7 6 0 0 100 
43 Swine effluent bacterium  3MH1 d9  7 0 0 0 100 
44 Pseudomonas sp.  57 d1  0 0 10 0 100 
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Because the HPLC separation and the combined collection of the separated substances were 
performed in a time-dependant manner, it is possible to calculate the retention time of antimicrobially 
active fractions. This enables to link the HPLC separation to the LC-MS analysis of the extract for further 
investigations. By a simple well count and a multiplication of the collection time for each well (50 s), 
the approximate retention time of the bioactive fraction can be determined.  
 
 
Figure 14: Fraction collection on a 96-well plate. 
The separated fractions were collected every 50 s in a meandering pattern. As a positive control (+), pure medium was used 
corresponding to 100% growth inhibition. For negative controls (-), fully grown cultures were used. Arrows indicate the 
meandering of fraction collection. 
 
The analysis of the 44 separated extracts led to the identification of several bioactive fracions on the 
96-well plates. Positively screened crude extracts and their corresponding retention times are listed in 
Table 8. 
In total, 15 crude extracts retained bioactivity after HPLC separation. Due to the use of a reverse phase 
C8 column, hydrophilic substances eluted at the very beginning and caused inhibitory effects in wells 
A9 and A10, respectively, thus resulting in two consistently bioactive fractions.2  
Apart from the strain FF6-H2O, almost all crude extracts active against Gram-negatives had lost their 
bioactivity after HPLC separation. The extract of the Serratia isolate FF6-H2O was further separated by 
HPLC and the obtained fractions were tested against E. coli. A broad tailing of anti-Gram-negative 
bioactivity was observed, even when applying low concentrations of crude extract. Therefore, work on 
this strain was intensified while the identification of active fractions continued for the remaining 15 
crude extracts (see Table 8) 
These 15 extracts exhibited very different patterns of bioactive fractions. For example, the C. albicans-
inhibiting MeOH extract of isolate Wild Mid 14 revealed three active fractions (A9/A10 and E7). The 
activity of fractions A9 and A10 can be regarded as unspecific as mentioned above. The fraction of well 
E7, which corresponds to fraction 49 (Figure 14), can be recalculated with a retention time of around 
                                                          
2 not listed in Table 8 
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40 minutes and 50 seconds. Often, more than one fraction of an extract showed antimicrobial effects 
as can be seen in the case of the M. smegmatis-inhibiting extract 3MA5 or the E.coli-inhibiting extract 
FF6-H2O. The latter is one of those bacterial extracts with broad antimicrobial activity identified in the 
primary screening (Table 7). After HPLC separation and microbiological screening of the collected 
fractions, a broad tailing was observed, as already mentioned above. Active fractions tailed from 18 
minutes 20 seconds to 25 minutes (wells C4-C12); moreover, a single fraction in well E2 (36 min 40s) 
was identified.  
The identification of active fractions is a crucial step for further analysis and de-replication of known 
bioactive compounds by LC-MS and MS-MS. Therefore, those 15 remaining crude extracts were 
analysed by LC-MS. To combine the calculated retention times for the de-replication process, the LC-
MS analysis was performed with the same HPLC protocol and the same type of C8 column. Also the LC 
instrument was of the same type as the one used for primary separation. Consequently, the retention 
times of both HPLC separation and LC-MS should approximately be in the same time range. 
 
Table 8: Bioactive fractions of the MeOH crude extracts after HPLC separation. 
Isolate Inhibition  Active well Retention time 
FF6-H2O E. coli C4-C12/E2 
18 min 
20s -25 min 
36min 
40s    
2FM1 d9  C. albicans  C1/E10/E11/E12 
15 min 
50s 
43 min 
20s 
44 min 
10s 
45 min 
00s     
Wild Mid 14 
d9  C. albicans E7 
40 min  
50s         
60 d9 
M. 
smegmatis D4 
32 min 
30s          
66 d9  
M. 
smegmatis F1/G1/G3/G4 
55 min 
00s 
55 min 
50s 
57 min 
30s 
58 min 
20s     
80 d9  
M. 
smegmatis D4/H12/H11/H8 
32 min 
30s 
65 min 
50s 
66 min  
40s 
69 min 
10s     
86 d9  
M. 
smegmatis G12/H8 
65 min 
00s 
69 min 
10s         
71 d9  
M. 
smegmatis 
F12/F11/F10/F8/ 
G6/G10/H6/H9 
45 min 
50s 
-49 min 
10s 
60 min 
00s 
63 min 
20s 
68 min 
20s 
70 min 
50s 
3FM1 d1  
M. 
smegmatis G11 
64 min 
10s          
3MA3  
M. 
smegmatis B9/B8/B7 
8 min 
20s 
9 min 
10s 
10 min 
00s       
3MA5 
M. 
smegmatis 
B3-B9/ C3-C8 
 
8 min 
20s 
-13 min 
20s 
17 min 
30s  
-21 min 
40s     
3MH1 
M. 
smegmatis G6-G10 
60 min 
00s 
60 min 
50s 
61 min 
40s 
62 min 
30s 
36 min 
20s   
2MH3-2 d9  S. aureus 
E10/F11/F9/F8/F7 
F4/F1 
43 min 
20s 
48 min 
20s 
49 min 
10s 
50 min 
0s 
52 min 
30s 
55 min 
00s 
2MH1 d1  S. aureus E12/F9/F8/F5/F2 
45 min 
0s 
48 min 
20s 
49 min 
10s 
51 min 
40s 
54 min 
10s   
2MH1_PGS 
d6 S. aureus F9/F8/F5 
48 min 
20s 
49 min 
10s 
51 min 
40s       
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Aim 3: Analytic and isolation of interesting candidates 
 
6.4 Liquid chromatography-mass spectroscopy (LC-MS) analysis 
During the past 70 years, the structure of myriads of bioactive natural products has been elucidated. 
Consequently, the rediscovery of known antibiotics is common. This fact underlines the value of de-
replication. Liquid chromatography – mass spectroscopy is therefore the method of choice to analyse 
the composition of crude extracts. The aim was to identify the active fractions obtained by HPLC 
separation of the crude extracts (see above. By taking into account the possibility of a slight retention 
time shifts, the LC-MS data were first scrutinised with Bruker the programme “DataAnalysis”. 
Subsequently, the natural products database "AntiBase” 2014 (Wiley) was searched possible hits 
corresponding to the major peaks in the metabolite pattern of each extract.  
Therefore, retention times of the antimicrobially active fractions were determined according to HPLC 
separation and screening results. Due to these calculations, it was possible to focus on defined 
retention time frames in each data set. The AntiBase search did not yeald defined results, i.e. a match 
with any of the entries compiled in the database. Moreover, because of the complex, labourius test 
procedure for anti-M. smegmatis activity, the focus was set on crude extracts inhibiting E. coli, 
S. aureus or, C. albicans, respectively.  
The extract 2MH3-2 was chosen here as an example for MS analysis. This extract inhibited the growth 
of S. aureus. The major peaks in the base peak chromatogram of this crude MeOH extract (Figure 15) 
were checked for known antimicrobial compounds at the calculated retention times (43 min 20 s as 
well as the time period from 48 min 20 s to 55 min, see Table 8). 
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Figure 15: LC-MS analysis of crude extract 2MH3-2. 
A: Base peak chromatogram (blue) of the crude extract 2MH3-2 and the extracted ion chromatogram (EIC, red) of m/z 760 
(±0.5). The major EIC peak with a retention time of 2490 s corresponds to m/z 760 ([M+H]+). 
B: The magnification of the LC-MS chromatogram in the time range of approximately 2490s exhibited the protonated 
pseudomolecular ion m/z 760.4824 as well as the corresponding sodium adduct m/z 782.4682.  
 
By taking into account a slight retention time shift, one major peak could be detected at 41 min 30 s. 
In contrast, no others were found (see Table 8). This peak corresponded to m/z 760.4824 ([M+H]+, 
Figure 15). A subsequent AntiBase search revealed a potential candidate corresponding to 
m/z 760.4842 ( m/z 2.4). According to these search results, an erythromycin analogue with the sum 
formula C39H70NO13 was considerered. However, MS/MS experiments disproved this hypothesis. 
Figure S1 displays the fragmentation pattern of the pseudomolecular ion of m/z 760.4677. The most 
notable feature was the multiple loss of H2O indicating the presence of -OH groups ( m/z 18). 
Addtional losses of ammonia (NH3), corresponding to a mass difference of m/z 17, were observed, 
indicating the presence of -NH2 groups. Differences of m/z 28 were shown to correspond to the loss of 
-CO. Taken togehter, the MS/MS analysis did not support the hypothesis of an erythromycin analogue. 
Moreover, a core skeleton could not be detected, even after adjusting the collision energy settings. 
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Due to the missing core skeleton, semi-preparative isolation and subsequent 1- and 2D-NMR were 
required to complete the structural elucidation of this bioactive metabolite. 
Aside from the extract of isolate 2MH3-2, the extract of strain FF6-H20 was analysed. HPLC separation 
and LC-MS/MS experiments revealed a pseudomolecular ion m/z 397.8521. Moreover, an AntiBase 
search for this candidate mass did not yield any hits. In contrast, a literature search for bioactive 
compounds isolated from S. plymuthica strains resulted in the hypothesis of zeamine I (m/z 397.8527) 
as the bioactive compound (Masschelein et al., 2013). A set of preliminary MS/MS data seemed to 
support this hypothesis for zeamine I (C47H93N3O6). Nevertheless, a subsequent detailed LC/MS and 
MS/MS investigation could not confirm the initially hypothesised mass of m/z 397.8527 and therefore 
zeamine I was excluded from further considerations. Therefore, semi-preparative isolation and NMR-
based structural elucidation were considered.  
After refermation, the MeOH crude extracts of strain FF6-H2O were tested not only against E. coli as 
before but also against S. aureus and P. aeruginosa. Notably, fractions of different bioactivity against 
the three pathogens tested have been observed. Antimicrobial effects against E. coli were recorded 
for factions corresponding to a retention time of 18 min 20s to 25 min as well as a single fraction at 36 
min 40s. Inhibition of S. aureus was observed from 20 min to 20 min 50s and again from 24 min 10s to 
25 min (see Figure 16). These inhibitory effects on E.coli and S. aureus were mainly present in the same 
fractions or in fractions close to each other. In contrast, the inhibition of P. aeruginosa was observed 
in two seperate fractions eluting at a retention time of 35 min and 49 min 10s, respectively 
(see Figure 16). Here, the retention time of 49 min 10s differs extremely from the other retention times 
of the separated FF6-H2O crude MeOH. This contradicts the hypotheses of either only a single zeamine 
derivative or an unknown compound as the active principle. Zeamine is targeting the cell wall 
unspecifically, which then should result in the same bioactive fractions inhibiting the pathogens tested.  
 
 
Figure 16: antimicrobial activity of FF6-H20 after HPLC separation of the MeOH extract. 
This scheme illustrates the distribution of fractions with antimicrobial activities against E. coli, S. aureus or P. aeruginosa, 
respectively Fraction collection was performed as described and indicated in Figure 14. The coloured wells correspond to a 
100% inhibition of the tested pathogens. 
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6.5 Flash chromatography  
6.5.1 Isolate 2MH3-2 
LC/MS as well as MS-MS analysis were not sufficient to identify distinctive pseudomolecular ions in the 
crude MeOH extract of the Serratia isolate 2MH3-2. Therefore, an NMR approach was the only way to 
identify the bioactive compound. In order to obtain sufficient amounts of purified material for 
2D-NMR, the fermentation process had to be scaled up. Due to the fast metabolite and high biomass 
production of the Serratia strain 2MH3-2, a 2 L fermentation was carried out in a 5 L Erlenmeyer flask. 
After freeze drying, the residue was extracted, yielding 15 g of dried MeOH extract. To further reduce 
the amount of this crude extract, and to prevent overloading of the flash chromatography column, 
proteins were precipitated with acetonitrile (MeCN) after redissolving in H2O. This way, the amount of 
crude extract was reduced by 40%. Both the aqueous phase and the MeCN precipitate were checked 
for inhibitory effects on S. aureus. Here, the strongest bioactivity was found in the aqueous phase. 
The dried aqueous phase of strain 2MH3-2 was redissolved in MeOH and loaded onto Cellite in a ratio 
of 1:1 (w/w). Afterward, a pre-column was filled with the loaded sample and separated by a gradient 
as described in Material and Methods.  
Due to the reverse phase of the column, hydrophilic compounds elute earlier than lipophilic 
compounds. Consequnetly, huge amounts of sugars and salts elute in the first 10 min of the purification 
process (Figure 17). As the intensity of the peaks containing these hydrophilic compounds is extremely 
high, smaller peaks eluting after 10 min are suppressed in their intensity. Due to the previous 
fractionation of the crude MeOH extract, the polarity of the bioactive fraction could roughly be 
estimated. Elution of the bioactive compound was previously achieved at 84% MeCN/ 16% H2O. From 
this, it was estimated that the bioactive fraction will elute from the flash column at 60% MeCN due to 
higher flow rate and column size. The fractions from the Puriflash column were collected in a peak-
dependent manner; however, the first 10 minutes were collected as single, large fraction containing 
all hydrophilic substances. Figure 17A shows the resulting chromatogram with the dominant peak of 
hydrophilic substances at the beginning. For a better resolution, the time frame containing substances 
of medium polarity (15 min to 42 min 30s) is magnified in Figure 17 B. 
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Figure 17: Flash chromatography elution profile of sample 2MH3-2. 
A: The elution profile shows a dominant peak from 5 to 10 min. This peak is caused by high amounts of hydrophilic 
substances e.g. sugars and salts. The high intensity of this peak led to an auto scaling whereby the following peaks of lower 
intensity are suppressed. This has also be taken into accoun for the estimated elution of the bioactive substance within the 
range of 60% MeCN. 
B: The different scale of the elution profile in the time range from 15 min to 42 min 30s reveals the peaks of lower intensity. 
The peak (=210 nm) with a retention time from 29 min to 39 min 30s (red box =fraction 3) contained the bioactive 
fraction. The coloured numbers above the profile indicate the respective code for collection tray and tube.  
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The flash purification yielded four larger fractions which were subsequently retested for S. aureus 
inhibition. As described above, the hydrophilic substances eluting during the first 10 min were 
manually combined and collected to prevent a possible loss of active substances. After that, the peaks 
were collected automatically and combined to logical fractions based on the obtained elution profile. 
Finally, that resulted in fraction 1 (1.21-1.40), fraction 2 (1.41-2.10), fraction 3 (2.11-3.04) and 
fraction 4 (3.05-3.22). Beside these fractions, also the waste was collected. After evaporation and 
redissolving of the eluted material, subsequent bioactivity testing within a serial dilution against 
S. aureus DSM 799 led to the identifiaction of the candidate fraction 3. Therefore, fraction 3 was 
considered for further purification by semipreparative HPLC. After testing the crude fraction 3 for 
analytical purity (Figure 18A), four additional fractions were generated by HPLC separation 
(Figure 18 B). Subsequently, these four fractions, the original crude fraction and the obtained HPLC 
waste were tested for bioactivity. Afterwards, fraction 3 was identified as the most active one, with 
inhibitory effects down to a concentration of 20 µg/mL extract.  
 
 
Figure 18: HPLC purification of the bioactive Flash chromatography fraction. 
Purification of the Flash chromatography fraction 3 to obtain high purity for NMR analysis. This resulted in four subfractions, 
which were tested for antimicrobial effects against S. aureus DSM799. 
A: HPLC elution profile of the active Flash chromatography fraction 3 before HPLC purification.  
B: The four subfractions as well as the crude extract (c) and the waste (w) were tested in a serial dilution against S. aureus 
from 25 µg to 0.01 µg/100 µL. This resulted in the identification of subfraction 3 as the most active one against S. aureus. 
C: HPLC elution profile of the purified subfraction 3. HPLC was performed to check for analytical purity, which is essential for 
further NMR analysis. 
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6.5.2 Isolate FF6-H20 
The strain FF6-H20 was fermented multiple times, extracted and fractionated by HPLC. Fraction 
collection was performed as shown in Figure 16 and guided by bioactivity testing. Multiple FLASH 
chromatography experiments were carried. Fractions were tested for bioactivity without a postive 
result. Obviously, the activity was lost even though the extracts were positively tested before. 
 After multiple fermentations the isolate FF6- H20 seemed to have lost its bioactivity. The crude extract 
was not able to inhibit any of those pathogens that have been positively tested before. Therefore, the 
fermentation broth was supplemented with synthetic N-(3 oxohexanoyl)-C6-homoserine lactone 
(2.5 mg/L) to induce the production of secondary metabolites. In contrast to the literature 
(Masschelein et al., 2013), no induction of antimicrobial activity was observed. This N-acyl homoserine 
lactone (AHL) is known to act as a quorum sensing molecule, thus activating the the biosynthetic gene 
cluster (BGC) for zeamine production.Furthermore, co-cultivation experiments with E. coli were also 
performed but without success (data not shown).  
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6.6 NMR analysis 
As already outlined above, the de-replication process of the S. aureus-inhibiting compound of the 
crude MeOH extract of Serratia strain 2MH3-2 could not be completed by well-established LC/MS and 
MS/MS approaches. Therefore, structural elucidation by nuclear magnetic resonance spectroscopy 
(NMR) had to be attempted. The purified antimicrobial compound displayed a pseudomolecular ion 
m/z 731.4464 ([M+H]+). NMR experiments indicated the presence of a cyclic lipodepsipentapeptide. A 
peptide of this size has already been described for S. marcescens and is known as serrawettin W2 
(Matsuyama et al., 1992), i.e. cyclo(3-hydroxydecanoyl-D-leucyl-L-seryl-L-threonyl-D-phenylalanyl-L-
isoleucyl).  
  
 
Figure 19: Identification of serrawettin W2. 
A: Bioactivity guided identification of the S. aureus-inhibiting fraction. The single blank well, circled in red, indicates the 
antimicrobially active fraction. 
B&C: LC/MS and MS-/MS experiments revealed a pseudomolecular ion m/z 731.4464 ([M+H]+). 
D: The cyclic lipodepsipentapeptide serrawettin W2 was identified by NMR. It consists of a ring of 5 amino acid residues and 
single fatty acid ester, i.e., cyclo(3-hydroxydecanoyl-D-leucyl-L-seryl-L-threonyl-D-phenylalanyl-L-isoleucyl).  
 
The pure compound serrawettin W2 was afterwards tested for its minimal inhibitory concentration 
(MIC) against both Gram-positive and Gram-negative bacteria (Table 9). The clinically highly relevant, 
methicillin-resistant S. aureus (MRSA) displayed the identical MIC value of 4 µg/mL as the other 
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Gram-positive bacteria tested. Apart from this, the Gram-negative test strains E. coli wildtype and the 
ΔTolC mutant exhibited no susceptibility to serrawettin W2 - the MIC value was higher than 128 µg/mL. 
The MIC values determined for serrawettin W2 underlined the antibiotic properties against Gram-
positive bacteria and extended its known range of activity to MRSA and L. monocytogenes. 
 
Table 9: Minimal inhibitory concentrations of pure serrawettin W2 against representative bacteria. 
test strain  accession number type MIC (ug/mL) 
E. coli ATCC 25922 wild type > 128 
E. coli ATCC 25922 ΔTolC mutant > 128 
B. subtilis DSM 10 wild type 4 
S. aureus ATCC 25923 MSSA 4 
S. aureus ATCC 33592 MRSA 4 
L. monocytogenes DSM 20600 wild type 4 
 
Moreover serrawettin W2 has been previously described as nematode repellent by Pradel et al. (2007). 
Therefore, an ecological role for the compound was hypothesised; and purified serrawettin W2 was 
tested for nematostatic or nematicidal effects on Ceanorhabditis elegans, respectivly (see Figure 20). 
Subsequently, 100% immotility at a concentration of 128 µg/mL was observed. Thus, the effective 
dosage (ED50) value of 25.27 µg/mL could be extrapolated, based on an exponential trend line. From 
these results, it could be concluded that serrawettin W2 is nematostatic at 128 µg/mL. However, after 
seeding the serrawettin-treated nematodes on NGM agar covered with a lawn of E. coli, 100% 
mortality was recorded at a concentration of 256 µg/mL. At a concentration of 128 µg/mL a reduced 
C. elegans population was observed, compared to thos treated with a lower dose. 
 
Figure 20: Nematode motility assay with serrrawettin W2 
Non-motile nematodes were counted under the microscope, and the percentage of non-motile animals was calculated. The 
resulting effective dose (ED50) was extrapolated directly from the graph displayed above. Average and standard error are 
given. 
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6.7 Bacterial genome sequencing  
Genomic DNA of selected bacterial isolates was subjected to whole-genome sequencing using the 
PacBio technology in order to receive full genomes of so far unidentified, bioactive isolates from the 
gut microbiome of N. vespilloides. Therefore the isolates 2ABFH4, inhibiting S. aureus and 
P. aeruginosa, Wild Mid 14, affecting C. albicans, and isolate 39, with bioactivity against E. coli and 
M. smegmatis, were prioritised. Approximately 1.3 to 1.7 gigabases (Gb) of sequencing information 
was generated per strain and used for de novo genome assembly followed by a genome circularization 
step (Table 10). Isolate 2ABFH4 has a genome size of 4.49 megabases (Mb) and gene prediction 
identified 4,070 putative genes. For the isolate Mid Wild 14, a 3.82 Mb genome was assembled and 
3,342 genes were predicted. In contrast, the genome of the isolate 39 was assembled into three 
contiguous sequences (contigs). The largest contig represents the circular bacterial chromosome with 
3.78 Mb and comprises 3,479 predicted genes. The genome additionally includes two 
extrachromosomal sequences with 63.95 kilobases (kb) and 107.43 kb. Sequence analyses have shown 
that both sequences most likely represent plasmid sequences. The 63.95 kb extrachromosomal 
sequence is circular and encodes for 78 open reading frames. For the larger extrachromosomal 
sequence (107.43 kb) 108 open reading frames were predicted. For this sequence, it was not possible 
to establish a circularized version using bioinformatics tools. In order to test if its sequence also 
represents a circular extrachromosomal sequence, PCR and subsequent Sanger sequencing spanning 
the gap is necessary.  
For phylogenetic classification of the three isolates, Sanger sequencing of the 16S rDNA region 
proposed 2ABFH4 to be most closely related to Providencia rettgeri (100% identity, ID), Wild Mid 14 
to Proteus mirabilis (~98-100% ID) and 39 to Arthrobacter sp. (~98-100% ID). However, a comparison 
of the isolates on the whole genome level to sequenced genomes deposited in public data bases 
revealed that only the isolate Mid Wild 14 and P. mirabilis share significant parts of their genomes 
(conserved DNA = 94.05%) with an overall ID of 99.43%. For the isolated strains 2ABFH4 and 39 the 
homologous regions with their next sequenced relatives are only 3.92% and 12.84%, respectively. 
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Table 10: Analysis of the PacBio sequencing effort on 3 selected isolates 
Isolate 2ABFH4 Wild Mid 14 39 
Sequenced bases [Gb] 1.30 1.55 1.69 
Contigs 1 1 3 
Genome size [Mb] 4.49 3.82 3.96 
G+C content 41.13 38.64 57.53 
CDS predicted  
(protein coding sequences) 
4,070 3,342 3,665 
Closest genetic relative available 
Providencia  
rettgeri 
FDAARGOS_330 
Proteus 
mirabilis 
AR379 
Glutamicibacter 
arilaitensis  
KLBMP 5180 
Conserved DNA  3.92% 94.05% 12.84% 
ANI  
(average nucleotide ID) 
86.50% 99.43% 88.47% 
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6.8 Analysis of biosynthetic gene clusters  
 
Most of the antibiotically active secondary metabolites are produced by polyketide synthases and non-
ribosomal peptide synthetases (PKS/NRPS) encoded in biosynthetic gene clusters. The de-replication 
of the observed bioactivity of the isolates 2ABFH4, Wild Mid 14 and 39 yielded no valuable results. 
Consequently, a bioinformatics approach was chosen. Whole genome sequencing (WGS) was used 
toidentify any present biosynthetic gene clusters (BGC). All three sequenced genomes were analysed 
using antiSMASH, a tool for the automated identification, annotation and analysis of secondary 
metabolite gene clusters. However, only strain 39 identified as Glutamicibacter sp. carries a hybrid 
type I PKS/NRPS cluster of 55,885 nucleotides. The predicted core BGC contains one type I PKS gene, 
three NRPS genes, one gene coding for a cytochrome P450-containing protein, one ACPS-type acetyl 
carrier protein (ACPS) and two thioesterase domains (TE) encoded in individual genes (Figure 21). The 
PKS gene consists of one ketosynthase (KS) domain, one acyltransferase (AT) domain and one peptidyl 
carrier protein (PCP) domain. The KS domain contains the conserved CSSSL and HGTGT motifs, which 
are essential for its functionality. One of the NRPS genes only contains one adenylation domain (A) and 
one peptidyl carrier protein PCP domain; each of the other two contain one A domain, one 
condensation (C) domain and one PCP domain, respectively. The PKS part of the BGC shares similarities 
to a BGC from Arthrobacter sp. IHBB11108 with an identity of 64%. However, the rest of the hybrid 
BGC does not share those similarities.  
 
Figure 21: Biosynthetic gene cluster of strain 39. 
A: The prediction tool antiSMASH detected a hybrid NRPS/PKS BGC. This BGC displays several core biosynthetic genes as well 
as additional genes encoding for enzymes associated with the synthesis of an unknown peptide. The predicted BGC shares 
similarity with an already known Arthrobacter BGC. Numbers underneath are explained in Table 11. 
B: The predicted compound of this gene cluster is build up from three amino acids and at least one keto group (green). Only 
one of these amino acids can be predicted as leucine. 
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Table 11: List of proteins encoded in the BGC 
Element 
Number 
Protein % Identity to Function 
1 ATP-grasp domain-containing protein  Arthrobacter sp. 
69% 
 
2 glyoxalase/bleomycin 
resistance/dioxygenase family protein 
Arthrobacter 
sp.86% 
 
3 hypothetical protein Arthrobacter sp. 
65% 
 
4 MFS transporter Arthrobacter sp. 
75% 
 
5 S9-family peptidase Arthrobacter sp. 
64% 
 
6 hypothetical protein Arthrobacter sp. 
65% 
 
7 ATP-grasp domain-containing protein  Arthrobacter sp. 
60% 
 
8 ATP-grasp domain-containing protein  Arthrobacter sp. 
75% 
 
9 Thioesterase Arthrobacter sp. 
69% 
TE  
10 amino acid adenylation domain-containing 
protein  
Arthrobacter sp. 
63% 
A and PCP  
11 type I polyketide synthase Arthrobacter sp. 
64% 
KS, AT and PCP  
12 non-ribosomal peptide synthetase Arthrobacter sp. 
59% 
C, A and PCP  
13 4'-phosphopantetheinyl transferase 
superfamily protein 
Kitasatospora 
purpeofusca 46% 
ACPS 
14 cytochrome P450 Arthrobacter sp. 
68% 
 
15 hypothetical protein Arthrobacter sp. 
69% 
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Element 
Number 
Protein % Identity to Function 
16 acyl-CoA dehydrogenase Arthrobacter sp. 
52% 
 
17 non-ribosomal peptide synthetase 
 
Arthrobacter sp. 
58% 
C, A and PCP  
18 N-acetylmuramoyl-L-alanine amidase Oscillatoriales 
(cyanobacterium) 
47% 
 
19 Thioesterase Arthrobacter sp. 
66% 
TE 
20 S9-family peptidase Arthrobacter sp. 
63% 
 
21 Unknown unknown  
22 GNAT family N-acetyltransferase Arthrobacter sp. 
79% 
 
 
While the automated structure prediction by antiSMASH always has to be reviewed critically, the basic 
chemical features of the compound encoded by the BGC can be deduced from the amino acid 
sequence. The presence of three A domains already indicates the incorporation of three amino acids 
into the final molecule. Nevertheless, the specificity prediction of the A domains resulted in only one 
defined result, namely leucine. Ultimately, the amino acid prediction and the resulting structure 
remain vague. Consequently, NMR analysis is required to advance this structural elucidation. 
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Discussion 
Aim 1: Isolation, cultivation and identification of the gut microbes 
 
7.1 The beetle  
For the start of the project it was necessary to obtain burying beetles. Therefore, catching of living, 
wild animals was prioritiesed. As the project started in April 2015, also laboratory-hatched 
N. vespilloides had to be used due to cold weather, which prevented a successful collection in the 
natural habitat. In the period from May to August, collection of the beetles with a carrion-baited trap 
was successful. Nevertheless, N. vespilloides appears to have a certain temperature preference for 
mating and breeding. In high temperatures of August, catching was often not successful. The literature 
describes a similar effect of the appearance of burying beetles. It also indicates a time- and species-
dependent breeding behaviour for burying beetle communities (Scott, 1998). This may explain the 
decreasing success of catching in the late summer months. Moreover, the area of distribution is 
specific to different Nicrophorus species. N. vespilloides has been described as a species commonly 
found in beech forests. The distribution of baited traps in this study was covering several types of areas, 
from pinewood to grassland. Almost all beetles were caught in the widely distributed beech and mixed 
beech/oak forests in the vicinity of Giessen/Germany. The same areal distribution was already 
described by Pukowski in 1933. 
Rearing of the beetles was possible under laboratory conditions but breeding was not successful. The 
larvae hatched and migrated but the development stopped in the phase of pupation. This might be an 
effect of aridity, which than inhibited the further developement of the pupae. The use of local soil 
material low in organic matter could be a reason for this (Rawls et al., 2003). Organic materials have a 
higher ability to bind humidity and to keep the soil moist. To prevent a change in both, the microbial 
community of the soil and the microbiome of the beetles, the soil material was not artificially changed. 
The method of N. vespilloides rearing was previously described by Jacobs et al. (2014). Beetles were 
kept at a constant temperature of 20°C and a day/night shift of ~ 15:9 hours. Most of the beetles in 
this study were kept in a dark incubator, which might influence the beetles’ development. Attempts of 
rearing the beetles at room temperature on the bench top resulted in a quick dehydration of the soil. 
A humidity of 80% as described for a peaty substrate (von Hoermann et al., 2013) was not achieved. 
This leads to the conclusion that the use of local soil, low in organic matter, is not suitable due to its 
low water capacity and the resulting humidity issues.  
Finally, the rearing of the beetles was stopped because of the multiple issues described above. 
Humidity and daylight control would require the use of a modern climate chamber, which was not 
available for this project. Moreover, the project was focussed on analysing the native mirobiome of 
the beetles. Therefore a constant supply of high nubers of beetles was not.necessary. It appeared that 
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catching during the warm period of the year and subsequent direct dissection was sufficient to provide 
the required material. During the winter time, laboratory-hatched beetles from the Max-Planck 
Institute for Chemical Ecology (Jena) were used, whenever necessary. 
 
7.2 The microbiome 
The key to a successful investigation of the antimicrobial potential of the N. vespilloides gut 
microbiome was the isolation and cultivation of the microbes hosted. In general, the cultivation of 
mircoorganisms is limited by environmental parameters i.e. temperature, pH-value, oxygen supply and 
nutrient composition including the availabilty of micro nutrients and trace elements. However it 
appears challenging to mimic these parameters under laboratory conditions. This fact is the reason for 
the so-called “great plate count anomaly” (Staley and Konopka, 1985). This phenomenon was 
described by the finding of a large discrepancy of bacteria observed under the microscope in contrast 
to those growing in culture under laboratory conditions (Razumov, 1932). Today, molecular methods, 
e.g. 16S rRNA gene amplification and sequencing provide insights into the vast diversity of microbial 
communities without the restrictions caused by cultivation (Head et al., 1998). Based on this 
knowledge, it was estimated that less than 1% of the microbial kingdom can be cultivated. Modern 
cultivation techniques, e.g. the use of the iChip, were recently shown to increase this number by 
cultivating bacteria in its natural habitat under environmental influences (Nichols et al., 2010).  
Cultivation approaches have beem performed previously in other burying beetle species. However, 
they were focused on the medically important bacteria (Solter et al., 1989; Berdela et al., 1994). The 
value of these studies was, however, impaired by the use of standart media for clinical microbiology. 
The first cultivation-independent study on the microbiome of burying beetles (Silphidae) unveiled the 
50 most abundant bacterial species, based on partial 16S amplicon sequences (Figure 22) 
(Kaltenpoth and Steiger, 2014). Also, the N. vespilloides hindgut discussed here was considered in this 
study. The hindgut composition of the Silphidae investigated was dominated by the phyla of Firmicutes 
and Proteobacteria, whereas Bacteriodetes and Fusobacteria were less abundant. The most abundant 
families in the phylum Firmicutes were identified as Enterococcaceae, Clostridiaceae and 
Rumininococcaceae, next to Xanthomonadaceae and Enterobacteriaceae of the phylum 
Proteobacteria. Kaltenpoth and Steiger underlined the remarkable differences in the microbiota 
composition of the Silphidae with the least diversity found in the hindgut of N. vespilloides. Most of 
the sequenced operational taxonomic units (OTUs) of N. vespilloides were Gammaproteobacteria. The 
most abundant families found were the Xanthomonadaceae and Enterobacteriaceae and the 
Enterococcaceae of the phylum Firmicutes. 
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Figure 22: Sequence-based analysis of the Silphidae microbiomes. 
The figure displays the 50 most abundant operational taxonomic units (OTUs) of the burying beetles (Silphidae) as reported 
by Kaltenpoth and Steiger (2014). The phylogenetic analysis was based on partial 16S rRNA gene sequences of a length of 300 
bp (amplicon). Phylogenetic sections were coloured to distinguish between bacterial orders and phyla.Figure reproduced 
with permission of the journal. 
 
Recent investigations on N. vespilloides were gained more detailed knowledge on the microbial gut 
community. Vogel et al. (2017) were able to specify the bacterial composition of both midgut and 
hindgut. Moreover, they performed fluorescence in situ hybridization (FISH) of the major bacterial taxa 
and were able to localise them in the gut. Their results supported the earlier findings of Kaltenpoth 
and Steiger (2014) who noticed a high abundance of the Enterococcaceae (phylum: Firmicutes), 
especially of the genus Vagococcus. Also, the family Enterobacteriaceae (phylum: Proteobacteria) was 
present, dominated by the genera Morganella, Providencia and Proteus as well as by the family 
Xanthomonadaceae (order: Xanthomonadales). FISH analysis illustrated the high bacterial load in the 
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gut. Moreover, the use of taxon-specific probes proved the high abundanc of the genera Vagococcus, 
Morganella, Tissieralla, Providencia and Proteus as well as of the family Xanthomonadaceae. 
 
 
Figure 23: Fluorescence in situ hybridization of the N. vespilloides hindgut. 
A general bacterial probe (green) was used to stain the microbiota inside the gut. Additionally, taxon specific probes (red) 
were used to colour the six major bacterial taxa. DAPI staining was performed to colour the gut epithelia (Vogel et al., 2017). 
Reproduced with permission of the journal. 
 
The results of this cultivation-based study are similar to those published by Kaltenpoth and Steiger 
(2014) and Vogel et al. (2017): 
The genera Proteus, Morganella and Providencia of the order Enterobacteriales 
(phylum: Proteobacteria) were among the five most abundant cultivates, followed by Serratia and 
Hafnia. Additionally, the family Xanthomonadaceae were cultivated in high abundance. Most of the 
bacteria isolated belong to the genus Stenotrophomonas. This genus was, next to Serratia 
(order: Enterobacteriales), most frequently isolated, followed by the genus Hafnia. Serratia has not 
been observed as a major component of the gut microbiota by Vogel et al. (2017). Nevertheless, 
Kaltenpoth and Steiger (2014) could investigate one of the 50 most abundant Silphidae associated 
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OTUs clustering next to Enterobacter and Serratia. Moreover, Berdela et al. (1994) was able to isolate 
Serratia from the gut of different species of burying beetles. Recently published data by Shukla et al. 
(2018) confirm the isolation of Serratia from the N. vespilloies gut. Surprisingly, in this study 
Providencia was less present than indicated by previous work of Vogel et al, (2017), for comparison 
see Figures 9 and 23. On the other hand, a higher abundance of Pseudomonas 
(order: Pseudomonadales) was isolated from the gut. In none of the previous studies Pseudomonas 
has been reported as one of the dominant genera in adult beetles. So far, Pseudomonas has only been 
reported from the larval gut of N. vespilloides (Vogel et al., 2017). The presence of the genus Hafnia 
has only been described for other carrion beetles (Berdela et al., 1994) but not for N. vespilloides. FISH 
analysis corroborate the high quantity of Vagococcus (order: Lactobacillales) in the gut. This is further 
supported by the results of the cultivation approach in this study. Within the Bacilli, Vagococcus was 
the most prominent genus cultivated. In addition, few unspecified bacteria (less than 98% identity via 
BLASTn) were cultured. Most of these share 16S sequence similarity to sequences in the NCBI 
database, which resulted from 16S amplification sub cloning efforts. Hence, no physiology or 
phylogenetic investigation has been previously performed.  
The genus Proteus (order: Enterobacteriales) is widely distributed in nature and can be found 
in soil, water and the human gut (Mobley and Belas, 1995). Furthermore, species of this genus can 
cause urinary tract infections. Proteus is notorious for the ability of swarming (Hoeniger, 1964), which 
has been intensively studied. Evidence for the swarming of P. mirabilis by the extracellular signal 
induction of putrescine has been investigated (Sturgill and Rather, 2004). Putrescine is a biogenic 
amine, which is produced enzymatically by bacterial decomposition of the amino acids ornithin and 
arginin, respectively (Wunderlichova et al., 2014). As described in the result section (chapter 6.3.1), 
swarming and overgrowing by Proteus isolates caused difficulties in the isolation of other 
microorganisms. Swarming was reduced by lowering the nutrient content of the growth medium to 
50%. The strategy of decreasing the amount of available nutrients inhibited the swarming of Proteus 
efficiently. This finding also underlines the hypothesis that swarming can be initiated by the presence 
of glutamine (Allison et al., 1993) which is also a constituent of the protein-rich BHI medium. 
Providencia (order: Enterobacteriales) is another globally distributed genus. It is known for 
causing nosocomial as well as urinary tract infections. This genus comprises a number of species with 
antibiotic resistances (Stock and Wiedemann, 1998). Moreover, few Providencia species have been 
reported as insect pathogens in Drosophila melanogaster (Galac and Lazzaro, 2011).  
The genus Hafnia (order: Enterobacteriales) has previously been isolated from carnivorous 
animals, e.g predatory birds and insects (Janda and Abbott, 2006). In rare cases, Hafnia was also 
documented as a human pathogen (Ramos and Damaso, 2000; Gunthard and Pennekamp, 1996; 
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Albert et al., 1991). Moreover, it was reported as a resource for green chemistry and the production 
of 1,3-propanediol (Drozdzynska et al., 2014).  
Morganella with its single species Morganella morganii has been isolated from a vast variety 
of sources, e.g. animals like dogs, chicken or snakes and human faeces. M. morganii was reported as a 
bacteriocine producer, biosynthesising morganocin (Coetzee, 1967).  
Vagococcus of the order of Lactobacillales was represented in this study by a single species, 
V. fessus, which has been isolated for the first time from marine mammals (Hoyles et al., 2000). Other 
vagococci, for example, have been obtained from wasps (Killer et al., 2014) and infected fish 
(Schmidtke and Carson, 1994).  
Serratia isolates were frequently cultivated in this project. Members of this genus have been 
isolated from a vast variety of environments, comprising air, water and soil. Moreover, strains 
associated with plants and insects are known (Grimont and Grimont, 1978). In the 1970s, Serratia 
gained some attention due to field trials of the US government on civilian population that were aimed 
at collecting data on the use of possible bioweapon agents in public places (Mahlen, 2011). Beside this, 
the species S. marcescens is a well-studied insect pathogen (Flyg et al., 1980). This species is mostly 
recognised by its red colonies. This colouration is caused by the red pyrrole alkaloid prodigiosin 
(Williams, 1973). However, none of the Serratia isolates cultivated here displayed this typical red 
pigmentation. In fact, S. marcescens, S. proteamaculans, S ficaria, S. plymuthica, S. liquefaciens and 
other Serratia spp. were isolated multiple times. Subspecies diversity and accuracy of the identification 
based on 16S analysis are limited. Consequently, species diversity remains unknown.  
In addition to Serratia, the genera Pseudomonas (order:  Pseudomonadales) and 
Stenotrophomonas (order: Xanthomonadales) were frequently isolated in high abundance. The former 
can be found ubiquitously but is also known as a pathogen of animals, humans and plants 
(Moore  al., 1996). Pseudomonas species are able to process a large variety of complex organic 
compounds, e.g the hydrolysis of fats (Goldman and Rayman, 1952). Due to the formation of lipases 
(Gilbert, 1993) and the ability to metabolise complex carbon sources, gut and diet of the beetles appear 
to be a suitable habitat for the isolated species P. brenneri, P. extremorientalis, P. fluorescens, P fragi 
and Pseudomonas sp. . 
The genus Stenotrophomonas has been orginally been described as Pseudomonas, then hosted 
in Xanthomonas and finally reclassified in Stenotrophomonas (Ryan et al., 2009). The main 
environmental sources for Stenotrophomonas are soil and plants, although the genus can be found in 
almost every environmental niche. Members of the Xanthomonaedaceae can grow in a broad 
temperature range; and several species are reported as oil-and petroleum-degrading 
(Chang and  Zylstra*, 2010). Notably, the genus is able to utilise a broad range of C- and N-sources. It 
is also known to produce the plant hormone indole-3- acetic acid (Park et al., 2005), thus stimmulating 
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the growth of both shoots and roots. Apart from that, S. malthophilia is an emerging human pathogen, 
typically causing respiratory tract infections (Brooke, 2012). It has also been reported as a source of a 
highly active keratinase (Cao et al., 2009). S. malthophillia was the most frequently isolated species of 
this genus. Being associated with plants and soil constitutes, a high potential of colonizing the gut of a 
soil associated beetle can be hypothesised. The keratinolytic activity can be beneficial for the beetle 
whilst dealing with the depilation of the carrion. Moreover, the ability to handle lipid-rich substrates 
is highly valuable for a gut symbiont of N. vespilloides.  
Alongside the bacteria, yeast and fungi were also cultivated successfully. Notably, yeasts of the genus 
Yarrowia (order: Saccaromycetales) are highly abundant in the rectum of N. vespilloides. The spectrum 
of isolatied species included Y. divulgata and Y. lipolytica; however the majority of isolates were 
Y. lipolytica-like species. Y. lipolytica is intensively studied yeast that is capable of degrading 
hydrophobic substances such as fatty acids, fat and oil (Fickers et al., 2005). It was shown that species 
of this genus are transferred to the carcass, thereby lowering abundance of soil-borne Candida species 
(Shukla et al., 2018). Besides Yarrowia, Shukla and colleagues reported on the presence of Candida on 
the tended carcass. Nevertheless, they also admitted the possibility of contamination due to its 
abundance in soil. In this context, it appears that Yarrowia species are able to outcompete other soil-
associated yeasts on the tended carcass. Thus, these authors postulated a major contribution to 
carcass preservation. 
The microbiome of N. vespilloides shares similarities to that of sarcophagus flies as already stated by 
Vogel et al. (2017). A large number of antibiotic resistant bacteria were found in the beetles’ gut, 
including numerous species that are potentially pathogenic to humans. Beside the genus Tissierella, all 
other dominant taxa found by Vogel et al. (2017) were detected in this cultivation approach. Tissierella 
is an obligately anaerobic genus of Gram-negative bacteria (Farrow et al., 1995). In this project, 
anaerobic cultivation was performed less prioritised. The anaerobic jar cultivation performed, 
supported the growth of facultatively anaerobic and microaerophilic bacteria. Those can use 
fermentation and anaerobic respiration but are often able to switch to oxygen dependant respiration. 
A lot of bacteria classically linked with soil or roots, e.g. members of the orders Actinomycetales or 
Rhizobiales (Guerrero et al., 2005), were isolated. Alongside, a large community of Lactobacilli and 
Enterobacteria was explored. A lot of the bacterial species e.g. Serratia marcescens have been 
reported as insect-associated  either as gut symbionts or pathogens (Broderick and Lemaitre, 2012). 
Moreover, lactobacilli are known as producers of bacteriocins (Martínez et al., 2016) which may help 
the beetle to preserve the carcass of the carrion by their antimicrobial properties. 
Together with the bacteriocin-producing Lactobacilli, other natural products (NP) producing genera 
were cultivated. Most genera of the order Actinomycetales have been reported as prolific sources of 
bioactive antimicrobial compounds, especially the filamentous genus Streptomyces. The latter has 
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been screened for NP production since the early 1940s and have been exploited a source of a 
remarkable number of antibiotics on the market (Watve et al., 2001). The abundance of the order of 
Actinomycetales in this study was relatively low. In this context it has to be considered that most 
species within this order are soil-borne spore formers. Consequently a count low in Actinomycetales 
corresponds to neglectable cross-contamination by soil- and air-borne propagules of this order.  
It is also noteworthy that the microbiome of N. vespilloides contains a large group of antimicrobial-
resistant bacteria, which have already been reported by Shukla et al., (2018). Resistances towards 
antibiotics are a naturally occurring phenomenon. In order to survive, any antibiotic-producing 
organism has to protect itself against self-harming. (Hopwood, 2007). Therefore, the bioinformatics 
approach on finding new natural products includes the screening of antibiotic resistances next to BGC 
analysis (Thaker et al., 2013), thus taking into account the relevance of these resistances. Nevertheless, 
a more classical approach of screening for bioactivities was chosen to uncover the antimicrobial 
potential of the cultivated microorganisms in this project. 
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Aim 2: Fermentation, chemical extraction and antimicrobial screening 
 
7.3 Antimicrobial bioactivities  
All bacteria and Yarrowia isolates were subsequently screened for antibacterial and antifungal activity. 
Therefore, bacterial isolates were selected based on the 16S best BLASTn results. From each species, 
at least one representative isolate was chosen and considered for fermentation. Because of 
practicability and common use, it was tried to obtain full 16S rRNA gene coverage with the primer set 
27F and 1492R. This resulted in a potential maximal read length of 1465 bp and therefore a high 
coverage of the 16S gene (Janda and Abbott, 2007). Generally, this approach is limited by the 
insufficiency to distinguish between sub-species or, in some cases, even species (Stackebrandt and 
Goebel, 1994). Hence, it is possible that potentially interesting isolates were not consiedered and thus 
remained undetected. 
In this study, a broad spectrum of bacteria was screened for antimicrobial effects, without preference 
for those, taxa (e.g. Actinomycetales, Burkholderiales and Bacillales [Fickers, 2012; Challinor and Bode, 
2015]) that have previously been exploited as producers of antimicrobial compounds. 
To evaluate the potential of the microbes to produce antimicrobially active secondary metabolites, a 
kinetic strategy was chosen for the fermentation: 
In order to enduce nutrient limitation, bacteria were grown up to 9 days until they reached 
stationary growth phase (Hopwood, 2007). This strategy obviously promoted the biosynthesis of 
antimicrobially activity secondary metabolites. As can be concluded from Table 6, the majority of 
extracts displayed antimicrobial activity, which increased by time. Cultures, e.g. strain 89 (Enterococcus 
avium) or strain FF6-H2O (Serratia plymuthica), were inhibiting less of the tested pathogens when 
harvested after day 1 of fermentation. Afterwards, the spectrum of antimicrobial activity changed. 
During that time, cultures might have reached nutrient limitation and entered the stationary growth 
phase. These effects have been summarised and discussed not only for Streptomyces but also for 
Enterobacteriaceae (Chater and Mervyn, 1997). The same effect was observed vice versa with bacteria 
producing antimicrobials in the early stage of growth. Once entering a later growth phase, no inhibition 
of the test pathogens could be observed, anymore. The MeOH extract of isolate 16 
(Serratia proteamaculans) displayed antimicrobial activity against M. smegmatis after day 1 of 
fermentation. After the following 8 days of cultivation this inhibiting effect was lost (Table 6). 
Despite several decades of antibiotic research, the question ofhow bacteria can be induced and 
optimised for antimicrobial compound production has yet not been fully resolved. Nevertheless, 
versatile strategies for induction of bioactive secondary metabolites can be applied (Knight et al., 2003; 
Onaka et al., 2011). The missing information on environmental parameters of the beetle’s gut 
decreased the chance to improve the conditions for secondary metabolite production. Hence, the 
Discussion 
69 
 
fermentation in complex media (BHI and TSB) was performed to observe the antimicrobial capacity of 
the bacterial isolates. Nevertheless, media selection and environmental parameters are known to 
exert a tremendous impact on secondary metabolite induction (Scherlach and Hertweck, 2009). The 
complex physiological conditions in the gut such as changing pH-values and oxygen distribution as well 
as nutrient degradation are important parameters, although dificult to reproduce artificially. The 
variation of different media can be an option for the optimisation or induction of antimicrobial 
secondary metabolite production (Bocker, 1978).  
After fermentation and chemical extraction, HPLC separation and fraction collection of the crude 
extracts were performed. Subsequently, after confirmation of bioactivity, LC/MS-and MS/MS-based 
de-replication was conducted.However it appeared that most of the crude extracts stored in MeOH at 
4 C completely lost their antimirobial activity. This unexpectedloss of bioactivity required 
refermentation (Table 7) and chemical extraction. Surprisingly, extracts of  3 months of age remained 
active, whereas older ones became inactive. Consequently, extracts must not be stored in MeOH for 
prolonged periods of time in order to retain their antibiotic activity. Afterwards, extracts where 
evaporated and stored at 4°C to ensure a safe storage.  
To limit the rediscovery of antimicrobial metabolites, LC/MS based de-replication with the natural 
products database “AntiBase” is of high value. Therefore, it is essential to lower the complexity of the 
crude extracts by HPLC separation and perform LC/MSexperiments. After biological testing of the 
separated extracts, the bioactive fractions can be scrutinised for known antimicrobials by LC/MS. In 
theory, the retention time should not differ too much when using the same experimental setup. All 
extracts that retained their bioactivity were analysed by LC/MS, but no hits inAntiBase were found. 
Surprisingly, most of the crude extracts revealed a HPLC elution profile devoid of major peaks in the 
calculated retention time window. Subsequent analysis of serrawettin W2 revealed a considerabele 
retention time shift of retention times observed during HPLC and LC/MS analysis. Therfore, it is 
hypothesised that the dereplacation of antimicrobial activies failed due to this shift in retention time. 
Thus, the discussion of the bioactivities observed is mainly based on literature data.  
Another omnipresent phenomenon in natural product research is the sudden loss of antimicrobial 
activity because the producing organism ceased the biosynthesis of an active compound. In this study, 
this phenomenon was observed with the majority of extracts active against Gram-negatives. 
As already mentioned above, the strategies for induction of the biosynthesis of secondary metabolites 
are diverse. Nutrients, vitamins and other precursors, homoserine lactones (Demain, 1998) or even 
the absence of another microbial strain can support or interrupt such induction 
(Mearns-Spragg et al., 1998; Pettit, 2009). Furthermore, other studies showed that cell-free 
supernatants can function as an appropriate inducer of antimicrobial production (Burgess et al., 1999).  
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In summary, most of the observed bioactivities were directed towards M. smegmatis. This species is 
known to be a highly sensitive substitute for screening anti-tuberculotics. However, it has to be drawn 
into account that it may yield to many positive hits. Therefore, the discrimination between positive 
hits and false positives, which is only possible by screening M. tuberculosis, remains inevitable 
(Mitscher and Baker, 1998).  
Additionally, wild type E. coli as well as a ΔTolC mutant of E. coli, were selected as test strains. Due to 
inconsistent inhibition results in the screening process, the ΔTolC mutant had to be excluded from the 
results afterwards (Apendix). TolC is, as well as the multidrug efflux pump element AcrAB, involved in 
the expulsion of antimicrobial compounds (Koronakis et al., 2004). The inhibition of this efflux pump 
generates hypersensitive E. coli screening strain (Augustus et al., 2004). Penetration of the 
Gram-negative cell membrane is one of the major challenges in antibiotic drug discovery and 
developement (Pages et al., 2008). Therefore, potential drugs inhibitng the ΔTolC E. coli strain would 
provide options for a combination with, e.g. AcrAB-TolC efflux pump inhibitors such as pimozide 
(Bohnert et al., 2013).  
Overall, extracts inhibiting Gram-negatives were scarce and derived mainly from Enterococcus and 
Serratia species as described previously. The inhibition of E. coli often co-occurred with that of 
P. aeruginosa. For Enterococus faecium, this has previously been reported (Zheng et al., 2015) and is 
similar to the antimicrobial activities observed here. Additionally, these antimicrobially active crude 
extracts from Enterococcus species frequently also inhibited Candida albicans. This is in contrast to the 
literature hitherto published in this field. Candida-active antimycotics derived from Enterococcus are 
rare but have been mostly identified and reported as one protein with activity on multi-drug resistant 
strains (Shekh and Roy, 2012). Besides that, numerous bacteriocins of Enterococcus species have been 
reported (De Vuyst et al., 2003). 
The red pigement prodigiosin is the most prominent antibiotic compound of the genus Serratia. 
Species producing prodigiosin are easily detectable by their phenotype (Williams, 1973; 
Lapenda et al., 2015). In this study, none of the Serratia isolates formed a red pigment. It has been 
described, that the induction of prodigiosin biosynthesis is mediated by quorum sensing 
(Thomson et al., 2000). Environmental parameters such as temperature and nutrients may also affect 
the induction. Notably, non-pigmented clinical isolates devoid of prodigiosin production are commonly 
recovered from human specimens (Grimmont & Grimmont, 1978). Apart from prodigiosin, other 
antimicrobially active secondary metabolites have been reported from this genus such as a -lactame 
antibiotics (Parker et al., 1982) or peptide antibiotics e.g. althiomycin (Gerc et al., 2012). 
Several unspecified isolates displayed antimicrobial activity. Most of these were active against 
M. smegmatis, but some were also inhibiting Candida and Pseudomonas aeruginosa, respectively. 
Because of the numerous antimicrobial effects against M. smegmatis and the necessity of a 
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sophisticated bioassay to confirm the hits, M. smegmatis activities were no longer considered for 
screening.  
Unspecified bacteria and strains not related to those genera known as classical producers of antibiotics 
were of high interest in this project. To increase the chances of discovering structurally new antibiotics, 
recent studies underlined the necessity to exploit new bacterial genera with genetic distance to the 
known compound producers. Finally, it was stated that chemical diversity depends on the genetic 
distance (Hoffmann et al., 2018).  
Microbial strains isolated in this study were classified by rRNA gene amplification, subsequent Sanger 
sequencing, and BLASTn analysis of the sequencing results against public databases (see Figure 9). 
Phylogenetic analysis of the 16S rRNA gene is a standard procedure in microbiology for the 
identification of bacteria (Woese et al., 1987; Weisburg et al., 1991; Lane, 1991). Nevertheless, 
identification based on 16S rRNA gene homology is often not sufficient to distinguish between species 
or even genera (Fox et al., 1992; Vandamme et al., 1996). Due to these drawbacks, in this study best 
BLASTn hits of rRNA gene sequences were only used to scrutinise the phylogenetic background of the 
strains and to predict the putative closest relative within the database. Commonly used homology 
thresholds to strictly define species (e.g. ≤ 98% 16S rRNA gene homology) were left aside and 
assignments of species names and genera have to be considered putative for the time beeing. 
Whole genome sequencing is the molecular method of choice to perform a more precise taxonomic 
identification (Poretsky et al., 2014). Three of the most promising strains from this study were 
therefore subjected to whole genome sequencing. One of these isolates was strain 39, which showed 
inhibitory effects against the Gram-negative E. coli (Table 7). The initial phylogenetic analysis via 
16S rRNA gene sequencing and BLASTn analysis had identified Arthrobacter sp. as the closest relative 
with a sequence identity of 100%. The newly sequenced genome of strain 39 was compared to NCBI’s 
“Reference Genomes” on the whole genome level. It was shown that the best match among the 
reference genomes was Glutamicibacter arilaitensis, but it has to be taken into account that the 
homologous region between both strains only comprises 12.8% of the genome sequences. While for 
this conserved DNA the overall sequence identity is 88.47%, the rest of the genomes have no significant 
similarities. Thus, the 16S-based classification and the whole-genome approach do not result in the 
same closest relative, which is not surprising, because the reference genome data base includes way 
less species than the database used for 16S BLAST analysis. Nevertheless Arthrobacter and 
Glutamicibacter are related species, since Glutamicibacter is a genus reclassified from Arthrobacter 
(Busse, 2016). However, a taxonomic classification of strain 39 on the genome level has to be 
postponed, due to the low amount of conserved DNA shared with so far sequenced and publically 
available bacterial genomes.  
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The genome of strain 39 comprises a small nonribosomal protein synthesis/polyketide synthesis 
(NRPS/PKS) biosynthetic gene cluster (BGC). Hence, further investigations on both the BGC as well as 
the strain itself will be necessary for phylogenetic classification of this strain and its antimicrobial 
compound. 
The strains 2ABFH4 and Wild Mid 14 were previously regarded as unspecified isolates, based on 16S 
best BLASTn. The whole genome BLASTn of strain 2ABFH4 resulted in the identification of Providencia 
rettgeri as its closest related species. However, the genome of strain 2ABFH4 and P. rettgeri only share 
3.92% of their genome. This rather small homologous region has a sequence identity of 86.5%. Due to 
these results, a phylogenetic identification is not possible for the time being. AntiSmash analyses were 
not able to detect any known BGC. Furthermore, a reclassification of that strain based on the 
bioinformatic analysis and compound isolation would certainly contribute to the identification of strain 
2ABFH4 and its spectrum of antimicrobials produced. Finally, it cannot be excluded that isolate 2ABFH4 
might also represent a new species.  
In contrast, the isolate Wild Mid 14 shares 94% of its genomic sequence with 99.4% identity with 
Proteus mirabilis. Because of this high similarity, it can be assumed that this isolate is a member of the 
genus Proteus. Strain Wild Mid 14 is therefore the only one of all three whole genome sequenced 
isolates that can be attributed to a defined genus. 
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Aim 3: Analytic and isolation of interesting candidates 
 
7.4 The isolated strain FF6-H2O 
Strain FF6-H2O was isolated from the gut of the burying beetle by long-term cultivation on 1.5% water 
agar. The nutrient deficiency led to slow growth of the bacteria and, therefore, prevented bacterial 
generalists to overgrow other, more specialised, slow-growing taxa. This isolate was identified as 
Serratia plymuthica and exhibited no red pigmentation. Hence, the production of prodigiosin under 
the experimental conditions applied could be excluded. Moreover, the isolates FF6- H2O and 56 were 
the only ones of the genus Serratia to display activity against all microbes tested. Because of this broad 
antimicrobial effect, LC/MS and MS/MS analyses were performed, and subsequently AntiBase 2014 
was searched for hits as previously described. Finally, a literature search for broad antimicrobial 
activity produced by Serratia species led to the hypothesis of zeamine I (C49H101N4O6) 
(Masschelein et al., 2013). Zeamines are known as broad-spectrum antibiotics encoded by a hybrid 
NRPS/PKS biosynthetic gene cluster. Notably, they also exhibit nematicidal activity (Hellberg et al., 
2015). The compound is targeting the cell wall unspecifically (Masschelein et al., 2015), thus explaining 
its broad antimicrobial activity. Further LC/MS experiments could not support the initial hypothesis. It 
was not possible to reconfirm a pesudomolecular ion of zeamine I as initially detected. Moreover, HPLC 
separation and fraction collection as well as subsequent bioactivity-guided testing revealed different 
bioactive fractions (Figure 16). This indicates either derivates of zeamine I e.g. bioactivty derivatives of 
the molecule, or an initial misidentification of the antimicrobially active compound as zeamine I. 
Therefore, FLASH chromatography followed by activity-guided screenings of the resulting fractions was 
performed multiple times, without a positve identification of a bioactive fraction. Additionally, 
different chemical extraction methods were evaluated for improving the compound isolation process. 
The following strategies were applied to obtain high amounts of crude extracts after fermentation: 
(i) liquid-liquid extraction with EtOAc, (ii) cultivation with the adsorbent XAD 2 and (iii) the classic 
freeze-drying approach as described above. Nevertheless, all extracts were devoid of bioactivity after 
large-scale fermentation. The use of N-(3-oxohexanoyl)-C6-homoserine lactone, a naturally occurring 
quorum sensing molecule, was not successful. Orininally, this molecule was described as an inducer of 
the zeamine I biosynthesis by S. plymuthica (Masschelein et al., 2013). Consequnetly, this negative 
result further supports the hypotheis of the presence of an antibiotic compound other than zeamine 
I. 
As previously mentioned, the loss of bioactivity is a global phenomenon, the reasons for which can 
often not be identified. Often, co-cultivation experiments or the supplementation with cell-free 
supernatant of other bacterial cultures are considered. The presence of other bacteria or metabolites 
can induce the antimicrobial compound production and would also be appropriate for fermentation 
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scale-up. Cell-free E. coli supernatant was therefore tested for the induction of zeamine I biosynthesis; 
however this approach was also unsuccessful.  
Whole genome sequencing is another possible method to uncover the antimicrobial potential of the 
strain FF6-H2O. Generally, this approach facillitates a defined phylogenetic identification as well as an 
identification of BGC’s by AntiSMASH. As previously shown in this study for isolate 39, 16S gene-based 
identification can be insufficient to identify a species. Therefore, the phylogenetic classification of the 
strain FF6-H2O had to remain hypothetical. Consequnently, whole genome sequenzing or PCR 
trargeting significant features of BGCs can support the identification (Lemetre et al., 2017). Therefore, 
any specific approach towards an induction of the BGC is based on hypothesis. 
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7.5. The isolated compound serrawettin W2 
Strain 2MH3-2 was identified as S. marcescens and exhibited antimicrobial activity against S. aureus. 
The HLPC separation and collection of the resulting fractions led to the identification of a medium-
polar antimicrobial compound. Subsequent isolation by FLASH chromatography yielded 5 mg of pure 
compound derived from 5 L fermentation. The genus Serratia, like most of the other 
Enterobacteriaceace, grows fast to high cell density. Moreover, the production of extracellular proteins 
resulted in a high amount of crude extract. Hence, to reduce its amount, proteins had to be 
precipitated to prevent overloading of the FLASH column and to facilitate an optimal separation.  
Further NMR analysis confirmed the production of the cyclic depsipeptide serrawettin W2, as 
previously hypothesised. Serrawettin W2 is a secondary metabolite produced by S. marcescens and 
has previously been reported as a bacterial surfactant (Matsuyama et al., 1986; 
Matsuyama et al., 1992). Bacterial surfactants, e.g. surfactin from Bacillus subtilis, are often 
lipopeptides (Raaijmakers et al., 2010), which are capable of lowering the surface tension. Thereby, 
the bacteria are able to spread on semisolid surfaces and therefore, these compounds are also called 
wetting agents (Matsuyama and Nakagawa, 1996). These biosurfactants are considered alternatives 
to other antimicrobial agents against different clinical infections (Fariq and Saeed, 2016). 
Serrawettin W2 has been tested for its antimicrobial activity and was able to suppress both 
Gram negative and -positive bacteria (Su et al., 2016). The latter findings are in contrast to the results 
of this project. Here, serrawettin W2 only inhibited Gram-positive bacteria such as B. subtilis, 
L. monocytogenes and S. aureus (MSSA and MRSA). 
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7.5.1 Ecological role of serrawettin W2  
Insect-associated beneficial bacteria and their bioactive secondary metabolites have gained much 
interest of the scientific community. For a long time, the contribution of microbial symbionts to the 
biosynthesis of low-molecular-weight compounds was neglected although the metabolites themselves 
have been known for decades. For example, the biosynthesis of the antitumour amide pederin has 
been discovered in an unculturable symbiont of the Paederus beetle (Piel, 2002). The highly toxic 
pederin is used by the beetle for chemical defence (Dettner, 1987). Moreover, antibiotic-producing 
symbiontic Streptomyces species have been intensively studied (Kaltenpoth, 2009) and reported to be 
part of the evolutionary evolved defensive symbiosis with the European beewolf Philantus triangulum 
(Krois et al., 2010; Engl et al., 2018). 
Due to these findings, it has been hypothesised that the preservation process of N. vespilloides is 
supported by beneficial bacteria producing bioactive low-molecular-weight compounds 
(Degenkolb et al., 2011). The recently published results of Shukla et al. (2018b) underline the ecological 
importance of the genus Serratia. Notably, a number of Serratia strains displaying antimicrobial 
bioactivities have been isolated and investigated in this thesis. The compound serrawettin W2 isolated 
from a S. marcescens strain displayed antimicrobial and nematostatic activities that were hypothesised 
to be of importance for carcass preservation. Additionally, serrawettin W2 has been previously 
reported as an efficient repellent against the nematode Caenorhabditits elegans by Pradel et al. (2007). 
Furthermore, the burying beetle N. vespilloides was found to be associated with parasitic nematodes 
(Richter, 1993). Recent studies investigated another parasitic nematode that resembles very much 
Rhabditoides regina. The authors stated a negative influence on carcass health, larval survival, and 
larval mass, respectively (Wang and Rozen, 2017; Wang and Rozen, 2018b). It is therefore conceivable 
that serrawettin W2 helps the beetle to control the nematode load on the carcass itself and in its 
immediate vicinity, as supported by the findings of this study. The inhibition of Gram-positive bacteria 
may also be beneficial for carcass sanitation and preservation.  
Notably, this thesis describes for the first time a structurally defined, low-molecular-weight 
antimicrobial and nematostatic compound as a secondary metabolite of a gut symbiont of 
N. vespilloides. However, further investigations are required to link this compound to the process of 
carcass preservation and the unique ecology of N. vespilloides.  
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7.6 The influence of the microbial gut symbionts on N. vespilloides and its life cycle 
The preservation process of the burying beetle is a poorly understood phenomenon, which still 
fascinates the scientific community. The antimicrobial effects, which are essential for preservation of 
a rich, but highly susceptible nutrient source, have to be exceptionally efficient on one hand, but must 
not harm the developement of larvae on the other. Therefore, the major question is whether the 
beetle itself, the gut microbiome, or both “components” synergistically preserve the carcass by the 
production of carcass-preserving and repellent agents.  
To answer this question, the N. vespilloides was investigated for the expression and secretion of 
antimicrobial peptides (AMPs). Those have been investigated extensively in insects, and some show 
promising antimicrobial potential (Wiesner and Vilcinskas, 2010; Tonk and Vilcinskas, 2017). 
Twenty-seven AMPs and three lysozymes have been reported for N. vespilloides. When the beetle was 
exposed to carrion, both c-lysozyme-2 and thaumatin-4 were found to be highly expressed 
(Jacobs et al., 2016). Both of these antimicrobial proteins are also present in the anal secretion of the 
beetle. Nevertheless, it is hypothesized that the sanitation of the carcass requires a broad spectrum of 
antimicrobial compounds (Jacobs et al., 2016), including AMP’s. Therefore, the target-oriented 
exploration of the gut microbiome might fill another gap in our current understanding of the 
preservation process. It has been previously shown that the burying beetle N. vespilloides hosts an 
unusual microbiome (Kaltenpoth and Steiger, 2014). Although the role of antimicrobial low-molecular-
weight compounds was previously hypothesised (Degenkolb et al., 2011), the production of antibiotic 
or carcass-preserving compounds has not yet been linked to a spectrum of defined microbial 
producers. To date, it could only be shown that certain microbes such as Wohlfartiimonas, Providencia, 
Morganella, Vagococcus, Myroides, and the yeast Yarrowia, are transferred to the carcass. Notably, 
these microbes are neither present on untreated carrion nor in the soil (Shukla et al., 2018).  
In this thesis, a cultivation-dependent approach has been used for the first time to investigate the 
antimicrobial potential of the N. vespilloides gut microbiome. To date, little is known if the 
antimicrobial potential observed in this project is of any relevance for the beetle. The multiple 
antimicrobial effects described in this study were observed under laboratory conditions, only. Thus, 
in vivo experiments are inevitably required to link those antimicrobial effects to the beetle’s unique 
ecology.  
Recently, co-cultivation experiments with Morganella morganii isolated from N. vespilloides gut and 
Serratia marcescens isolated from decomposing mice carcasses were conducted. Wang and Rozen 
(2018a) demonstrated the inhibition of their S. marcescens strain by the M. morganii isolated. In this 
study, the same authors isolated a red-pigmented S. marcescens, which corresponds to the production 
of prodigiosin (Hejazi and Falkiner, 1997). In contrast, the Serratia strains isolated in the project 
reported here, never exhibited any red pigmentation. This gives evidence to the phylogenetic and 
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chemical differences to the strain used by Wang and Rozen. The ecological relevance of the genus 
Serratia for N. vespilloides is unclear until now. Due to the result of Serratia being one of the most 
prominent genera on tended carcasses (Shukla et al., 2018b), it can be assumed that this genus and its 
secondary metabolites are of importance for carcass health and preservation. This also supports the 
high abundance of Serratia strains isolated in this project and their antimicrobial effects (Figure 13). 
Isolates FF6-H2O and 56 displayed broad-spectrum inhibition of the pathogens tested whereas others 
e.g. isolate 2MH3-2 exclusively inhibited Gram-positives. Consequently, it can be stated that isolates 
of the genus Serratia are benefitial to the beetle`s ecology. 
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Perspective 
The exceptional lifestyle of N. vespilloides has attracted the interest of scientist for centuries 
(Fabre, 1914; Pukowski, 1933). Recent contributions addressed the preservation strategy and the 
chemically diverse spectrum of antimicrobial compounds produced (Degenkolb et al., 2011; 
Jacobs et al., 2016; Vogel et al., 2017). The knowledge-based approach to explore this untapped 
resource for natural products resulted in the identification of numerous bacteria with antimicrobial 
activity. Beside those, several unspecified bacteria producing a broad spectrum of antimicrobial 
bioactivities were found. Some of those were chosen for whole genome sequencing and biosynthetic 
genecluster analysis to to gain more detailed insights into the antimicrobial potential of the gut 
microbiome. Furthermore, this project contributed to the understanding of the preservation process 
from the bacterial side.  
Still, additional experiments and investigations are necessary to understand the preservation process 
of N. vespilloides in more detail. To access further bacterial gut symbionts, a variety of cultivation 
approaches with media designed to meet the physiological parameters and needs of the gut symbionts 
are required. This strategy may lead to the target-oriented discovery and cultivation of hitherto 
uncultivated microorganisms. The use of complex and minimal media without consideration of 
pH-value and oxygen conditions in the gut resulted in a rather undirected cultivation of 
microorganisms. Imitating the gut’s physiological conditions could support the growth of more 
specialised, gut-adopted taxa. This may lead to the detection and production of a more diverse 
spectrum of bioactive secondary metabolites.  
The primary screening (see 6.3.1 and Table S2) revealed a variety of antimicrobial effects. 
Nevertheless, most of the Gram-negative inhibition was lost in the course of HPLC separation. 
Therefore, further experiments to trigger the induction of the desired, original bioactivity are 
required.A first possibility would be the co-cultivation with a microbial competitor to induce the 
natural defence mechanisms of the strain. Another option could include a variety of different 
cultivation media to screen for bioactivity induction within different nutrient settings. 
Alternatively, cultivation and induction-independent approaches to broaden the antimicrobial 
potential of the gut microbiome should be promising. The expanded screening for BGCs based on full 
genome sequencing can be an appropriate but comparatively expensive option. Without the 
bioactivity-guided selection of strains, this could end up in high costs with rather low outcome. 
Moreover, such strategy is not suitable for a high-throughput screening.  
Further on, strain 39 could not be identified as Glutamicibacter on whole genome level. Its NRPS/PKS 
BGC is intended for heterologous expression in a Streptomyces species. In parallel, classical compound 
isolation can be performed in case of activity loss after expression.  
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Future work should be aimed at the genome announcement of strain 39 and the bioactivity-guided 
identification of the antimicrobial compound produced by this strain. Also, strain 2ABFH4 is another 
possible candidate for genome announcement. With its homology of 3.9% shared with Providencia 
rettgeri, the possibility of discovering a new species is comparetively high. 
To finally proof the ecologically relevance of serrawettin W2 for N. vespilloides, LC/MS analysis of the 
anal secretions can be conducted to search for the presence of this peptide. Also matrix-assisted laser 
desorption ionization imaging (MALDI) would be a state-of-the-art option to verify the production of 
serrawettin W2 by S. marcescens in the beetle’s gut. This would further coroborate the discoveries 
made under laboratory conditions, thus confirming the observation that N. vespilloides is using both 
its own AMPs as well as antimicrobial compounds for carcass preservation.  
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Table S1: List of Isolates from the gut of N. vespilloides 
Abbreviations used:  1. Capital letter:  M= male 
     F= female 
   2. Capital letter: F= forgut 
     M= midgut 
     H= hindgut 
 
   Wild = wild-living species 
   Faek= Fecal isolate 
   a= anaerobic cultivated 
   AB= agar supplemented with antibiotics 
   Man= agar supplemented with mannitol 
   H2O= isolated from water agar after long-time cultivation 
   BHI/YGC/PGS= sued media for cultivation 
 
Strain ID Best BLASTn: closest genetic relative available 
70 Achromobacter piechaudii strain Na28 16S ribosomal RNA gene, partial 
sequence 
45 Acinetobacter guillouiae isolate OTU-b62 16S ribosomal RNA gene, 
partial sequence 
39 Arthrobacter sp. GH01 16S ribosomal RNA gene, partial sequence 
40 Arthrobacter sp. GH01 16S ribosomal RNA gene, partial sequence 
YGC-10 Candida ghanaensis small subunit ribosomal RNA gene, complete 
sequence 
Man._F._mid._1-2 Carnobacterium maltaromaticum strain BSS448 16S ribosomal RNA gene, 
partial sequence 
Man._F._mid._2 Carnobacterium maltaromaticum strain BSS448 16S ribosomal RNA gene, 
partial sequence 
Man._F._hind._2 Carnobacterium maltaromaticum strain Fish 09690 16S ribosomal RNA 
gene, partial sequence 
a-7 Carnobacterium maltaromaticum strain Fish 11.890 A2 K 12 16S 
ribosomal RNA gene, partial sequence 
Man._F._mid._1-1 Carnobacterium maltaromaticum strain Fish 11.890 A2 K 12 16S 
ribosomal RNA gene, partial sequence 
Man._F._mid._4-1 Carnobacterium maltaromaticum strain Fish 11.890 A2 K 12 16S 
ribosomal RNA gene, partial sequence 
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Strain ID Best BLASTn: closest genetic relative available 
Man._F._mid._4-2 Carnobacterium maltaromaticum strain G117 16S ribosomal RNA gene, 
partial sequence 
76 Carnobacterium sp. ES-11 16S rRNA gene, strain ES-11 
a-1 Carnobacterium sp. K3 16S ribosomal RNA gene, partial sequence 
a-8 Carnobacterium sp. K3 16S ribosomal RNA gene, partial sequence 
Man._F._hind._1-1 Carnobacterium sp. K3 16S ribosomal RNA gene, partial sequence 
Mannitol_MF3 Carnobacterium sp. K3 16S ribosomal RNA gene, partial sequence 
AB2 Chryseobacterium meningosepticum HO1J100 16S ribosomal RNA gene, 
partial sequence 
68 Chryseobacterium sp. T86F.09.P.MUS.NO.H.Kidney.D.M 16S ribosomal 
RNA gene, complete sequence 
AB1 Chryseobacterium sp. T86F.09.P.MUS.NO.H.Kidney.D.M 16S ribosomal 
RNA gene, complete sequence 
13 Citrobacter koseri partial 16S rRNA gene, isolate 248 
95 Enterobacter asburiae partial 16S rRNA gene, strain LH74 
1MM3 Enterobacter asburiae partial 16S rRNA gene, strain LH74 
a-10 Enterobacter asburiae partial 16S rRNA gene, strain LH74 
a-9 Enterobacter cloacae strain B9 16S ribosomal RNA gene, partial sequence 
Faek1-2 Enterobacteriaceae bacterium ENUB8 16S ribosomal RNA genes, partial 
sequence 
Faek3_BHI Enterobacteriaceae bacterium ENUB8 16S ribosomal RNA genes, partial 
sequence 
1FF2 Enterobacteriaceae bacterium Pokym2-a 16S ribosomal RNA genes, 
partial sequence 
89 Enterococcus avium gene for 16S ribosomal RNA, partial sequence, 
isolate: 3-1-22 
38 Enterococcus durans strain ChOPR-I-str31 16S ribosomal RNA gene, 
partial sequence 
Faek_1-1 Enterococcus faecalis strain OGR1 16S ribosomal RNA gene, partial 
sequence 
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Strain ID Best BLASTn: closest genetic relative available 
2FM6_PGS Enterococcus malodoratus gene for 16S ribosomal RNA, partial sequence, 
strain: JCM 8730 
2FH5_PGS Enterococcus malodoratus strain NBRC 100489 16S ribosomal RNA gene 
3FA2 Enterococcus moraviensis strain NBRC 100710 
3MA5 Enterococcus phoeniculicola strain NBRC 100711 
2MF6_PGS Enterococcus raffinosus gene for 16S ribosomal RNA, partial sequence, 
strain: JCM 8733 
42 Enterococcus sp. INBio_4507C 16S ribosomal RNA gene, partial seq. 
FF7_H20_BHI Erwinia amylovora strain HSA 6 16S ribosomal RNA gene, partial seq. 
YGC-12 Galactomyces geotrichum strain LMA-15 18S ribosomal RNA gene 
2FH1_PGS Hafnia alvei FB1, complete genome 
2FH2_PGS Hafnia alvei FB1, complete genome 
2FH2-1_PGS Hafnia alvei FB1, complete genome 
36 Hafnia alvei partial 16S rRNA gene, isolate 212 
82 Hafnia alvei partial 16S rRNA gene, isolate 212 
2MF5_PGS Hafnia alvei partial 16S rRNA gene, isolate 212 
24 Hafnia alvei strain FDAARGOS_158, complete genome 
2FM5_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
2MF2_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
2MF3_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
2MM1_BHI Hafnia alvei strain FDAARGOS_158, complete genome 
FH6_BHI Hafnia alvei strain FDAARGOS_158, complete genome 
FM1_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
MF3_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
MF5_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
MH2_PGS Hafnia alvei strain FDAARGOS_158, complete genome 
1FH3 Hafnia sp. 3-12(2010) 16S ribosomal RNA gene, partial sequence 
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Strain ID Best BLASTn: closest genetic relative available 
2FH1_BHI Hafnia sp. 3-12(2010) 16S ribosomal RNA gene, partial sequence 
2FM3_BHI Hafnia sp. 3-12(2010) 16S ribosomal RNA gene, partial sequence 
2FM3_PGS Hafnia sp. 3-12(2010) 16S ribosomal RNA gene, partial sequence 
Man._F._hind._1-2 Hafnia sp. 3-12(2010) 16S ribosomal RNA gene, partial sequence 
Mannitol_FH1 Hafnia sp. 3-12(2010) 16S ribosomal RNA gene, partial sequence 
1FM1 Hafnia sp. B315 16S ribosomal RNA gene, partial sequence 
2FM1_BHI Hafnia sp. B315 16S ribosomal RNA gene, partial sequence 
Faek2_PGS Hafnia sp. B315 16S ribosomal RNA gene, partial sequence 
FF9_H20_BHI Hafnia sp. B315 16S ribosomal RNA gene, partial sequence 
3MM1 Lactococcus garvieae ATCC 49156 strain ATCC 49156 16S ribosomal RNA 
2FH3_PGS Lactococcus garvieae partial 16S rRNA gene, strain qz-367 
2MH3-3_BHI Lactococcus garvieae strain H25 16S ribosomal RNA gene, partial 
sequence 
2MH3-1_BHI Lactococcus garvieae strain JB275804/2 16S ribosomal RNA gene, partial 
sequence 
2FM4-2_BHI Lactococcus garvieae strain JB282647 2 16S ribosomal RNA gene, partial 
sequence 
2MF2-1_BHI Lactococcus garvieae strain JB282647 2 16S ribosomal RNA gene, partial 
sequence 
2MM3_BHI Lactococcus lactis strain FT697 16S ribosomal RNA gene, partial sequence 
2FH3 Lactococcus lactis strain Guimu 24 16S ribosomal RNA gene, partial 
sequence 
3 Leifsonia lichenia strain 2Sb 16S ribosomal RNA gene 
51 Microbacterium oxydans strain Abk8 16S ribosomal RNA gene, partial 
sequence 
30 Microbacterium sp. y2 16S ribosomal RNA gene, partial sequence 
31 Microbacterium sp. y2 16S ribosomal RNA gene, partial sequence 
WH_einzel10^7 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
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Wild_Anal_1 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Anal_2 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Anal_3 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Anal_4 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Hind_2 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Hind_4 Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Hind_einzel Morganella morganii strain wf-1 16S ribosomal RNA gene, partial 
sequence 
Wild_Anal_6 Morganella morganii strain ZW45-1 16S ribosomal RNA gene, partial 
sequence 
3MM2 Morganella morganii subsp. morganii KT 16S ribosomal RNA 
Wild_Hind_3 Morganella morganii subsp. morganii KT, complete genome 
Wild_Hind_5 Morganella morganii subsp. morganii KT, complete genome 
2AB_MH1 Myroides odoratus strain 154 (C4Plas©) 16S ribosomal RNA gene, partial 
sequence 
2AB_MH2 Myroides odoratus strain 154 (C4Plas©) 16S ribosomal RNA gene, partial 
sequence 
2AB_MH4 Myroides odoratus strain 154 (C4Plas©) 16S ribosomal RNA gene, partial 
sequence 
55 Nocardioides oleivorans gene for 16S rRNA, partial sequence 
10 Ochrobactrum sp. KAR47 16S ribosomal RNA gene, complete sequence 
35 Ochrobactrum sp. KAR47 16S ribosomal RNA gene, complete sequence 
YGC-2 Penicillium lagena gene for 18S rRNA, partial sequence 
Wild_Mid_12 Proteus mirabilis strain AER311-8 16S ribosomal RNA gene, partial 
sequence 
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Wild_Mid_6 Proteus mirabilis strain AER311-8 16S ribosomal RNA gene, partial 
sequence 
Wild_Mid_18 Proteus mirabilis strain QHD 16S ribosomal RNA gene, partial sequence 
Wild_Mid_7 Proteus mirabilis strain QHD 16S ribosomal RNA gene, partial sequence 
Wild_Hind_1 Proteus mirabilis strain R2 16S ribosomal RNA gene, partial sequence 
Wild_Mid_10 Proteus mirabilis strain R2 16S ribosomal RNA gene, partial sequence 
Wild_Mid_11 Proteus mirabilis strain R2 16S ribosomal RNA gene, partial sequence 
Wild_Mid_13 Proteus mirabilis strain R2 16S ribosomal RNA gene, partial sequence 
Wild_Mid_15 Proteus mirabilis strain R2 16S ribosomal RNA gene, partial sequence 
Wild_Mid_20 Proteus mirabilis strain R2 16S ribosomal RNA gene, partial sequence 
101 Proteus sp. 632B2_12AEMB 16S ribosomal RNA gene, partial sequence 
100 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
102 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
103 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
104 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
105 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
Wild_Mid_16 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
Wild_Mid_21 Proteus sp. BUR10 16S ribosomal RNA gene, partial sequence 
3MA1 Providencia rettgeri strain DSM 4542 
3MH3 Providencia rettgeri strain DSM 4542 
2FH2 Providencia sp. BAB-5308 16S ribosomal RNA gene, partial sequence 
1FH2 Providencia sp. BIHB 1402 16S ribosomal RNA gene, partial sequence 
1FM2 Providencia sp. BIHB 1402 16S ribosomal RNA gene, partial sequence 
1MH1 Providencia sp. BIHB 1402 16S ribosomal RNA gene, partial sequence 
3MA2 Pseudochrobactrum kiredjianiae strain CCUG 49584 
2AB_FF1 Pseudochrobactrum saccharolyticum strain ALK626 16S ribosomal RNA 
gene, partial sequence 
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2AB_FF2 Pseudochrobactrum saccharolyticum strain ALK626 16S ribosomal RNA 
gene, partial sequence 
2AB_FF7 Pseudochrobactrum saccharolyticum strain ALK626 16S ribosomal RNA 
gene, partial sequence 
93 Pseudochrobactrum saccharolyticum strain W14 16S ribosomal RNA 
gene, partial sequence 
2AB_FF6 Pseudochrobactrum sp. H-VRE-110b 16S ribosomal RNA gene, partial 
sequence 
80 Pseudomonas brenneri strain BD09-00307 16S ribosomal RNA gene, 
partial sequence 
85 Pseudomonas brenneri strain BD09-00307 16S ribosomal RNA gene, 
partial sequence 
81 Pseudomonas extremorientalis strain NSPtBx02 16S ribosomal RNA gene, 
partial sequence 
60 Pseudomonas fluorescens strain n10 16S ribosomal RNA gene, partial 
sequence 
65 Pseudomonas fluorescens strain n10 16S ribosomal RNA gene, partial 
sequence 
26 Pseudomonas fluorescens strain PCL1751, complete genome 
62 Pseudomonas fragi strain F26 16S ribosomal RNA gene, partial sequence 
27 Pseudomonas sp. 27Kp1 16S ribosomal RNA gene, partial sequence 
90 Pseudomonas sp. 27Kp1 16S ribosomal RNA gene, partial sequence 
88 Pseudomonas sp. 35_2 16S ribosomal RNA gene, partial sequence 
57 Pseudomonas sp. BTN10 16S ribosomal RNA gene, partial sequence 
84 Pseudomonas sp. FBF110 partial 16S rRNA gene, isolate FBF110 
86 Pseudomonas sp. LC182 16S ribosomal RNA gene, partial sequence 
66 Pseudomonas sp. n5(2012) 16S ribosomal RNA gene, partial sequence 
58 Pseudomonas sp. PP103 16S ribosomal RNA gene, partial sequence 
20 Pseudomonas sp. P-W-3 16S ribosomal RNA gene, partial sequence 
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44 Rhodococcus qingshengii strain PVL12 16S ribosomal RNA gene, partial 
sequence 
Feak1_PGS Serratia ficaria strain YJ1 16S ribosomal RNA gene, complete sequence 
Mannitol_MF4 Serratia liquefaciens strain 24K11 16S ribosomal RNA gene, partial 
sequence 
Man._M._for._2-2 Serratia liquefaciens strain FDAARGOS_125, complete genome 
97 Serratia liquefaciens strain KAR19 16S ribosomal RNA gene, complete 
sequence 
2MF1_PGS Serratia marcescens strain 16DR 16S ribosomal RNA gene, partial seq. 
2MH1_PGS Serratia marcescens strain IARI-CRK 16 16S ribosomal RNA gene, partial 
sequence 
2MH3-2_BHI Serratia marcescens strain N1.14 16S ribosomal RNA gene, partial 
sequence 
2FH4_BHI Serratia marcescens strain S20 16S ribosomal RNA gene, partial sequence 
Mannitol_MF5 Serratia marcescens subsp. sakuensis strain RN25 16S ribosomal RNA 
gene, partial sequence 
2MH1_BHI Serratia marcescens subsp. sakuensis strain RY21 16S ribosomal RNA 
gene, partial sequence 
2MH2-1_BHI Serratia marcescens subsp. sakuensis strain RY21 16S ribosomal RNA 
gene, partial sequence 
FF6_H20_BHI Serratia plymuthica strain KAR17 16S ribosomal RNA gene, complete 
sequence 
56 Serratia plymuthica strain UBCR_12 16S ribosomal RNA gene, partial 
sequence 
87 Serratia proteamaculans partial 16S rRNA gene, strain TRS1-WB 
15 Serratia proteamaculans strain 1Cg-44 16S ribosomal RNA gene, partial 
sequence 
2 Serratia proteamaculans strain B34 16S ribosomal RNA gene, partial 
sequence 
16 Serratia proteamaculans strain B34 16S ribosomal RNA gene, partial 
sequence 
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23 Serratia proteamaculans strain B34 16S ribosomal RNA gene, partial 
sequence 
52 Serratia proteamaculans strain G32 16S ribosomal RNA gene, partial 
sequence 
Feak3_BHI Serratia sp. #YN-5 gene for 16S ribosomal RNA, partial sequence 
18 Serratia sp. 73 16S ribosomal RNA gene, partial sequence 
28 Serratia sp. 73 16S ribosomal RNA gene, partial sequence 
67 Serratia sp. 73 16S ribosomal RNA gene, partial sequence 
61 Serratia sp. BACM14 16S ribosomal RNA gene, partial sequence 
1 Serratia sp. JW65.6a partial 16S rRNA gene, strain JW65.6a 
17 Serratia sp. KB17 16S ribosomal RNA gene, partial sequence 
78 Serratia sp. KB17 16S ribosomal RNA gene, partial sequence 
83 Serratia sp. KB17 16S ribosomal RNA gene, partial sequence 
91 Serratia sp. KB17 16S ribosomal RNA gene, partial sequence 
9 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
33 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
43 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
47 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
59 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
73 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
74 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
75 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
6 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
Mannitol_MF9 Serratia sp. L0305 16S ribosomal RNA gene, partial sequence 
Faek1_PGS Serratia sp. PSTB2 16S ribosomal RNA gene, partial sequence 
Mannitol_FM2 Serratia sp. Q3 16S ribosomal RNA gene 
63 Serratia sp. TWJ22 16S ribosomal RNA gene, partial sequence 
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Faek3_PGS Serratia sp. UA-JF0212 16S ribosomal RNA gene, partial sequence 
Feak1-2 Serratia sp. UA-JF0212 16S ribosomal RNA gene, partial sequence 
71 Stenotrophomonas humi strain R-32729 16S ribosomal RNA gene 
AB4 Stenotrophomonas maltophilia 16S ribosomal RNA gene, partial 
sequence 
2AB_MF1 Stenotrophomonas maltophilia strain 261ZG10 16S ribosomal RNA gene, 
partial sequence 
2AB_MM1 Stenotrophomonas maltophilia strain 261ZG10 16S ribosomal RNA gene, 
partial sequence 
2AB_MF3 Stenotrophomonas maltophilia strain 262XG3 16S ribosomal RNA gene, 
partial sequence 
53 Stenotrophomonas maltophilia strain 262XG5 16S ribosomal RNA gene, 
partial sequence 
21 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
92 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
94 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
96 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
99 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
2AB_FH2 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
2AB_FH3 Stenotrophomonas maltophilia strain 2Kp7a 16S ribosomal RNA gene, 
partial sequence 
41 Stenotrophomonas maltophilia strain 4K1A 16S ribosomal RNA gene, 
partial sequence 
49 Stenotrophomonas maltophilia strain 4K1A 16S ribosomal RNA gene, 
partial sequence 
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AB5 Stenotrophomonas maltophilia strain D1 16S ribosomal RNA gene, partial 
sequence 
69 Stenotrophomonas maltophilia strain LZC3 16S ribosomal RNA gene, 
partial sequence 
2AB_FF3 Stenotrophomonas maltophilia strain LZC3 16S ribosomal RNA gene, 
partial sequence 
2AB_FF4 Stenotrophomonas maltophilia strain LZC3 16S ribosomal RNA gene, 
partial sequence 
2AB_FF5 Stenotrophomonas maltophilia strain LZC3 16S ribosomal RNA gene, 
partial sequence 
32 Stenotrophomonas maltophilia strain QH31 16S ribosomal RNA gene, 
partial sequence 
3MA3 Stenotrophomonas pavanii strain LMG 25348 
46 Stenotrophomonas sp. 4NR6 16S ribosomal RNA gene, partial sequence 
2AB_FH1 Stenotrophomonas sp. 4NR6 16S ribosomal RNA gene, partial sequence 
72 Stenotrophomonas sp. CanL-50 16S ribosomal RNA gene, partial 
sequence 
64 Stenotrophomonas sp. DA1 16S ribosomal RNA gene, partial sequence 
98 Stenotrophomonas sp. SB341 16S ribosomal RNA gene, partial sequence 
3FA1 Streptomyces herbaricolor strain NBRC 3932 
3MH2 Vagococcus fessus strain m2661/98/1 
3MA4 Vagococcus fessus strain m2661/98/1 16S ribosomal RNA gene 
3MM3 Vagococcus fessus strain m2661/98/1 16S ribosomal RNA gene 
29 Variovorax boronicumulans partial 16S rRNA gene, isolate 0911ARD9I2 
34 Variovorax sp. MG3 16S ribosomal RNA gene, partial sequence 
3FM1 Wohlfahrtiimonas larvae strain KBL006 16S ribosomal RNA 
AB3 Yarrowia divulgata isolate F6-17 18S ribosomal RNA gene 
YGC-6 Yarrowia lipolytica partial 23S rRNA gene, strain K 
YGC-1 Yarrowia lipolytica strain ATCC 9773 18S ribosomal RNA gene 
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YGC-19 Yarrowia lipolytica strain ATCC 9773 18S ribosomal RNA gene 
YGC-4 Yarrowia lipolytica strain ATCC 9773 18S ribosomal RNA gene 
YGC-7 Yarrowia lipolytica strain ATCC 9773 18S ribosomal RNA gene 
YGC-11 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-13 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-14 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-16 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-26 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-27 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-5 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-8 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
YGC-9 Yarrowia sp. D30L 18S ribosomal RNA gene, partial sequence 
4 Uncultured bacterium clone 10-472 16S ribosomal RNA gene, partial 
sequence 
2MF5_BHI Uncultured bacterium clone 8817-D40-PY-O-1B 16S ribosomal RNA gene, 
partial sequence 
77 Uncultured bacterium clone C6 16S ribosomal RNA gene, partial 
sequence 
Man._F._hind._4 Uncultured bacterium clone C6 16S ribosomal RNA gene, partial 
sequence 
12 Uncultured bacterium clone KNB33 16S ribosomal RNA gene, partial 
sequence 
50 Uncultured bacterium clone KNB33 16S ribosomal RNA gene, partial 
sequence 
2AB_MF2 Uncultured bacterium clone LF4FR5D05 16S ribosomal RNA gene, partial 
sequence 
2MH4_BHI Uncultured bacterium clone MgKI1c003b02 16S ribosomal RNA gene, 
partial sequence 
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48 Uncultured bacterium clone RL185_aaj72c11 16S ribosomal RNA gene, 
partial sequence 
a-12 Uncultured bacterium clone rRNA198 16S ribosomal RNA gene, partial 
sequence 
2AB_FH4 Uncultured bacterium clone SINI672 16S ribosomal RNA gene, partial 
sequence 
2MF3_BHI Uncultured bacterium clone SINI836 16S ribosomal RNA gene, partial 
sequence 
2FM5_PGS Uncultured bacterium partial 16S rRNA gene, amplicon K 
79 Uncultured gamma proteobacterium clone FTLpost17 16S ribosomal RNA 
gene, partial sequence 
2MH3-1_PGS Uncultured Lactococcus sp. clone S1_G08 16S ribosomal RNA gene, 
partial sequence 
2MH3-3_PGS Uncultured Lactococcus sp. clone S5_A12 16S ribosomal RNA gene, 
partial sequence 
2MM2_BHI Uncultured Lactococcus sp. gene for 16S rRNA, partial sequence, clone: 
CLZX63 
54 Uncultured Microbacterium sp. clone KNB18 16S ribosomal RNA gene, 
partial sequence 
2MH3-2_PGS Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000142 
small subunit ribosomal RNA gene, partial sequence 
Mannitol_MF1 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000257 
small subunit ribosomal RNA gene, partial sequence 
1FF1 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000327 
small subunit ribosomal RNA gene, partial sequence 
2FH4-2_BHI Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000327 
small subunit ribosomal RNA gene, partial sequence 
2FH5 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000327 
small subunit ribosomal RNA gene, partial sequence 
2FM2_PGS Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000327 
small subunit ribosomal RNA gene, partial sequence 
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FF8_H20_BHI Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000327 
small subunit ribosomal RNA gene, partial sequence 
FF9_H2O Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000327 
small subunit ribosomal RNA gene, partial sequence 
MH2 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000450 
small subunit ribosomal RNA gene, partial sequence 
1MF1 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
1MF2 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
1MM2 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
2FM4-1_BHI Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
2MF2-2_BHI Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
Mannitol_MF6 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
Mannitol_MF7 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
MH3 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
MM1 Uncultured organism clone ELU0075-T355-S-NIPCRAMgANa_000498 
small subunit ribosomal RNA gene, partial sequence 
Wild_Mid_14 Uncultured organism clone ELU0159-T329-S-NIPCRAMgANa_000317 
small subunit ribosomal RNA gene, partial sequence 
2MH3-3_PGS unknown 
3MH1 96%: Wohlfahrtiimonas larvae strain KBL006 16S ribosomal RNA 
3MA6 97,6% Vagococcus fessus strain m2661/98/1 16S ribosomal RNA gene 
3MA7 98% Vagococcus fessus strain m2661/98/1 16S ribosomal RNA gene 
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Table S2: antimicrobial effects of all screened extracts 
Strain growth inhibition [%]  
  
Ecol 
ATCC25922 Ecol dTolC 
Paer 
ATCC27853 
Saur 
ATCC25923 
C. albicans 
FH2173 Msme ATCC 709 
  10 10 10 10 10 10 10 10 10 10 10 10 
10% BHI MeOH 12 15 6 7 -15 -20 -66 -95 -32 -14 33 33 
10% BHI EtOAc  31 -5 34 39 6 -1 1 2 9 -20 23 2 
TBS EtOH 29 9 -1 18 -2 7 -16 -60 0 0 0 0 
TBS MeOH 23 -5 -23 11 -10 -4 -36 -85 0 0 0 0 
8 d1 MeOH -6 6 -1 9 -127 -60 -107 -124 -152 -172 53 62 
8 d1 EtOAc 31 46 45 41 -3 -10 -19 -17 -53 -70 15 5 
8d6 MeOH 23 -5 24 28 -22 -27 -105 -150 -147 -166 65 33 
8d6 EtOAc 16 -9 -13 -5 -4 3 7 3 5 -12 40 23 
8d9 MeOH -31 -24 -23 -5 -36 -16 -49 -86 -157 -125 34 39 
8d9 EtOAc 3 0 14 13 3 -12 -2 -2 -12 -138 -7 24 
13d1 MeOH 20 34 58 67 -9 -50 -91 -115 -65 -77 77 70 
13d1 EtOAc 1 -7 24 43 -11 -63 4 -6 -15 -101 -16 2 
13d6 MeOH 24 27 42 34 10 -63 -48 -53 11 66 81 81 
13d6 EtOAc 15 2 12 1 -39 -15 -5 2 -28 43 43 35 
13d9 MeOH 18 20 24 15 -3 -8 -46 -54 -21 -72 80 79 
13d9 EtOAc 7 -5 -6 -13 14 -18 2 -4 -39 -58 1 37 
45d1 MeOH 24 -24 7 26 -7 -23 -113 -122 -120 -182 63 54 
45d1 EtOAc 6 -5 32 -2 -6 0 0 -11 -80 -136 2 0 
45d6 MeOH -5 11 23 20 -13 -18 -57 -72 -104 -111 73 72 
45d6 EtOAc 30 29 12 15 -4 5 4 -2 39 -73 25 -9 
45d9 MeOH -2 2 14 12 -17 -19 -66 -79 -58 2 62 59 
45d9 EtOAc 30 43 40 35 -4 -18 -6 -21 19 -18 4 -8 
70d1 MeOH -3 3 -9 -5 -35 -28 -76 -90 -91 -132 44 27 
70d1 EtOAc 20 -11 4 -8 3 8 -4 -15 38 -15 -18 -15 
70d6 MeOH -12 11 16 13 -9 -11 -35 -30 -105 -106 24 32 
70d6 EtOAc 8 10 7 -10 4 -23 0 -7 -11 -18 16 -19 
70d9 MeOH -14 6 6 -7 -12 -72 -41 -51 -71 -110 75 71 
70d9 EtOAc -16 -7 -12 -5 1 3 4 -24 -30 -98 -13 -18 
AB1d1 MeOH 7 22 74 56 -104 -144 -70 -76 -25 -93 9 -19 
AB1d1 EtOAc 6 20 13 -2 -11 -3 -30 -60 -10 -105 -17 -25 
AB1d6 MeOH 5 38 51 51 -65 -44 -60 -90 -35 -23 2 1 
AB1d6 EtOAc 4 19 16 21 15 -2 -50 -62 -127 -50 -7 -4 
AB1d9 MeOH 0 19 23 30 -37 -41 -61 -87 -4 -10 -3 -20 
AB1d9 EtOAc -3 13 9 -8 -15 -10 -46 -62 -112 -71 -10 -29 
AB2d1 MeOH -6 7 11 6 -21 -21 -104 -88 -117 -45 26 20 
AB2d1 EtOAc -14 6 9 3 -5 -8 -1 -35 -9 -48 18 8 
AB2d6 MeOH 13 4 26 13 -20 -48 -105 -125 20 20 38 35 
AB2d6 EtOAc -15 -1 -1 5 -10 -8 -7 -12 7 -2 22 16 
AB2d9 MeOH -34 -9 10 19 -20 -20 -72 -106 20 -58 31 26 
AB2d9 EtOAc -19 2 -1 5 -6 -4 -1 -9 3 22 17 23 
1FF2d1 MeOH 4 21 33 32 -9 -12 -87 -114 -73 -140 -56 -67 
1FF2d1 EtOAc 25 21 33 25 -10 -9 -11 -12 -68 -76 -20 3 
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1FF2d6 MeOH -2 12 6 10 -34 -14 -75 -87 8 -163 63 62 
1FF2d6 EtOAc -7 3 19 -9 5 -7 -3 -14 -31 -54 -29 -32 
1FF2d9 MeOH -6 7 29 13 -18 -24 -63 -82 -90 -54 74 77 
1FF2d9 EtOAc -20 -6 -4 -2 14 -5 -6 -9 17 -30 -28 25 
1MM3d1 MeOH 5 15 7 -3 -29 -37 -6 -49 -52 -39 -2 -4 
1MM3d1 EtOAc 17 -4 36 -2 -3 -9 0 -27 -62 42 -48 -51 
1MM3d6 MeOH 2 20 16 17 -2 -21 -63 -102 11 -103 28 34 
1MM3d6 EtOAc 18 -7 29 -8 -8 -9 -24 -16 -18 -40 -43 -47 
1MM3d9 MeOH 15 28 24 18 -20 -16 -45 -75 -38 -47 27 24 
1MM3d9 EtOAc 21 31 36 32 -7 6 -11 -16 -36 -19 -31 -21 
10d1 MeOH 11 12 15 15 -137 -34 -117 -98 -90 -91 73 68 
10d1 EtOAc 29 34 35 29 -3 -9 -85 -60 -102 -131 -24 12 
10d6 MeOH 15 27 15 28 -89 -19 -108 -110 -89 -113 83 80 
10d6 EtOAc 23 -3 26 -5 -37 10 3 9 10 -27 -25 -7 
10d9 MeOH 16 15 15 17 -56 -3 -114 -109 -41 -98 82 84 
10d9 EtOAc 33 12 40 38 12 1 -8 10 -33 -51 -21 -4 
30d1 MeOH 2 4 7 6 -17 -99 -125 -110 -87 -107 45 70 
30d1 EtOAc 38 37 38 30 -6 -6 -23 -10 -2 -67 15 13 
30d6 MeOH 31 35 32 32 -8 -4 -85 -79 -4 -76 82 85 
30d6 EtOAc 0 2 3 -2 6 5 -2 10 14 -20 -1469 -19 
30d9 MeOH 19 25 26 21 -72 -11 -112 -75 60 38 82 87 
30d9 EtOAc -7 11 24 7 12 -3 5 10 9 -50 -17 -1 
36d1 MeOH 18 27 17 23 -9 -33 -140 -115 -69 -52 57 57 
36d1 EtOAc 45 42 35 33 3 -14 -4 6 10 -84 -16 -19 
36d6 MeOH 11 0 8 6 -24 -35 -120 -107 -98 -92 46 57 
36d6 EtOAc -8 -12 19 -1 1 -1 -2 8 0 -82 0 0 
36d9 MeOH 15 17 18 18 -13 -32 -85 -85 -40 -70 -72 -27 
36d9 EtOAc 8 38 35 31 2 0 -13 4 -62 67 15 24 
51d1 MeOH 7 17 22 9 -42 -158 -95 -65 -115 -90 71 77 
51d1 EtOAc 1 42 32 27 -18 -9 -12 -7 41 44 -39 -2 
51d6 MeOH 20 19 21 21 -36 -131 -122 -101 -124 -54 85 88 
51d6 EtOAc 25 34 32 34 -6 -10 -9 2 -35 -24 -15 -10 
51d9 MeOH 15 18 17 17 -165 -1 -110 -68 -98 -88 87 84 
51d9 EtOAc -8 38 35 28 -11 -19 -15 2 -53 33 -35 -18 
1FH3d1 MeOH 26 26 48 39 -24 -36 -92 -100 -55 -41 25 19 
1FH3d1 EtOAc 21 40 26 32 -4 -11 -13 -6 -89 5 -8 99 
1FH3d6 MeOH -2 -11 46 36 -25 -40 -93 -50 -35 -47 84 81 
1FH3d6 EtOAc 21 29 28 30 -4 -8 -10 1 14 -12 25 16 
1FH3d9 MeOH 23 32 94 83 -40 -46 -81 -70 -9 8 87 89 
1FH3d9 EtOAc -4 3 11 2 -8 -9 -16 4 -17 22 -46 24 
2FM1d1 MeOH 31 27 37 41 -35 -46 -106 -96 5 -31 54 58 
2FM1d1 EtOAc 17 28 24 22 -12 -19 -14 -7 -120 7 -26 -2 
2FM1d6 MeOH 16 18 80 57 -42 -73 -90 -83 -43 -11 96 94 
2FM1d6 EtOAc 14 -1 1 -3 -10 -16 -9 6 7 -67 -37 -17 
2FM1d9 MeOH 40 7 90 88 -45 -47 -77 -72 65 43 95 94 
2FM1d9 EtOAc -2 -8 10 3 -5 -12 -12 3 14 10 22 -1 
2MM1d1 MeOH 16 16 14 14 -36 -38 -103 -94 -20 -45 31 59 
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2MM1d1 EtOAc 17 1 26 29 -8 -4 -23 -16 -16 -37 13 22 
2MM1d6 MeOH 4 11 4 3 -22 -30 -53 -86 -77 -34 65 58 
2MM1d6 EtOAc 41 39 22 35 -12 -15 -12 -6 -46 -31 -12 -5 
2MM1d9 MeOH 41 28 39 19 -41 -47 -70 -46 60 -108 50 54 
2MM1d9 EtOAc 21 17 27 16 -12 -19 -19 -1 -14 -39 -31 -16 
2MM2-2d1 
MeOH 12 14 12 8 -31 -36 -109 -100 71 41 25 45 
2MM2-2d1 
EtOAc 5 6 4 -1 -10 -9 -1 4 15 -15 -41 -4 
2MM2-2d6 
MeOH 11 10 14 7 -26 -14 -55 -58 59 76 44 48 
2MM2-2d6 
EtOAc -10 -10 8 13 -1 -9 -1 -1 40 42 -18 6 
2MM2-2d9 
MeOH 11 10 13 8 -35 -30 -80 -70 14 -12 31 50 
2MM2-2d9 
EtOAc 33 30 32 37 -11 -27 -8 -9 11 -1 14 23 
2MH3-2d1 
MeOH 19 12 10 2 -22 -30 30 -21 -50 15 77 76 
2MH3-2d1 
EtOAc 26 29 22 28 5 -6 -26 -15 -67 17 -19 3 
2MH3-2d6 
MeOH 9 9 10 -12 -31 -40 -48 65 -7 -43 43 54 
2MH3-2d6 
EtOAc 26 31 20 24 -7 -41 -31 -17 -13 -52 -27 -10 
2MH3-2d9 
MeOH 8 14 8 7 -30 -49 99 72 -8 -34 102 101 
2MH3-2d9 
EtOAc 24 24 17 18 -25 -8 -30 -25 -115 -29 -34 -18 
2FH3d1 MeOH 3 19 2 -4 -36 -42 -110 -84 25 1 53 58 
2FH3d1 EtOAc 2 36 17 4 13 -6 -2 13 -95 26 -1 -10 
2FH3d6 MeOH 12 14 40 30 100 99 -20 35 -64 -104 58 52 
2FH3d6 EtOAc 5 27 19 25 4 2 -16 -4 18 -36 14 14 
2FH3d9 MeOH -13 -27 25 23 -16 -50 -38 -42 -2 -90 58 48 
2FH3d9 EtOAc -6 -12 2 7 -8 7 -2 -7 43 29 -17 -5 
3 
d1 EtOAc 36 33 44 42 49 36 -20 -31 -53 -77 18 -28 
3 
d1 MeOH 6 7 6 8 -86 -63 -25 -92 -38 -43 74 49 
3 
d6 EtOAc 42 44 24 39 -12 -9 -25 -57 -37 -34 -29 -24 
3 
d6 MeOH 2 4 18 14 -92 -123 -42 -97 -39 -56 73 66 
3 
d9 EtOAc -2 -16 -13 -22 -22 -30 17 -21 -7 -7 4 7 
3 
d9 MeOH 0 -2 2 -20 -45 -39 -47 -100 -53 -83 71 76 
15 
d1 EtOAc 24 28 12 6 14 7 -3 -18 -46 -43 -17 9 
15 
d1 MeOH 20 24 39 26 -105 -16 -21 -92 -77 -83 81 77 
15 
d6 EtOAc 26 24 27 28 -13 -6 19 -12 -55 -34 -45 -10 
15 
d6 MeOH 15 16 17 17 -149 -100 -44 -78 -42 -64 86 82 
15 
d9 EtOAc -13 4 21 7 -8 2 11 -7 -17 -27 -11 -30 
15 
d9 MeOH 15 14 24 18 -40 -26 -37 -97 -33 -66 94 90 
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16 
d1 EtOAc 34 34 32 35 -16 -19 19 -16 -44 -47 -75 -71 
16 
d1 MeOH 18 15 25 18 -12 0 -15 -42 -8 -32 84 82 
16 
d6 EtOAc 2 23 -2 13 -5 1 14 5 -17 -22 -13 -39 
16 
d6 MeOH 16 17 8 1 -9 -18 -45 -92 24 17 41 77 
16 
d9 EtOAc 3 -16 0 18 -5 -5 36 11 -29 -48 -16 -28 
16 
d9 MeOH 16 21 19 11 -20 -27 -36 -67 -13 6 22 44 
27 
d1 EtOAc 29 24 19 23 -7 -14 0 -18 -11 -41 -16 -22 
27 
d1 MeOH 9 7 22 5 8 -6 -1 -69 14 -6 82 60 
27 
d6 EtOAc -1 2 5 -16 4 7 26 19 2 -21 -14 -48 
27 
d6 MeOH 7 1 15 21 2 -4 -33 -96 -7 -19 83 81 
27 
d9 EtOAc -10 -3 -11 -4 -3 3 29 4 -10 -13 -7 -38 
27 
d9 MeOH 20 21 21 17 -4 -6 -21 -101 1 -11 80 76 
44 
d1 EtOAc -3 16 16 -7 8 7 46 22 1 -38 -11 -16 
44 
d1 MeOH -22 -21 -41 -25 -24 -24 -15 -69 -28 -57 73 80 
44 
d6 EtOAc 17 34 -10 -6 -5 -5 19 3 -18 -15 25 10 
44 
d6 MeOH 8 16 18 9 15 8 -32 -94 -52 -75 93 92 
44 
d9 EtOAc -5 29 16 28 0 6 35 8 26 -16 -29 17 
44 
d9 MeOH 11 15 17 9 3 -6 -31 -89 -13 -39 81 81 
52 
d1 EtOAc 14 35 34 34 -20 -12 19 -13 -14 -30 -17 -47 
52 
d1 MeOH 21 21 18 21 -24 -4 11 -13 0 -23 34 55 
52 
d6 EtOAc 8 16 22 21 1 -5 34 8 -37 -47 -51 -40 
52 
d6 MeOH 22 21 9 -2 -4 -12 -29 -66 5 6 72 77 
52 
d9 EtOAc -12 -13 4 2 -3 4 37 3 -32 -51 16 -8 
52 
d9 MeOH 19 23 23 14 -11 -7 -4 -61 31 13 68 73 
55 
d1 EtOAc 25 39 20 19 1 6 36 6 -6 -50 10 4 
55 
d1 MeOH 5 15 11 -1 -20 -23 -30 -87 7 63 70 73 
55 
d6 EtOAc -4 28 19 13 -3 -2 29 13 -4 -6 0 -27 
55 
d6 MeOH 4 3 8 -1 -14 -2 -16 -75 -19 -54 79 76 
55 
d9 EtOAc 31 35 34 21 -20 -14 7 -31 -50 -62 -27 -45 
55 
d9 MeOH 9 19 30 28 -26 -26 -33 -112 -6 -4 67 67 
60 
d1 EtOAc 32 30 45 29 -15 -9 20 -40 -46 -65 -45 -66 
60 
d1 MeOH 23 22 31 25 -11 -8 -35 -95 -24 -38 56 67 
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60 
d6 EtOAc 30 36 38 27 -19 -9 2 -45 -67 -85 -21 -27 
60 
d6 MeOH 19 26 28 19 -19 -15 -24 -73 24 25 98 97 
60 
d9 EtOAc 38 30 34 26 -16 -16 26 -5 -32 -49 34 14 
60 
d9 MeOH 11 26 23 12 -18 -19 -27 -85 -34 -72 97 96 
62 
d1 EtOAc 26 45 23 3 -22 -20 1 -38 -6 -50 -39 -19 
62 
d1 MeOH 9 18 10 17 -13 -29 -38 -107 -36 -59 75 72 
62 
d6 EtOAc 13 16 19 25 0 -3 -9 -42 -9 -43 25 2 
62 
d6 MeOH 21 20 24 22 -26 -27 -39 -81 -25 -9 96 97 
62 
d9 EtOAc 13 26 28 20 -11 -6 24 -2 -19 -38 20 -20 
62 
d9 MeOH 24 21 24 20 -22 -5 -14 -61 20 22 97 97 
66 
d1 EtOAc 35 38 31 31 -14 -18 32 5 -22 -57 6 10 
66 
d1 MeOH 11 17 30 24 -10 -27 -31 -93 1 -76 59 62 
60 
d6 EtOAc 33 41 37 32 -20 -15 26 -5 -17 -36 29 2 
66 
d6 MeOH 13 35 21 12 -1 -40 -30 -95 -38 -87 98 97 
66 
d9 EtOAc 10 21 16 4 -2 -1 36 20 12 -22 7 12 
66 
d9 MeOH 16 16 16 9 -9 -13 -28 -73 -21 -46 96 96 
80 
d1 EtOAc 31 30 42 8 -22 -17 -12 -47 -49 -80 -68 -13 
80 
d1 MeOH 14 14 18 15 -5 -5 -36 -83 -18 -56 51 77 
80 
d6 EtOAc 32 33 43 35 -20 -20 -4 -44 -53 -82 -40 -44 
80 
d6 MeOH 11 13 19 11 -16 -18 -40 -103 -41 -91 99 97 
80 
d9 EtOAc 32 39 20 3 -13 -18 22 -3 -15 -59 4 22 
80 
d9 MeOH 8 12 22 14 4 -9 -31 -88 -4 -77 97 96 
81 
d1 EtOAc 20 39 35 19 -22 -12 -4 -39 -66 -71 -25 -34 
81 
d1 MeOH 10 10 13 6 -42 -38 -35 -94 -26 -67 71 65 
81 
d6 EtOAc 33 32 26 28 -19 -14 -8 -34 -42 -70 -24 -17 
81 
d6 MeOH 5 3 -16 8 -17 -17 -44 -118 4 -17 100 99 
81 
d9 EtOAc 35 36 34 33 -20 -13 -12 -36 -68 -62 5 -15 
81 
d9 MeOH 6 12 12 -1 4 -6 -43 -102 -15 -52 100 99 
84 
d1 EtOAc 33 33 33 22 -23 -17 -31 -53 -72 -76 3 -15 
84 
d1 MeOH 13 18 6 20 -20 -6 -44 -112 -14 -39 41 57 
84 
d6 EtOAc 33 37 27 15 -23 -13 5 -29 -54 -78 7 -6 
84 
d6 MeOH 1 8 11 -6 6 -12 -36 -96 -71 -70 96 97 
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84 
d9 EtOAc 0 0 0 0 0 0 0 0 0 0 100 100 
84 
d9 MeOH 0 0 0 0 0 0 0 0 0 0 100 100 
86 
d1 EtOAc 36 32 17 36 -1 5 -66 -35 -20 -40 -62 -41 
86 
d1 MeOH 18 16 17 13 -8 -21 -120 -98 -47 -42 48 50 
86 
d6 EtOAc 43 20 36 33 -4 -6 -99 -57 -27 -22 -46 -53 
86 
d6 MeOH 5 4 98 93 -4 -2 -125 -82 -77 -73 97 99 
86 
d9 EtOAc 44 41 36 35 -2 -13 -43 -14 -20 -14 -40 -28 
86 
d9 MeOH 3 5 92 97 0 4 -123 -85 -77 -76 98 101 
87 
d1 EtOAc 40 36 7 22 -22 -18 -55 -25 -42 -42 -37 -42 
87 
d1 MeOH 21 21 30 22 7 -3 -133 -95 -41 -27 55 74 
87 
d6 EtOAc 5 34 -5 13 3 4 -9 5 -31 -12 -63 -69 
87 
d6 MeOH 19 18 22 21 -24 -19 -149 -89 20 7 71 71 
87 
d9 EtOAc 14 -1 11 10 5 1 -13 3 -32 -3 -90 -26 
87 
d9 MeOH 21 18 25 26 -19 -17 -129 -94 42 -5 67 63 
101 
d1 EtOAc 30 32 34 4 -3 2 -80 -31 -44 -32 -83 -41 
101 
d1 MeOH 15 13 18 14 -3 -16 -131 -95 -61 -54 77 71 
101 
d6 EtOAc 39 39 45 32 -3 -6 -61 -46 -28 -26 -41 -46 
101 
d6 MeOH 14 12 14 17 -9 -24 -124 -90 62 42 53 62 
101 
d9 EtOAc 20 -2 13 13 10 3 -57 7 -32 -6 -56 -26 
101 
d9 MeOH 2 -20 38 14 -23 -4 -147 -92 -59 -53 36 36 
105 
d1 EtOAc 32 23 41 37 -1 -4 -41 -14 -68 -79 -38 -90 
105 
d1 MeOH -3 14 23 16 -18 1 -124 -91 -13 -42 66 67 
105 
d6 EtOAc 40 38 39 46 -9 -8 -76 -43 -24 -21 -56 -78 
105 
d6 MeOH 11 10 13 13 -15 -5 -130 -101 53 25 75 77 
105 
d9 EtOAc 11 10 11 13 -2 9 -12 -7 -34 -16 -7 -4 
105 
d9 MeOH 36 38 21 20 -19 -15 -124 -83 83 20 72 70 
Wild Mid 10 
d1 EtOAc 42 36 1 40 -13 -13 -73 -26 7 -9 -55 -51 
Wild Mid 10 
d1 MeOH 16 33 16 20 -15 -4 -124 -99 -44 -9 76 75 
Wild Mid 10 
d6 EtOAc 28 24 36 32 -14 -44 -97 -55 -84 -59 -85 -65 
Wild Mid 10 
d6 MeOH 16 13 15 16 -15 -14 -140 -108 13 -48 36 75 
Wild Mid 10 
d9 EtOAc 11 10 -1 30 7 3 -9 6 -17 7 -14 -29 
Wild Mid 10 
d9 MeOH 14 11 10 20 -12 -10 -114 -78 63 19 64 67 
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Wild Mid 12 
d1 EtOAc 42 44 27 26 -10 -5 -60 -33 -17 -16 -20 -63 
Wild Mid 12 
d1 MeOH 10 9 18 14 -12 2 -125 -92 -34 -59 57 60 
Wild Mid 12 
d6 EtOAc 44 38 35 39 -10 -9 -84 -33 -26 -16 -39 -11 
Wild Mid 12 
d6 MeOH 16 2 11 12 -17 -8 -134 -100 29 23 57 74 
Wild Mid 12 
d9 EtOAc 37 32 25 33 -5 -9 -40 -8 -18 -15 -66 -54 
Wild Mid 12 
d9 MeOH -5 10 12 19 -22 -12 -118 -66 82 34 76 74 
Wild Mid 18 
d1 EtOAc 36 32 35 43 -11 -10 -56 -12 -31 -23 -81 -89 
Wild Mid 18 
d1 MeOH 17 27 21 17 -13 -2 -113 -76 -11 -51 41 53 
Wild Mid 18 
d6 EtOAc 43 32 42 28 -16 -12 -56 -39 -41 3 -42 -82 
Wild Mid 18 
d6 MeOH 15 7 16 13 -52 -20 -132 -101 -69 -3 72 64 
Wild Mid 18 
d9 EtOAc 12 21 15 24 -7 -2 -22 1 -23 -3 -67 -24 
Wild Mid 18 
d9 MeOH 17 8 13 14 -29 -17 -126 -87 56 11 65 68 
Wild Hind 5 
d1 EtOAc 16 11 22 26 -3 -2 -46 -14 -35 -3 -29 -26 
Wild Hind 5 
d1 MeOH 14 13 28 22 -16 -14 -138 -97 72 44 49 51 
Wild Hind 5 
d6 EtOAc 29 6 22 21 -3 2 -19 4 -26 -22 -54 -53 
Wild Hind 5 
d6 MeOH 14 12 16 17 -14 -13 -126 -94 86 53 6 34 
Wild Hind 5 
d9 EtOAc 29 33 26 32 -12 -8 -23 -6 -33 -20 -62 -81 
Wild Hind 5 
d9 MeOH 26 27 42 24 -15 -14 -128 -99 -56 -54 64 66 
Fäk1.1 
d1 EtOAc 36 34 36 33 -12 -10 -65 -13 -52 -14 -78 -63 
Fäk1.1 
d1 MeOH 26 17 22 24 -28 -32 -115 -86 -15 -78 63 70 
Fäk1.1 
d6 EtOAc 22 24 19 11 -10 -15 -45 -10 -17 -5 -52 -31 
Fäk1.1 
d6 MeOH 26 28 28 25 -20 -17 -105 -74 -15 -53 12 13 
Fäk1.1 
d9 EtOAc 16 25 16 27 -8 -11 -23 -7 -51 -2 -71 -72 
Fäk1.1 
d9 MeOH 26 29 34 35 -27 -28 -106 -58 -54 -54 21 18 
1FM2 
d1 EtOAc 38 33 24 34 -9 -17 -65 -13 -107 -25 -80 -49 
1FM2 
d1 MeOH 13 14 23 17 -20 -21 -133 -91 7 -24 54 50 
1FM2 
d6 EtOAc 30 25 40 34 -14 -17 -83 -45 -78 -28 -56 -41 
1FM2 
d6 MeOH 17 14 13 10 -28 -22 -148 -112 -66 -61 -47 38 
1FM2 
d9 EtOAc 37 30 30 27 -18 -21 -48 -12 -49 -33 -5 -91 
1FM2 
d9 MeOH 14 12 14 15 -18 -10 -134 -101 37 -52 5 13 
2MH1 
d1 EtOAc 35 26 37 33 -16 -15 -35 -13 -37 -46 -100 -98 
2MH1 
d1 MeOH 12 17 22 17 -137 -23 82 79 -70 7 49 48 
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2MH1 
d6 EtOAc 36 27 31 33 -9 -22 -40 -17 -33 -58 -88 -94 
2MH1 
d6 MeOH 16 18 19 20 -15 -15 16 63 69 -21 100 103 
2MH1 
d9 EtOAc 38 25 43 32 -7 -18 -38 -13 -42 -46 -92 -58 
2MH1 
d9 MeOH 8 9 14 12 -19 -25 -27 -14 76 29 101 104 
2MH3-2 
d1 EtOAc 22 20 27 18 -9 -7 71 59 -45 -52 41 41 
2MH3-2 
d1 MeOH 19 16 21 23 -12 -11 9 49 -98 -59 66 62 
2MH3-2 
d6 EtOAc 23 7 29 19 -4 32 -56 -35 -32 -59 -34 -77 
2MH3-2 
d6 MeOH 20 13 18 19 -28 -21 12 33 -55 -27 100 102 
2MH3-2 
d9 EtOAc 18 0 21 27 -3 13 -127 -66 2 -36 -16 -40 
2MH3-2 
d9 MeOH 15 13 20 19 -25 -34 16 57 -12 -38 101 104 
2ABFF1 
d1 EtOAc 43 25 8 10 -24 -26 -106 -90 -73 -89 -43 -37 
2ABFF1 
d1 MeOH 28 21 32 31 -34 -13 -155 -109 -63 -69 62 60 
2ABFF1 
d6 EtOAc 43 30 20 4 -27 -28 -84 -28 -71 -67 -62 -96 
2ABFF1 
d6 MeOH 25 19 8 27 -24 -12 -148 -111 -79 -92 54 39 
2ABFF1 
d9 EtOAc 0 0 0 0 0 0 0 0 0 0 100 100 
2ABFF1 
d9 MeOH 0 0 0 0 0 0 0 0 0 0 100 100 
2ABFF6 
d1 EtOAc 34 38 6 33 39 -9 -16 -45 -94 -42 1 -18 
2ABFF6 
d1 MeOH 23 22 32 34 -19 -15 -73 -62 -76 -66 49 49 
2ABFF6 
d6 EtOAc 29 34 38 31 34 15 -58 -57 -58 -79 -26 -46 
2ABFF6 
d6 MeOH 25 29 32 31 -18 -25 -84 -71 -92 -91 45 33 
2ABFF6 
d9 EtOAc 33 37 9 29 -2 -10 -19 -45 -60 -66 -34 -43 
2ABFF6 
d9 MeOH 24 26 39 36 -11 3 -84 -65 -77 -84 6 8 
2ABMH1 
d1 EtOAc 35 39 -2 1 -5 2 -32 -33 -78 -88 -27 5 
2ABMH1 
d1 MeOH 10 24 27 30 -2 -8 -12 -75 -81 -77 90 82 
2ABMH1 
d6 EtOAc 33 0 1 -5 -1 -1 3 13 4 -17 -20 -11 
2ABMH1 
d6 MeOH -3 -1 34 7 -18 -18 -82 -62 -39 -66 75 66 
2ABMH1 
d9 EtOAc 41 -13 -15 -5 -7 4 15 14 -10 -17 -47 -41 
2ABMH1 
d9 MeOH -11 -7 17 0 -44 -69 -80 -60 -47 -93 88 87 
FF6-H2O 
d1 EtOAc 35 35 26 24 -2 4 0 1 -10 -32 62 59 
FF6-H2O 
d1 MeOH 70 68 65 96 64 17 81 59 84 66 91 91 
FF6-H2O 
d6 EtOAc -10 12 -2 -3 -2 -6 -10 -1 -30 -55 -17 -23 
FF6-H2O 
d6 MeOH 41 44 100 99 32 33 100 101 79 62 101 103 
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FF6-H2O 
d9 EtOAc 37 33 5 19 -5 -5 -4 3 -40 -47 -33 -39 
FF6-H2O 
d9 MeOH 100 100 100 90 100 100 76 68 97 99 101 103 
FF7-H2O 
d1 EtOAc 23 21 28 31 10 6 2 8 -83 -65 -73 -86 
FF7-H2O 
d1 MeOH 10 15 11 11 -18 -2 -58 -59 -38 -91 79 66 
FF7-H2O 
d6 EtOAc 31 25 43 31 -2 4 -27 -23 -48 -67 -48 -79 
FF7-H2O 
d6 MeOH 6 20 16 14 -7 -3 -71 -60 46 57 76 48 
FF7-H2O 
d9 EtOAc 27 31 5 29 -1 3 -47 -49 -49 -52 -58 -41 
FF7-H2O 
d9 MeOH 12 18 18 14 -17 -26 -67 -61 44 65 57 21 
Wild Anal 1 
d1 EtOAc 36 37 29 21 -5 -1 -36 -32 -51 -78 -60 -57 
Wild Anal 1 
d1 MeOH 21 17 23 28 -3 -6 -71 -51 20 -25 43 48 
Wild Anal 1 
d6 EtOAc 21 30 36 37 0 -1 -45 -36 -49 -47 -29 -39 
Wild Anal 1 
d6 MeOH 5 13 7 5 -10 -2 -87 -66 31 -5 -21 -27 
Wild Anal 1 
d9 EtOAc 30 32 0 10 -7 -1 -9 -27 -13 -26 -20 -47 
Wild Anal 1 
d9 MeOH 10 12 9 6 -15 17 -64 -56 9 33 39 45 
4 d1 EtOAc 41 35 -4 1 4 12 -14 -16 -106 -135 -40 18 
4 d1 MeOH 5 5 -35 -17 -51 1 -121 -134 -141 -150 76 77 
4 d6 EtOAc 40 38 9 -7 -1 -17 -10 -23 -78 -136 2 48 
4 d6 MeOH 6 6 -56 -46 -46 -19 -109 -136 -109 -102 67 71 
4 d9 EtOAc 40 40 13 6 3 13 -6 -12 -95 -100 -22 42 
4 d9 MeOH 1 -1 -51 -41 -69 -47 -113 -145 -103 -106 54 63 
20 d1 EtOAc 24 25 -8 -20 -21 8 -46 -69 -121 -32 -38 22 
20 d1 MeOH 11 7 -28 -44 -38 3 40 62 69 76 78 87 
20 d6 EtOAc 40 36 5 -7 -32 -2 -18 -13 -131 -137 -29 45 
20 d6 MeOH 1 0 -50 -55 -6 3 -113 -135 -160 -1 99 100 
20 d9 EtOAc 42 40 -12 -8 4 11 -13 -44 -112 -36 -14 12 
20 d9 MeOH 12 9 -37 -49 -4 3 -114 -127 -131 12 97 99 
26 d1 EtOAc 33 32 -7 -17 -24 -8 -26 -52 -230 -70 -42 8 
26 d1 MeOH 12 4 -32 -42 -3 -41 -117 -145 -141 -118 64 79 
26 d6 EtOAc 40 32 -1 -3 6 8 -10 -42 -172 -133 -20 30 
26 d6 MeOH 7 3 -41 -49 4 9 -115 -135 -122 -87 99 100 
26 d9 EtOAc 35 32 -11 -19 -8 10 -18 -38 -76 -52 -33 23 
26 d9 MeOH 8 9 -43 -49 -26 3 -149 -140 -106 -123 99 98 
29 d1 EtOAc 42 33 12 -15 1 -21 -2 -18 -152 -129 -56 27 
29 d1 MeOH 0 2 -37 -43 91 82 -127 -121 -57 44 81 89 
29 d6 EtOAc 37 19 1 -2 -5 5 -17 -23 -189 -175 101 102 
29 d6 MeOH -9 -12 -15 -16 -17 -20 -54 -68 -227 -244 101 102 
29 d9 EtOAc 40 38 9 0 -5 2 3 -12 -134 -99 -28 25 
29 d9 MeOH -6 -7 0 -37 -23 -19 -65 -160 86 40 77 85 
34 d1 EtOAc 30 34 -14 -16 -3 -8 -22 -52 -144 -178 -55 7 
34 d1 MeOH 24 21 -11 -33 -7 -5 -107 -133 -238 -252 56 71 
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34 d6 EtOAc 34 30 -27 -23 -5 15 -26 -55 -48 -126 -1 30 
34 d6 MeOH 27 29 -6 -16 -5 -2 -70 -76 -225 -137 97 90 
34 d9 EtOAc 34 31 -12 -26 -6 2 -22 -23 -56 -94 -6 36 
34 d9 MeOH 32 28 -7 -10 -10 -4 -83 -80 -245 -250 68 80 
48 d1 EtOAc -13 18 7 5 -6 9 -2 -21 -18 -48 -57 18 
48 d1 MeOH -14 -14 -92 -72 -15 -13 -128 -144 -154 -156 75 83 
48 d6 EtOAc 11 -1 5 12 -6 9 -7 -31 -109 -92 -21 41 
48 d6 MeOH 18 17 -34 -30 7 14 -133 -145 -148 -126 91 92 
48 d9 EtOAc 28 24 21 -4 -4 -25 -3 -9 -107 -243 -49 4 
48 d9 MeOH 9 8 -39 -47 4 9 -142 -142 -125 -104 93 96 
50 d1 EtOAc 30 30 -31 -20 3 11 -21 -40 -182 -5 -37 17 
50 d1 MeOH 7 7 -45 -54 -57 -14 -154 -142 -123 -154 58 80 
50 d6 EtOAc 39 33 18 -2 -1 -2 -8 -35 -140 -192 -13 42 
50 d6 MeOH 6 3 -7 -19 -10 5 -74 -88 9 12 98 99 
50 d9 EtOAc 40 31 5 4 3 -12 -11 -17 -150 -134 -13 39 
50 d9 MeOH 8 4 -7 -23 -14 1 -67 -98 17 28 98 99 
54 d1 EtOAc 19 20 0 -10 -9 -2 -27 -34 -66 -147 -23 35 
54 d1 MeOH -4 -21 -20 -53 -76 -24 -100 -129 -85 20 79 86 
54 d6 EtOAc 13 10 16 -2 -1 9 -13 -19 -127 -126 -2 39 
54 d6 MeOH 7 13 -14 -13 -23 -9 -89 -125 -134 65 95 99 
54 d9 EtOAc 29 30 13 -2 3 3 -1 -13 -109 -61 -26 16 
54 d9 MeOH 14 19 8 -10 -48 -13 -79 -85 -179 -194 91 93 
56 d1 EtOAc 33 34 -13 -29 7 -4 -45 -58 -156 -126 -4 36 
56 d1 MeOH 84 91 85 79 88 81 99 97 91 98 96 98 
56 d6 EtOAc 32 35 -8 -15 -1 3 -2 -13 -102 -140 -3 40 
56 d6 MeOH 26 31 99 100 -35 -4 97 97 65 89 101 101 
56 d9 EtOAc 31 38 1 -3 -2 -1 -1 -16 -180 -83 2 37 
56 d9 MeOH 100 100 101 101 100 100 101 101 101 107 101 102 
71 d1 EtOAc 34 38 14 -2 -5 -1 -4 -24 -196 -48 -38 30 
71 d1 MeOH -9 -8 -49 -53 -23 -36 -149 -151 50 24 83 86 
71 d6 EtOAc 1 8 9 -3 -5 -3 -23 -36 -112 -84 3 28 
71 d6 MeOH 5 4 -59 -66 -65 -20 -174 -198 -143 -153 69 89 
71 d9 EtOAc 35 30 4 -7 -1 5 -25 -32 -113 -282 -18 37 
71 d9 MeOH -3 -6 -59 -63 -77 -54 -123 -127 73 -208 87 93 
79 d1 EtOAc 36 36 0 -10 -3 4 -21 -36 -62 -113 -62 9 
79 d1 MeOH 7 -3 -39 -38 -44 -48 -107 -80 -88 -143 78 87 
79 d6 EtOAc 19 21 7 -9 -11 1 -19 -37 -39 -99 17 49 
79 d6 MeOH 1 -1 -24 -61 -6 -4 -113 -135 19 -126 98 100 
79 d9 EtOAc 25 18 14 5 8 -2 -1 -23 -135 -97 -3 38 
79 d9 MeOH 2 2 -9 -22 1 -6 -65 -89 -21 -142 95 97 
93 d1 EtOAc 29 32 -6 -21 -2 -6 -37 -21 -160 16 -23 9 
93 d1 MeOH 13 7 -29 -33 -1 1 -99 -117 -195 -186 50 78 
93 d6 EtOAc 31 23 -17 -14 6 9 -30 -61 -149 -128 -50 16 
93 d6 MeOH 14 8 -36 -39 -10 5 -129 -150 -179 -206 71 50 
93 d9 EtOAc 28 25 -23 -26 -5 10 -14 -69 -58 -39 -45 14 
93 d9 MeOH 16 18 -27 -38 -12 -5 -119 -142 -223 -192 69 74 
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2ABFH4  d1 
EtOAc 30 30 -22 -31 0 7 -25 -58 22 -68 -26 28 
2ABFH4 d1 
MeOH 23 21 -28 -9 -11 -12 -73 -90 -126 -148 40 63 
2ABFH4 d6 
EtOAc 31 30 -5 -1 -7 -5 -7 -32 -123 -158 -21 7 
2ABFH4 d6 
MeOH 11 9 -56 -55 -15 -14 -134 -150 -110 -111 39 73 
2ABFH4 d9 
EtOAc 5 38 8 5 -2 17 -6 -24 -96 -115 -12 29 
2ABFH4 d9 
MeOH 18 8 -46 -48 -13 -12 -138 -152 -143 -97 -86 67 
2ABMF2  d1 
EtOAc 14 22 9 2 1 10 -106 -86 -89 -181 -82 -44 
2ABMF2 d1 
MeOH -9 9 12 11 5 7 -33 -54 -227 -167 82 83 
2ABMF2 d6 
EtOAc 23 32 -5 10 -11 -2 -20 -17 -25 -91 -22 -39 
2ABMF2 d6 
MeOH -10 0 22 -14 -75 -47 -75 -65 -18 -84 92 89 
2ABMF2 d9 
EtOAc 17 28 4 21 -11 -13 -22 -10 -71 -95 -19 -36 
2ABMF2 d9 
MeOH 36 27 7 11 3 -29 -54 -73 -99 -116 93 87 
2AB_FH4 -BHI 
d1 EtOAc 18 25 4 21 -10 5 -19 -4 -39 -131 -29 -21 
2AB_FH4-BHI d1 
MeOH -30 8 100 99 99 99 97 97 -171 -178 -37 -24 
2AB_FH4-BHI d6 
EtOAc 3 -6 14 1 -45 -6 -20 -33 -66 -6 -62 -77 
2AB_FH4-BHI d6 
MeOH -7 9 -14 -20 3 10 -112 -111 -103 -90 17 7 
2AB_FH4-BHI d9 
EtOAc -5 24 7 18 -8 -11 -26 -22 -75 -109 -39 -53 
2AB_FH4-BHI d9 
MeOH -7 14 -17 -16 31 46 -58 -76 -146 -6 16 -1033 
2MF3 d1 EtOAc 19 30 -2 5 10 17 -8 -11 -66 -96 -60 -63 
2MF3 d1 MeOH -14 -3 -13 -12 -15 -9 -105 -41 77 -97 27 28 
2MF3 d6 EtOAc 17 24 4 29 10 14 -13 -3 -116 -102 -84 -40 
2MF3 d6 MeOH -6 -3 -25 -28 -13 3 -107 -129 6 44 50 51 
2MF3 d9 EtOAc 18 30 3 12 7 17 -22 -9 -101 -95 -54 -75 
2MF3 d9 MeOH -3 21 -18 -13 -25 -7 -71 -118 -115 -75 35 26 
2MF4-BHI d1 
EtOAc 29 22 22 7 6 4 -16 -24 -62 -68 -25 -22 
2MF4-BHI d1 
MeOH -25 -10 -18 -36 -40 -28 -63 -90 -81 -62 67 62 
2MF4-BHI d6 
EtOAc -34 -3 15 16 4 3 -11 7 0 -72 -74 -44 
2MF4-BHI d6 
MeOH -22 -5 1 0 -96 -18 -51 -28 -2 -4 81 64 
2MF4-BHI d9 
EtOAc -40 -14 -10 15 10 14 -2 0 -4 -95 -23 -61 
2MF4-BHI d9 
MeOH -16 -9 -9 -4 -32 -17 -71 -61 70 76 67 61 
2MF5 d1 EtOAc 1 35 -7 17 0 -2 -21 -9 -137 -58 -60 -49 
2MF5 d1 MeOH -26 12 -34 -25 65 77 -95 -87 -168 -30 -5 -41 
2MF5 d6 EtOAc -11 16 2 27 6 12 -33 -8 -98 -47 -76 -55 
2MF5 d6 MeOH -12 1 -11 9 17 19 -86 -83 -127 -132 -23 -18 
2MF5 d9 EtOAc 20 32 12 22 -1 11 -28 -12 -75 -136 -65 -77 
2MF5 d9 MeOH -31 -7 -6 -8 40 51 -77 -87 -171 -88 6 -1 
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2MH2 d1 EtOAc 16 31 12 13 -22 5 -18 2 -7 -30 -33 -47 
2MH2 d1 MeOH -14 -1 -24 -26 -28 4 -96 -86 62 75 37 42 
2MH2 d6 EtOAc 18 26 -1 5 -1 9 -28 -8 20 -64 -72 -47 
2MH2 d6 MeOH -15 3 -27 -21 -12 -4 -75 -71 76 -26 29 -163 
2MH2 d9 EtOAc 17 27 3 7 6 11 -39 -26 -168 -107 -57 -70 
2MH2 d9 MeOH -8 -13 -25 -34 -7 4 -142 -122 65 12 20 -6 
2MH4 d1 EtOAc -23 -10 10 19 9 6 3 -6 -16 -56 -11 -35 
2MH4 d1 MeOH -17 8 -13 -6 100 13 -87 -78 -180 -196 -42 -43 
2MH4 d6 EtOAc 10 9 13 15 -1 -9 -18 -11 -44 -58 -23 -18 
2MH4d6 MeOH -2 17 102 100 101 99 -31 -15 -86 -21 -37 -33 
2MH4 d9 EtOAc -2 8 15 8 6 2 -13 2 -60 -16 -57 -68 
2MH4 d9 MeOH 1 4 31 99 100 99 -69 -55 -106 -84 -63 -24 
Fäk1_2 d1 EtOAc 14 23 -2 1 15 9 -31 -17 -145 -131 -49 -73 
Fäk1_2 d1 
MeOH -16 3 -21 -23 -10 -8 -101 -103 -96 -98 82 87 
Fäk1_2 d6 EtOAc 5 17 5 -4 7 16 -11 -7 -127 -164 -56 -48 
Fäk1_2 d6 
MeOH -7 12 -5 -5 -12 -17 -106 -88 -5 -10 82 60 
Fäk1_2 d9 EtOAc -18 0 2 18 4 17 -11 -23 -147 -70 -30 -12 
Fäk1_2 d9 
MeOH -7 2 -19 -22 -56 -24 -135 -107 -84 -100 58 28 
Wild Mid 14 d1 
EtOAc 9 -3 -7 6 -3 6 -81 -55 -125 -161 30 9 
Wild Mid 14  d1 
MeOH -18 2 -26 -26 -15 -26 -135 -118 -63 -101 41 56 
Wild Mid 14  d6 
EtOAc 6 31 4 9 1 3 -31 -7 -61 -21 -29 -72 
Wild Mid 14 d6 
MeOH -6 8 -8 -3 -7 -1 -93 -118 -6 -50 18 74 
Wild Mid 14 d9 
EtOAc -17 20 -7 1 12 13 -40 0 -100 -115 -41 -54 
Wild Mid 14 d9 
MeOH -6 7 -8 2 -10 -4 -62 -63 89 99 -100 -64 
38 d1 EtOAc 9 30 -22 100 11 30 -39 -27 -119 -27 16 -19 
38 d1 MeOH 85 81 37 31 13 8 -15 -34 -84 51 41 42 
38 d6 EtOAc 24 0 100 28 4 -5 -39 -35 -113 -43 31 -32 
38 d6 MeOH 97 100 99 100 99 95 93 89 42 71 99 97 
38 d9 EtOAc 18 7 100 -1 1 29 -8 -18 -62 0 18 -14 
38 d9 MeOH 21 25 10 31 22 35 -58 -66 -72 -58 63 51 
39 d1 EtOAc 25 13 14 5 -3 27 -26 -10 -100 -29 1 -17 
39 d1 MeOH 15 2 -3 19 -50 8 -57 -64 -125 -43 40 19 
39 d6 EtOAc 30 3 1 36 -7 1 -22 -19 -34 -79 13 -19 
39 d6 MeOH 69 91 97 50 2 48 -18 -45 -57 -45 104 104 
39 d9 EtOAc 19 0 15 29 8 -1 -4 -6 -47 -110 -21 -93 
39 d9 MeOH -1 -17 0 21 -73 -1 -63 -68 -81 -33 104 103 
41 d1 EtOAc 37 6 -31 -9 12 -12 22 12 -93 8 13 -38 
41 d1 MeOH 17 -1 98 17 -37 -1 -66 -75 40 66 67 73 
41 d6 EtOAc 38 -19 100 10 14 -4 10 4 -69 -38 9 -18 
41 d6 MeOH 17 -26 83 15 0 -3 81 87 83 89 105 105 
41 d9 EtOAc 35 21 14 32 8 -2 6 11 -98 -32 101 68 
41 d9 MeOH 11 0 32 48 -58 -26 97 97 -58 19 105 105 
42 d1 EtOAc 25 -2 -3 1 -23 -38 4 20 5 -28 -32 -15 
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42 d1 MeOH 30 99 95 54 -13 3 -42 -56 -108 59 38 30 
42 d6 EtOAc 40 11 -27 -3 5 19 15 9 -70 -14 8 -14 
42 d6 MeOH 100 100 100 100 100 100 101 100 75 89 99 97 
42 d9 EtOAc 38 15 -31 -5 6 9 22 14 -169 -28 -47 -47 
42 d9 MeOH 54 36 28 44 100 100 -25 -1 86 70 56 52 
57 d1 EtOAc -3 -19 -13 -3 -93 -1 -25 -33 16 72 -113 -93 
57 d1 MeOH 11 -12 -2 17 -105 -50 13 6 -119 -53 100 99 
57 d6 EtOAc 8 -13 -24 6 -16 -46 -22 -36 -66 12 21 9 
57 d6 MeOH 8 -5 -3 8 -102 -35 -68 -59 -54 -13 105 105 
57 d9 EtOAc 14 -23 101 7 -63 -70 -26 -44 34 -1 -52 -75 
57 d9 MeOH 3 53 62 3 -60 -14 -58 -74 -81 -42 105 105 
58 d1 EtOAc 2 -32 -30 2 10 -10 13 12 -86 6 -14 -16 
58 d1 MeOH 32 0 6 33 -3 -27 -18 -37 -46 -22 36 39 
58 d6 EtOAc 8 -22 101 5 17 26 20 10 -56 11 0 5 
58 d6 MeOH 19 5 0 13 19 3 -84 -110 -73 30 102 102 
58 d9 EtOAc -10 11 101 5 16 16 21 13 -19 2 25 -13 
58 d9 MeOH 8 -7 86 5 4 12 -84 -99 56 69 102 101 
76 d1 EtOAc 44 22 -25 1 11 -18 19 19 50 5 -41 -79 
76  d1 MeOH 33 4 -1 33 -18 -1 -46 -62 61 68 53 40 
76  d6 EtOAc 40 -5 10 7 14 5 11 4 22 -9 5 -19 
76  d6 MeOH 51 57 100 100 33 28 -28 -24 -64 -73 104 104 
76  d9 EtOAc 38 21 -9 15 0 18 7 0 -91 -5 -14 -17 
76  d9 MeOH 38 -6 1 12 6 5 -10 29 -88 67 50 39 
77 d1 EtOAc 16 -12 101 4 8 -3 9 4 -3 8 -28 -32 
77 d1 MeOH 17 -9 51 59 13 9 4 -24 40 -40 58 68 
77 d6 EtOAc 23 12 -23 5 7 -32 11 5 -28 24 -6 -41 
77 d6 MeOH 63 30 87 96 14 3 -24 0 41 -9 56 52 
77 d9 EtOAc 20 7 -25 9 10 -25 9 6 -31 37 -55 -42 
77 d9 MeOH 23 3 7 24 -9 -5 -58 -72 -29 -17 37 22 
88 d1 EtOAc 37 6 -8 101 5 7 -8 -18 -81 -20 -10 -39 
88  d1 MeOH 39 21 16 19 5 7 -33 -75 -58 -34 73 35 
88  d6 EtOAc 31 12 19 7 6 15 12 8 -68 -73 8 -29 
88  d6 MeOH 24 3 -11 7 3 17 -60 -73 -92 -35 103 102 
88 d9 EtOAc 7 -21 -23 14 16 25 20 11 -117 -9 15 10 
88  d9 MeOH 44 20 0 18 4 6 -57 -64 -48 -19 101 100 
89 d1 EtOAc 7 -29 -26 10 8 22 18 7 11 -16 -18 -17 
89 d1 MeOH 39 -1 100 34 1 28 41 -1 97 96 41 8 
89 d6 EtOAc 39 19 -12 6 11 5 14 -1 -35 -29 -57 -23 
89 d6 MeOH 100 101 100 100 101 101 101 101 78 45 55 72 
89 d9 EtOAc 38 4 -5 34 7 -2 -5 -9 -57 44 -25 -51 
89 d9 MeOH 100 101 101 101 101 101 101 99 -96 -13 55 83 
2FH1_PGS d1 
EtOAc 0 -3 22 14 6 7 10 -1 -55 -1 -51 -31 
2FH1_PGS d1 
MeOH 43 10 18 54 -13 -14 -16 -46 66 40 74 64 
2FH1_PGS d6 
EtOAc 12 -13 -16 13 3 8 12 -16 -44 -2 -21 -13 
2FH1_PGS d6 
MeOH 97 89 97 96 -26 -19 58 -64 -18 17 95 89 
Appendix 
117 
 
2FH1_PGS d9 
EtOAc 8 -2 -18 10 6 -16 12 -18 -49 -42 -3 -19 
2FH1_PGS d9 
MeOH 63 100 29 53 -29 -20 -22 -45 35 80 69 64 
2FH3_PGS d1 
EtOAc 13 -22 11 10 3 14 6 -24 -48 19 -49 -89 
2FH3_PGS d1 
MeOH 30 -12 93 99 -20 -18 -84 10 67 71 75 72 
2FH3_PGS d6 
EtOAc 36 9 -3 23 13 -2 -6 -33 7 -28 -41 -43 
2FH3_PGS d6 
MeOH 13 -11 99 98 -29 -56 -60 -6 -65 -29 -30 -65 
2FH3_PGS d9 
EtOAc 30 8 19 22 11 -23 -3 -55 -36 -10 -11 -26 
2FH3_PGS d9 
MeOH 6 -6 100 98 -39 -33 -63 -41 -31 33 -17 -66 
2FM6_PGS d1 
EtOAc 37 10 -2 22 -2 22 -5 -65 61 -51 1 -19 
2FM6_PGS d1 
MeOH 37 4 100 18 0 2 -41 -73 -123 83 52 41 
2FM6_PGS d6 
EtOAc 35 -2 -1 29 3 16 -7 -71 -60 -30 -35 -15 
2FM6_PGS d6 
MeOH 100 101 101 100 100 101 100 100 37 3 70 74 
2FM6_PGS d9 
EtOAc 11 25 11 101 -10 -11 -12 -62 -56 11 0 -22 
2FM6_PGS d9 
MeOH 42 25 95 87 101 101 29 88 53 79 57 58 
2MF1_PGS d1 
EtOAc 62 12 11 101 15 -8 -36 -34 -112 -356 -27 -30 
2MF1_PGS d1 
MeOH 83 24 -32 -22 -15 1 0 15 -173 -290 9 45 
2MF1_PGS d6 
EtOAc 15 19 9 -15 -3 17 -16 -39 -16 -127 -42 -34 
2MF1_PGS d6 
MeOH 34 4 86 26 1 -43 94 79 -10 -198 104 104 
2MF1_PGS d9 
EtOAc 15 18 5 -22 12 16 -35 -52 -3 -44 -51 -55 
2MF1_PGS d9 
MeOH 3 5 -38 64 7 -54 53 36 -79 -58 104 104 
2MF6_PGS d1 
EtOAc 12 10 2 -25 4 4 -41 -42 -33 -153 -19 -37 
2MF6_PGS d1 
MeOH 14 33 -11 -16 43 37 -56 -76 -112 -258 -96 -21 
2MF6_PGS d6 
EtOAc 4 21 9 -1 -13 1 0 13 -67 -242 -68 -74 
2MF6_PGS d6 
MeOH 99 99 89 101 99 97 100 101 -206 -208 26 25 
2MF6_PGS d9 
EtOAc 4 36 15 4 2 -3 8 5 -60 -81 -17 -25 
2MF6_PGS d9 
MeOH 99 98 99 101 100 96 95 100 38 -151 25 37 
2MH1_PGS d1 
EtOAc 18 25 11 -6 -3 -27 -3 0 -55 -240 -88 -87 
2MH1_PGS d1 
MeOH 2 10 -32 -41 -64 -65 -15 -38 -100 -314 59 66 
2MH1_PGS d6 
EtOAc 24 26 10 4 2 -7 2 4 77 -230 -73 -51 
2MH1_PGS d6 
MeOH 0 4 3 18 -13 -20 72 64 -14 -115 104 104 
2MH1_PGS d9 
EtOAc 25 18 15 102 5 0 -1 -7 34 -17 -59 -79 
2MH1_PGS d9 
MeOH 19 23 -7 73 -22 -52 -65 -68 -95 -165 104 104 
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Man. F. hind 1 
d1 EtOAc 24 5 12 1 5 14 10 5 -52 -243 -98 -21 
Man. F. hind 1  
d1 MeOH 32 24 -5 -2 3 -11 -55 -81 87 -198 48 59 
Man. F. hind 1  
d6 EtOAc 23 24 -13 -7 0 0 7 0 16 -213 -40 -13 
Man. F. hind 1  
d6 MeOH 46 37 14 23 -40 -65 7 3 57 -86 99 98 
Man. F. hind 1  
d9 EtOAc 27 18 11 -5 6 -2 11 5 -74 -124 -77 -39 
Man. F. hind 1  
d9 MeOH 37 59 95 34 -96 0 -51 -65 -14 -187 92 89 
Man. F. hind 2 
d1 EtOAc 26 35 10 4 5 -3 9 4 -55 -81 -109 -114 
Man. F. hind 2  
d1 MeOH 37 36 -13 27 8 42 20 -7 -71 -246 48 45 
Man. F. hind 2  
d6 EtOAc 32 26 8 8 -6 -10 6 0 -63 -177 -54 -29 
Man. F. hind 2  
d6 MeOH 5 6 -28 -31 -23 -21 -65 -69 -75 -176 -23 27 
Man. F. hind 2  
d9 EtOAc 16 -14 16 4 20 12 7 -1 -62 -105 -28 -13 
Man. F. hind 2  
d9 MeOH -11 -3 -39 -41 -110 -65 -64 -77 81 -84 104 103 
Man. F. mid 1 d1 
EtOAc 32 -5 8 13 10 5 17 5 -67 -108 -25 -70 
Man. F. mid 1   
d1 MeOH 19 27 -14 -3 13 6 16 -20 -76 -272 41 37 
Man. F. mid 1   
d6 EtOAc 23 -10 0 1 7 5 3 0 -24 -114 -74 -53 
Man. F. mid 1 d6 
MeOH 17 -5 13 101 -11 -3 12 38 -128 -27 33 43 
Man. F. mid 1   
d9 EtOAc 24 -9 -2 4 7 11 0 -5 37 -55 -41 -27 
Man. F. mid 1   
d9 MeOH 26 19 4 11 2 1 22 36 -108 -91 38 43 
Man. F. mid 4 d1 
EtOAc 26 31 8 -7 6 2 8 -8 -23 -190 -104 -32 
Man. F. mid 4   
d1 MeOH 9 11 -23 -20 11 3 -70 -75 -103 -258 43 43 
Man. F. mid 4   
d6 EtOAc 13 17 2 2 -21 -9 3 -5 -97 -71 -62 -38 
Man. F. mid 4 d6 
MeOH 10 -15 99 4 -15 -14 26 23 -109 -5 34 37 
Man. F. mid 4  
d9 EtOAc -10 -4 14 -1 0 12 6 -3 8 -58 -38 -40 
Man. F. mid 4  
d9 MeOH 7 -21 10 13 -15 1 28 24 -40 -162 38 39 
Man. MF4 d1 
EtOAc 18 -6 101 4 11 6 15 8 -67 -85 -116 -66 
Man. MF4    d1 
MeOH 66 13 7 92 -25 -16 2 34 19 -10 63 66 
Man. MF4    d6 
EtOAc 27 -12 11 9 7 5 9 4 -47 -89 -65 -26 
Man. MF4  d6 
MeOH 4 8 68 99 -18 -26 -1 -18 50 21 9 -12 
Man. MF4   d9 
EtOAc 23 30 1 -8 11 5 -7 -1 -7 -130 -62 -41 
Man. MF4   d9 
MeOH -6 -5 8 55 -35 -43 0 -7 -99 -175 100 101 
Fäk1_PGS d1 
EtOAc 10 27 1 -1 3 6 14 2 -118 -133 -86 -20 
Fäk1_PGS  d1 
MeOH 25 24 -11 -30 0 -16 -47 -60 -63 -332 58 67 
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Fäk1_PGS  d6 
EtOAc 22 9 -2 -8 8 19 6 -11 -44 -65 -31 -72 
Fäk1_PGS d6 
MeOH -4 -3 -35 -47 -2 -7 -78 -88 -99 -19 81 88 
Fäk1_PGS d9 
EtOAc -12 -10 4 9 14 8 10 4 15 -70 -30 -35 
Fäk1_PGS d9 
MeOH -13 8 -21 0 -6 -29 -59 -65 59 100 104 104 
21 d1 EtOAc 30 -5 -40 2 1 -2 -39 -18 -95 -53 -18 -23 
21  d1 MeOH -4 0 -94 -49 -78 -75 -135 -90 -82 -96 59 50 
21  d6 EtOAc 13 15 -22 100 3 5 1 -20 -17 2 19 20 
21 d6 MeOH 11 4 -100 95 -62 -72 -105 -139 -87 -45 16 23 
21 d9 EtOAc 1 8 -39 -32 0 0 -17 -117 -69 -31 5 6 
21 d9 MeOH 15 1 -34 100 -28 -8 -109 -160 -56 -27 102 101 
32 d1 EtOAc 25 32 -37 3 1 8 -31 -32 -169 -49 -15 -67 
32 d1 MeOH 0 7 -79 -11 -18 -1 -128 -83 -111 -65 62 41 
32  d6 EtOAc 10 17 -19 -22 9 2 -9 -20 -18 -1 84 92 
32 d6 MeOH 19 23 -47 -39 -2 -11 -73 -141 -64 -33 102 103 
32 d9 EtOAc 36 33 -32 101 -2 -3 -29 -33 -51 -32 37 34 
32 d9 MeOH -5 -5 -116 -48 -109 -11 -123 -152 -103 -50 57 52 
46 d1 EtOAc 18 33 -72 -13 1 -2 -11 -50 -37 -5 30 8 
46  d1 MeOH -16 -5 -92 -52 -23 2 -130 -90 -106 -51 60 54 
46  d6 EtOAc 10 14 -26 -22 1 -1 -16 -26 -26 -3 35 32 
46 d6 MeOH 9 4 -76 -59 -19 -5 -73 -149 -47 -7 64 46 
46 d9 EtOAc 5 11 -16 -22 1 3 -39 -28 -96 -30 21 15 
46 d9 MeOH 7 3 -65 -23 -99 -8 -108 -142 -78 -41 51 42 
53 d1 EtOAc 27 -6 -35 -51 -4 -7 -32 -81 -79 -21 61 43 
53  d1 MeOH 22 28 -55 -6 -7 -9 -121 -45 -71 -38 39 22 
53  d6 EtOAc 1 15 -31 -17 3 0 -9 -26 -34 -6 42 43 
53 d6 MeOH -4 -7 -97 -58 -41 -18 -118 -159 -80 -61 63 54 
53 d9 EtOAc 12 32 -51 5 -4 -3 -9 -27 -33 -5 38 44 
53 d9 MeOH 12 3 94 -56 -19 -9 -122 -159 -63 -32 54 40 
64 d1 EtOAc 31 32 -26 -8 -9 -7 -48 -37 -86 -39 37 34 
64  d1 MeOH 23 9 -89 76 -9 -15 -88 -66 -111 -74 -13 25 
64  d6 EtOAc 7 12 -13 -30 -1 2 -36 -27 -61 -15 38 46 
64 d6 MeOH 10 9 99 -39 -7 -8 -123 -118 -83 -38 47 25 
64 d9 EtOAc 23 32 102 -1 -6 -4 -53 -35 -50 -31 22 37 
64 d9 MeOH -5 2 -50 -34 -12 -24 -154 -46 -102 -70 63 45 
69 d1 EtOAc 32 3 -26 -48 -3 2 -28 -22 -63 -33 48 42 
69  d1 MeOH 16 -9 -91 -65 -2 -26 -113 -164 -52 -42 72 40 
69  d6 EtOAc 6 31 -74 -3 4 -8 -9 -53 -61 0 57 43 
69 d6 MeOH -4 11 -89 93 -18 -31 -126 -155 -81 -44 56 46 
69 d9 EtOAc 7 23 -59 -19 4 3 -3 -37 -14 9 43 27 
69 d9 MeOH -6 7 -97 6 -111 -18 -130 95 -62 -39 102 103 
72 d1 EtOAc 25 -1 -29 -38 -7 3 -43 -22 -74 -41 -2 19 
72  d1 MeOH 21 13 100 101 16 15 -82 -42 -66 -13 61 45 
72  d6 EtOAc 4 24 102 -24 -1 -6 -21 -27 -50 -32 37 32 
72 d6 MeOH 5 3 -83 90 -22 -27 -123 -101 -74 -43 102 103 
72 d9 EtOAc 30 19 -26 -34 -8 -5 -40 -20 -40 -34 56 59 
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72 d9 MeOH 16 2 -116 -51 -15 -22 -63 -123 -56 -34 58 44 
98 d1 EtOAc 31 34 -32 -33 -10 -13 -30 -32 -67 -22 53 50 
98  d1 MeOH 0 -2 -51 -66 7 -8 -108 -112 -55 -34 42 19 
98 d6 EtOAc 31 30 102 -28 -9 -6 -26 -33 -55 -39 41 45 
98 d6 MeOH 4 1 -63 -55 -16 -21 -116 -158 -63 -30 47 32 
98 d9 EtOAc -11 28 -58 -32 -2 1 -4 -46 -1 -9 17 16 
98 d9 MeOH 31 15 -66 -33 -26 15 -108 -65 -44 -57 57 31 
AB5 d1 EtOAc 25 8 102 -31 -8 0 -33 -27 -70 -35 42 41 
AB5  d1 MeOH 30 2 -49 -52 -10 -8 -108 -110 -42 -34 27 36 
AB5  d6 EtOAc 27 33 -20 -40 -8 -5 -32 -26 -60 -33 40 43 
AB5 d6 MeOH 10 8 -63 -38 -12 -11 -76 -103 -27 -5 65 56 
AB5 d9 EtOAc 35 18 102 -23 -4 -6 -24 -42 -31 -18 46 32 
AB5 d9 MeOH 15 9 -60 -27 -13 -17 -93 -104 -30 -9 63 58 
2AB_MF1 d1 
EtOAc 29 15 101 -33 -8 -9 -30 -32 -60 -40 52 22 
2AB_MF1  d1 
MeOH 1 14 -95 -43 -15 -5 -114 -70 -89 -69 40 61 
2AB_MF1  d6 
EtOAc 21 29 -54 -3 -8 5 -34 -59 -64 -45 101 103 
2AB_MF1 d6 
MeOH 9 17 -58 102 21 6 -59 -40 -28 -52 99 102 
2AB_MF1 d9 
EtOAc 22 21 -48 102 -4 0 -26 -38 -89 -54 36 36 
2AB_MF1 d9 
MeOH 1 12 -88 -49 -19 11 -106 -62 -80 -57 64 51 
Wild_Anal_6 d1 
EtOAc 24 31 102 -14 -8 0 -24 -33 -74 -35 28 30 
Wild_Anal_6 d1 
MeOH 12 1 -52 -29 -5 -13 -55 -141 -38 -16 -17 -38 
Wild_Anal_6  d6 
EtOAc 2 27 -59 101 3 -3 -14 -42 -39 -10 32 27 
Wild_Anal_6 d6 
MeOH 15 11 -45 101 0 -9 -84 -133 -74 -51 15 -45 
Wild_Anal_6  d9 
EtOAc 6 26 -42 -29 2 13 -26 -24 -38 -30 49 34 
Wild_Anal_6 d9 
MeOH -1 13 -78 -31 0 -13 -123 -142 -79 -61 47 -6 
2AB_MF3 d1 
EtOAc 14 18 -63 -9 -1 -4 -64 -71 -81 -57 59 48 
2AB_MF3  d1 
MeOH 8 16 -43 -33 -14 5 -75 -26 -40 -32 52 7 
2AB_MF3  d6 
EtOAc 10 14 -58 -30 14 9 -44 -37 -36 -34 102 102 
2AB_MF3 d6 
MeOH 19 -12 -72 -66 -6 -10 -71 -141 -11 10 102 103 
2AB_MF3 d9 
EtOAc 15 17 -47 -1 7 2 -26 -34 -37 -67 44 35 
2AB_MF3 d9 
MeOH -10 7 -96 -29 -31 -5 -121 -124 -98 -81 63 51 
H10 d1 EtOAc 5 19 -83 4 3 16 -28 -61 -18 -24 26 17 
H10 d1 MeOH 17 2 -23 -54 12 4 -93 -115 -102 -64 -28 -52 
H10 d6 EtOAc 10 34 -29 -3 -5 23 -56 -42 -57 -57 18 -8 
H10 d6 MeOH 9 -1 96 -44 -8 1 -96 -122 -110 -64 45 29 
H10 d9 EtOAc 16 36 -22 102 -2 20 -31 -70 -43 -66 31 21 
H10 d9 MeOH 2 -4 100 -34 -4 -4 -111 -99 -92 -69 -21 -67 
B02 d1 EtOAc 36 15 -16 101 0 3 -56 -33 -6 -5 26 22 
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B02 d1 MeOH 27 -8 -62 -344 -50 -16 -136 -106 -52 -45 -15 -30 
B02 d6 EtOAc 10 7 99 101 -23 6 -7 -20 -10 1 12 8 
B02 d6 MeOH 14 -4 -64 -334 -79 -74 -136 -156 -30 -34 -39 -19 
B02 d9 EtOAc 7 -1 -29 -305 -1 -55 -30 -129 -35 -26 4 -8 
B02 d9 MeOH 16 3 89 99 -35 -11 -155 -164 -37 -35 13 30 
C11 d1 EtOAc 31 19 -14 -215 0 6 -33 -23 1 -1 39 39 
C11 d1 MeOH 8 -3 89 -237 -21 -2 -159 -139 -48 -43 20 21 
C11 d6 EtOAc 6 14 9 -274 -19 -6 -25 -23 8 15 5 8 
C11 d6 MeOH 8 23 98 -355 -1 -7 -86 -147 -49 -49 99 99 
C11 d9 EtOAc 10 -5 -7 103 -1 1 -17 -28 -11 -3 13 33 
C11 d9 MeOH 0 13 71 -362 -44 -16 -156 -163 -24 -36 0 -7 
E02 d1 EtOAc 0 2 -39 -220 2 -1 -13 -52 -17 -1 32 32 
E02  d1 MeOH 11 -10 -56 -373 -10 -5 -144 -98 -56 -50 64 74 
E02  d6 EtOAc 10 -5 -30 102 -1 -1 -15 -22 -11 0 27 29 
E02  d6 MeOH 15 -3 -57 -368 -30 -62 -87 -164 -43 -32 45 -24 
E02  d9 EtOAc 14 -5 -33 -265 -2 2 -35 -26 -10 -2 25 25 
E02  d9 MeOH 15 -4 -37 -250 -28 -2 -145 -165 -43 -36 -19 -4 
F05 d1 MeOH 39 -11 -2 -383 -7 2 -44 -88 -56 -51 -20 -26 
F05 d1 EtOAc -2 28 36 103 3 -5 -146 -52 -17 -8 27 30 
F05 d6 EtOAc 1 5 101 -260 -2 8 -14 -27 6 1 18 23 
F05 d6 MeOH 0 -14 61 -428 -55 -24 -146 -175 -11 -12 61 65 
F05 d9 EtOAc 4 -1 -39 104 -3 -4 -40 -22 -4 5 30 30 
F05 d9 MeOH 18 -5 95 -375 -21 -9 -151 -172 -30 -32 53 43 
3FM1 d1 EtOAc 37 -19 -8 -194 -10 -3 -57 -49 -14 3 36 33 
3FM1 d1 MeOH 9 0 -62 65 -15 -22 -113 -161 -49 -42 99 99 
3FM1 d6 EtOAc 9 26 101 104 1 1 -45 -29 -5 -10 27 29 
3FM1 d6 MeOH 37 2 -45 -309 -6 -11 -134 -108 -44 -37 60 60 
3FM1 d9 EtOAc 30 -5 -22 -321 -9 -3 -67 -33 -15 0 35 37 
3FM1 d9 MeOH -6 4 37 -327 -18 -23 -186 -106 -57 -44 102 101 
3MA3 d1 EtOAc 39 -11 -4 -333 -8 10 -42 -23 11 10 44 41 
3MA3 d1 MeOH 33 -19 -57 -407 -6 -64 -140 -189 -34 -24 56 32 
3MA3 d6 EtOAc 25 4 -31 -204 8 -5 -23 -48 -6 6 45 35 
3MA3 d6 MeOH 8 -50 -57 60 -28 -34 -151 -160 -10 -7 102 102 
3MA3 d9 EtOAc 15 19 -31 -218 9 0 -5 -40 -30 -17 101 101 
3MA3 d9 MeOH 2 3 -64 -262 -75 -37 -161 95 22 1 102 102 
3FA1 d1 EtOAc 39 -6 -9 106 -8 10 -47 -10 20 22 23 33 
3FA1 d1 MeOH 11 -15 89 -262 24 12 -72 -19 4 -11 41 44 
3FA1 d6 EtOAc 5 24 -34 106 0 3 -14 -27 1 -5 22 40 
3FA1 d6 MeOH 12 0 -66 -380 -28 -25 -151 -98 -76 -71 85 72 
3FA1 d9 EtOAc 7 -6 101 -286 -11 3 -42 -9 6 2 27 42 
3FA1 d9 MeOH 14 -4 -54 101 -23 -22 -77 -136 -54 -52 101 101 
3MA5 d1 EtOAc 39 -1 -7 105 -12 -7 -37 -24 -7 15 34 42 
3MA5 d1 MeOH 12 0 -50 -348 4 -47 -117 -143 -71 -68 -6 -9 
3MA5 d6 EtOAc 9 5 -15 105 -7 3 -35 -39 -3 8 38 40 
3MA5 d6 MeOH 16 -2 -48 -385 -22 -40 -122 -181 -79 -79 94 96 
3MA5 d9 EtOAc 5 -5 -39 105 12 12 -17 -13 -3 -1 4 17 
3MA5 d9 MeOH 34 -10 -19 104 -6 7 -78 -52 -17 -22 62 63 
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3FA2 d1 EtOAc 30 -4 -10 106 -10 2 -39 -26 -7 3 31 28 
3FA2 d1 MeOH 26 -2 -48 102 -19 -12 -97 -98 -65 -59 12 -7 
3FA2 d6 EtOAc 36 4 -18 -310 -11 3 -36 -32 1 6 43 48 
3FA2 d6 MeOH 28 7 -37 102 -18 5 -99 -110 -39 -50 41 20 
3FA2 d9 EtOAc 20 22 102 105 -8 1 -28 -19 6 9 40 45 
3FA2 d9 MeOH 20 7 -35 103 -14 -8 -120 -111 -62 -51 43 28 
3MH2 d1 EtOAc 42 1 -13 -310 -8 6 -32 -17 11 21 37 24 
3MH2 d1 MeOH 7 10 -46 101 -24 8 -105 -73 -56 -38 -22 -1 
3MH2 d6 EtOAc 32 26 -25 -172 -5 2 -43 -58 -14 -7 17 27 
3MH2 d6 MeOH 12 -6 -27 -323 13 11 -50 -25 -8 -19 27 42 
3MH2 d9 EtOAc 32 24 -17 -286 -4 -4 -29 -49 -17 -35 43 43 
3MH2 d9 MeOH -4 8 -66 103 -31 15 -132 -67 -49 -56 43 36 
3FA1.1 d1 EtOAc 33 25 -13 -236 -13 -2 -46 -39 -19 -20 97 46 
3FA1.1 d1 
MeOH 26 -12 -32 -310 -3 4 -66 -155 -50 -41 73 50 
3FA1.1 d6 EtOAc 11 21 -30 -271 10 6 -14 -42 -23 1 33 21 
3FA1.1 d6 
MeOH 29 -3 97 100 4 1 -118 -138 -36 -33 29 32 
3FA1.1 d9 EtOAc -2 6 -39 106 2 4 -37 -24 -2 -9 29 15 
3FA1.1 d9 
MeOH 6 7 96 -283 0 12 -152 -141 -45 -34 101 101 
3MH1 d1 EtOAc 24 -6 -34 -264 1 -7 -66 -83 -30 -14 22 30 
3MH1 d1 MeOH -4 -3 -13 -330 22 18 -99 -23 -11 -36 5 15 
3MH1 d6 EtOAc 12 -2 102 -261 -6 -1 -50 -33 -8 -34 15 31 
3MH1 d6 MeOH 22 -15 100 -385 -29 -41 -81 -156 -32 -43 101 101 
3MH1 d9 EtOAc 11 18 -30 -259 5 -6 -31 -40 -33 -34 36 35 
3MH1 d9 MeOH 0 13 -78 -280 -28 -18 -147 -144 -29 -35 101 101 
3MH3 d1 EtOAc 5 -6 101 -281 17 5 -32 -31 -20 -25 14 22 
3MH3 d1 MeOH 40 -12 -18 -366 15 5 -122 -130 -33 -26 27 32 
3MH3 d6 EtOAc 6 13 -23 -242 -17 2 -53 -29 -59 -30 20 16 
3MH3 d6 MeOH 16 -8 -63 -351 -6 -7 -126 -103 -19 -23 45 26 
3MH3 d9 EtOAc 10 24 102 -239 12 -9 -26 -33 -61 -49 13 35 
3MH3 d9 MeOH 9 -10 83 -363 -9 -7 -142 -104 -32 -17 10 -5 
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Figure S1: fragmentation pattern of the pseudomolecular ion m/z 760.4677 in the MeOH crude extract of strain 2MH3-2 
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Figure S1: 1H NMR (400 MHz, CH3OH-d4,) spectrum of serrawettin W2  
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Figure S2: 13C NMR (400 MHz, CH3OH-d4,) spectrum of serrawettin W2 
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Figure S3: COSY spectrum of serrawettin W2 
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Figure S4: HSQC spectrum of serrawettin W2 
 
Appendix 
128 
 
Figure S5: HMBC spectrum of serrawettin W2 
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